data_1dkc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dkc _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.476 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 110.094 -0.335 . . . . 1.58 110.094 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.15 164.97 49.73 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.232 -1.147 . . . . 0.99 110.232 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.5 p -155.46 174.53 15.12 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.288 -1.125 . . . . 0.51 110.325 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.453 ' HB ' ' HA2' ' A' ' 8' ' ' GLY . 47.3 mt -128.62 125.32 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.148 -0.97 . . . . 1.36 110.36 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -51.94 9.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.73 110.746 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.39 61.8 4.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.368 -0.832 . . . . 1.45 110.709 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.35 61.74 0.17 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.14 -1.029 . . . . 0.51 110.747 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.453 ' HA2' ' HB ' ' A' ' 4' ' ' ILE . . . -99.2 156.56 19.99 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.419 -1.473 . . . . 0.33 109.419 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 tpt85 -108.9 131.86 54.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.991 -1.299 . . . . 0.59 110.797 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.9 p -142.19 173.52 11.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.15 -0.969 . . . . 0.35 110.945 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.82 99.16 3.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.591 -0.693 . . . . 0.5 110.45 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . . . -76.05 -11.06 59.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.472 -0.767 . . . . 1.17 110.793 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -93.51 -15.41 25.54 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.291 -0.881 . . . . 0.82 111.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.45 38.53 4.13 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.13 -0.981 . . . . 1.11 111.192 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' O ' ' HD3' ' A' ' 17' ' ' PRO . . . 84.46 78.69 1.12 Allowed Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.138 -1.185 . . . . 0.93 110.138 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 40.2 Cg_endo -67.18 110.1 1.91 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.803 1.423 . . . . 1.03 111.266 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 15' ' ' GLY . 42.5 Cg_endo -75.91 -78.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.58 1.305 . . . . 0.62 110.591 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.476 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 40.0 p90 -169.83 138.65 1.82 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.889 -1.132 . . . . 1.6 110.444 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 7.5 m -91.77 -178.38 5.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.899 -1.125 . . . . 0.24 109.937 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.13 -32.86 61.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.04 -1.037 . . . . 0.28 111.561 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -123.32 27.81 7.35 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.023 -1.048 . . . . 0.49 111.592 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.552 ' HB3' ' O ' ' A' ' 21' ' ' SER . 22.6 t 71.13 -4.14 1.87 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 112.702 0.63 . . . . 0.43 112.702 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 36.0 t80 -105.6 148.91 26.79 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.46 -1.4 . . . . 0.79 110.77 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.585 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 25.9 t -152.4 117.0 5.04 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.382 -0.599 . . . . 0.31 109.382 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.654 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.0 t80 -102.2 109.92 21.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.85 110.196 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.526 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.8 tt0 -125.57 149.07 48.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.4 -0.812 . . . . 0.82 110.254 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.28 164.71 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.478 -0.764 . . . . 1.26 110.722 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.56 91.43 8.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.43 110.7 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.29 -69.73 0.02 OUTLIER Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.556 -1.418 . . . . 0.9 109.556 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -111.09 5.33 20.08 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.551 -0.97 . . . . 1.4 111.191 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.59 58.0 0.53 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.283 -0.885 . . . . 0.99 109.515 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.437 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 45.7 p90 -137.56 136.42 37.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.428 -0.795 . . . . 1.13 111.193 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -129.63 151.88 19.41 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.145 -1.182 . . . . 0.31 110.145 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.654 HG23 ' HB3' ' A' ' 25' ' ' PHE . 34.1 m -117.98 136.97 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.455 -1.027 . . . . 1.13 109.462 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 36.0 m -88.32 152.8 21.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.714 -1.241 . . . . 0.24 111.602 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -151.69 -173.03 4.39 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.46 -0.791 . . . . 0.5 111.024 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 21' ' ' SER . 7.6 m120 -76.66 -167.3 0.8 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.261 0.553 . . . . 0.7 110.714 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.469 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.813 . . . . 0.92 110.098 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.443 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 120.94 0.4 . . . . 1.68 110.004 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.29 167.55 40.26 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 109.658 -1.377 . . . . 0.88 109.658 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 10.2 p -160.7 153.75 21.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.251 -1.146 . . . . 0.7 110.434 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 32.1 mm -96.07 131.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.997 -1.064 . . . . 1.5 109.468 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -72.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.81 111.583 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.48 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 69.0 m-80 -125.28 101.5 7.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.872 -1.143 . . . . 0.73 110.5 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.91 62.33 0.49 Allowed Glycine 0 N--CA 1.499 2.842 0 N-CA-C 110.14 -1.184 . . . . 0.54 110.14 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -116.78 -157.82 11.04 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.707 -1.357 . . . . 0.57 109.707 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -139.2 132.76 30.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.348 -1.089 . . . . 0.75 110.431 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -128.37 165.71 20.06 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.935 -1.103 . . . . 0.33 111.508 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -115.72 178.1 4.43 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 0.74 110.574 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 -8.99 59.72 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.213 -0.929 . . . . 1.03 111.575 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 t -121.1 -171.09 2.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.927 -1.108 . . . . 1.11 110.603 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.86 144.59 27.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.872 . . . . 1.21 110.493 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 164.55 -154.69 25.66 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.727 -1.349 . . . . 0.69 109.727 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.717 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.29 -32.92 61.11 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 O-C-N 123.801 1.422 . . . . 0.55 113.789 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.717 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.5 Cg_endo -78.43 66.03 8.5 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-N 118.868 0.631 . . . . 0.71 111.072 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.443 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 42.6 p90 -109.29 161.83 14.89 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.049 -1.032 . . . . 0.5 110.919 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 32.6 m -88.67 173.5 8.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.177 -0.952 . . . . 0.32 110.849 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 11.0 t -89.41 -48.64 7.2 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.728 -1.233 . . . . 0.41 113.049 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 37' ' ' ASN . 74.4 m -98.93 -73.49 0.62 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.103 -0.998 . . . . 0.87 110.695 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -174.33 23.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.39 111.702 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 12.6 t80 -119.24 139.36 52.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.675 -1.266 . . . . 0.83 110.772 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.9 t -153.03 108.62 3.28 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.744 -0.662 . . . . 0.26 109.315 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.49 ' HB3' HG21 ' A' ' 34' ' ' VAL . 4.9 t80 -89.11 79.8 7.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.77 109.445 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.557 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 5.0 tt0 -109.43 154.17 22.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.776 -0.577 . . . . 0.52 110.474 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.01 168.99 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.381 -0.825 . . . . 1.19 110.592 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.91 128.07 35.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.227 -0.92 . . . . 0.77 110.75 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.92 -53.4 0.49 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.204 -1.158 . . . . 0.76 110.204 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.444 ' O ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -127.82 7.45 6.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.358 -1.084 . . . . 2.68 111.949 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 11.3 t 59.57 52.19 5.88 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.249 -0.907 . . . . 0.52 110.011 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -138.78 139.7 38.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.669 0.747 . . . . 1.35 110.846 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.557 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -162.5 178.45 38.27 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.635 -1.386 . . . . 0.31 109.635 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 16.1 m -114.58 136.02 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.332 -1.099 . . . . 1.18 110.822 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.9 m -88.6 158.66 18.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.3 111.215 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -151.6 166.18 32.01 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.229 -0.896 . . . . 0.5 110.109 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.607 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 24.5 m-20 -83.38 -61.22 1.9 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.122 -1.066 . . . . 0.78 108.122 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.306 0 CA-C-N 116.313 -0.403 . . . . 0.88 109.989 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.492 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.823 0.344 . . . . 1.27 110.428 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.55 145.15 19.39 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.803 -1.319 . . . . 0.76 109.803 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 p -141.0 159.72 41.61 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.255 -1.144 . . . . 0.69 111.086 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 7' ' ' GLY . 51.6 mt -128.3 106.01 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.414 -0.804 . . . . 1.41 109.687 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.473 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 3.2 mptt -54.63 -32.54 59.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.523 -0.736 . . . . 0.89 111.6 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -97.41 8.58 44.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.103 -0.998 . . . . 0.97 112.25 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 167.02 58.76 0.03 OUTLIER Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.11 -1.519 . . . . 0.58 111.591 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.8 -178.04 47.86 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 109.027 -1.629 . . . . 0.42 109.027 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -135.44 141.01 45.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.856 -1.379 . . . . 0.97 110.769 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.74 -167.15 2.74 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.253 -0.904 . . . . 0.47 111.117 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -151.09 -164.69 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.788 -0.57 . . . . 1.23 110.676 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.52 60.7 4.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 1.16 110.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 m -147.59 120.59 8.8 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.233 -0.917 . . . . 1.79 110.373 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.47 72.57 4.02 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.822 -1.174 . . . . 1.74 110.47 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . -140.64 -137.77 3.49 Favored Glycine 0 N--CA 1.499 2.875 0 C-N-CA 120.192 -1.004 . . . . 1.87 110.728 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.7 Cg_endo -65.44 -33.1 48.26 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 O-C-N 123.814 1.428 . . . . 1.74 114.602 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.666 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 48.5 Cg_endo -74.07 62.79 5.05 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 CA-C-N 118.96 0.664 . . . . 1.6 111.155 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 6.8 p90 -97.31 160.03 14.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.077 -1.015 . . . . 0.85 110.324 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 90.8 m -80.7 175.86 10.31 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.043 -1.036 . . . . 0.4 111.336 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' HD2' ' A' ' 5' ' ' LYS . 1.5 t -87.44 -31.38 20.06 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.24 -0.912 . . . . 0.53 112.697 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.473 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -112.9 -75.46 0.6 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.154 -0.967 . . . . 0.43 109.95 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -172.38 14.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.345 -0.847 . . . . 1.19 112.706 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 40.3 t80 -132.01 152.0 51.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.312 -1.493 . . . . 0.97 111.981 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 2.0 t -153.57 115.74 4.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 120.92 0.391 . . . . 0.26 110.239 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' HG21 ' A' ' 34' ' ' VAL . 3.2 t80 -93.83 98.33 11.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.302 -0.874 . . . . 0.75 109.496 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.665 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.6 tt0 -111.34 155.87 22.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.88 110.442 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -125.34 168.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.414 -0.804 . . . . 1.25 110.569 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.73 24.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 1.1 111.846 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.36 0.89 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.625 -1.79 . . . . 0.54 108.625 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 31' ' ' SER . 1.7 tt0 -151.79 -80.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.892 -0.769 . . . . 1.56 110.082 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.9 OUTLIER 174.33 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.957 -0.757 . . . . 1.17 108.957 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -138.14 126.97 23.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.005 -1.06 . . . . 0.68 110.972 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 26' ' ' GLN . . . -141.18 163.45 26.7 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.191 -1.004 . . . . 0.42 110.635 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.7 HG21 ' HB3' ' A' ' 25' ' ' PHE . 15.3 m -109.38 134.89 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.61 -0.935 . . . . 1.07 109.309 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 82.4 m -88.39 155.03 19.92 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.435 1.112 . . . . 0.35 112.192 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.415 ' CE ' ' HA ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -151.21 -166.28 2.49 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.042 -0.981 . . . . 0.5 109.834 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 21' ' ' SER . 7.3 m120 -60.6 -76.81 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.38 -0.825 . . . . 0.75 111.348 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.187 -0.946 . . . . 1.61 111.101 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.479 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.116 0.484 . . . . 1.33 109.925 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.32 163.54 38.68 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.943 -1.263 . . . . 0.67 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 4.7 p -153.7 168.43 26.28 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.56 110.202 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.505 ' HB ' ' HA3' ' A' ' 8' ' ' GLY . 4.7 mt -128.49 87.69 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.099 -1.001 . . . . 1.47 110.267 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -68.42 -17.77 64.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.556 -0.715 . . . . 1.24 111.642 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -97.42 51.37 1.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.198 -0.939 . . . . 0.93 111.083 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.21 55.25 1.86 Allowed Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.072 -1.018 . . . . 0.52 110.671 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -70.03 -170.4 8.27 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.554 -1.418 . . . . 0.42 109.554 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.478 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -126.38 136.0 52.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.077 -1.249 . . . . 0.76 110.919 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -149.43 173.9 13.06 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.718 0.77 . . . . 0.28 111.171 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 20.9 t-20 -155.62 143.44 19.76 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.436 -0.579 . . . . 0.59 109.436 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.33 -20.71 66.16 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.409 -0.807 . . . . 1.13 111.811 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -122.2 45.96 2.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.84 -1.163 . . . . 1.47 111.169 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 11' ' ' ASN . . . -121.16 -71.38 0.74 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.003 . . . . 1.02 110.722 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.69 -75.49 0.3 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.022 -1.085 . . . . 0.59 110.71 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.725 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.8 Cg_endo -61.58 -37.05 72.75 Favored 'Trans proline' 0 CA--C 1.552 1.408 0 O-C-N 123.708 1.373 . . . . 0.6 114.315 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.725 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 53.6 Cg_endo -73.94 65.82 5.03 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.168 0.738 . . . . 0.46 110.299 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.479 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 28.2 p90 -83.4 160.13 21.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.3 -0.875 . . . . 0.46 110.629 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 81.1 m -90.86 173.23 8.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.224 -0.922 . . . . 0.28 111.402 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 6.6 t -78.47 -54.84 5.73 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.163 -0.961 . . . . 0.45 113.023 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 70.0 m -101.1 -73.36 0.65 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 1.14 110.827 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -168.9 18.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.177 -0.952 . . . . 0.56 112.386 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.8 t80 -117.22 144.17 45.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.524 -1.36 . . . . 0.97 110.715 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.626 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 17.6 t -152.54 108.06 3.3 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.521 -0.548 . . . . 0.31 109.521 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.2 t80 -95.71 90.11 5.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.101 -1.0 . . . . 1.08 110.13 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.679 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.9 tm0? -117.98 144.83 45.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.92 110.937 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 163.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.486 -0.759 . . . . 1.18 110.737 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.46 0.53 57.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.5 -0.75 . . . . 1.12 111.757 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.85 45.36 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.642 -1.383 . . . . 0.69 109.642 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.96 5.59 9.32 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -1.061 . . . . 1.33 111.147 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.81 48.71 3.12 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.477 -0.764 . . . . 1.0 110.764 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -138.88 144.17 39.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.8 110.182 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.679 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -144.21 168.63 26.55 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.431 -1.366 . . . . 0.35 111.757 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 26.9 m -123.32 134.66 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.862 -0.787 . . . . 1.16 110.201 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 77.3 m -88.78 158.21 18.23 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.29 111.894 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -151.54 -162.38 1.52 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.333 -0.849 . . . . 0.64 110.187 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.466 ' H ' ' HD3' ' A' ' 36' ' ' LYS . 7.6 m120 -69.34 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.568 -0.707 . . . . 0.62 110.48 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.153 -0.967 . . . . 1.08 110.408 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.857 0.361 . . . . 3.1 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.89 85.54 0.59 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.243 -1.143 . . . . 1.04 110.243 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 p -152.19 165.0 36.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.167 -1.196 . . . . 0.43 110.48 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.3 mt -120.59 122.24 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 1.42 109.433 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -52.33 -43.27 64.49 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.528 -0.732 . . . . 0.6 111.573 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -130.42 99.96 5.19 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.514 -0.741 . . . . 1.59 110.604 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.84 68.21 0.78 Allowed Glycine 0 N--CA 1.499 2.833 0 N-CA-C 109.928 -1.269 . . . . 0.52 109.928 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.35 172.72 14.77 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.551 -1.42 . . . . 0.35 109.551 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.61 132.7 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.139 -1.212 . . . . 1.09 110.719 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p -150.34 -171.14 3.84 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.124 -0.985 . . . . 0.28 111.268 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.19 138.48 11.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.67 109.593 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 60.55 6.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.333 -0.855 . . . . 1.23 110.276 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -136.81 -162.96 1.34 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.427 -0.796 . . . . 0.85 110.663 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.56 101.53 13.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.165 -0.959 . . . . 1.08 110.428 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.9 0.21 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.193 -1.163 . . . . 0.63 110.193 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.91 120.14 7.21 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.914 1.481 . . . . 0.61 111.046 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.16 -164.52 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.945 1.497 . . . . 0.64 110.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -58.05 153.09 15.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.286 -0.884 . . . . 1.45 111.051 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 m -72.51 -171.87 0.87 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.26 -0.9 . . . . 0.26 110.7 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -70.77 -39.31 73.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.656 -1.278 . . . . 0.27 112.436 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 10.1 m -101.11 -75.0 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.36 109.333 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.627 ' HB3' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -175.64 18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.726 -0.609 . . . . 0.35 111.92 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 23.3 t80 -137.93 154.19 49.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.504 -1.372 . . . . 0.67 111.791 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.512 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -151.33 120.62 6.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.407 -0.96 . . . . 0.32 108.407 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t80 -113.44 114.8 27.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.8 110.981 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.571 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 41.4 tt0 -126.59 147.64 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 1.18 111.174 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.18 169.7 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.724 . . . . 1.28 110.892 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.05 155.32 26.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.486 -0.759 . . . . 1.48 111.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.54 -47.33 1.03 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.472 -1.851 . . . . 1.17 108.472 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.37 -2.94 1.76 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.761 -0.846 . . . . 1.97 111.9 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t 64.96 51.98 1.64 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.012 -1.055 . . . . 1.11 110.15 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -126.06 134.53 51.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.339 -0.851 . . . . 1.11 110.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 26' ' ' GLN . . . -121.61 149.5 17.21 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.007 -1.237 . . . . 0.54 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.503 ' CG2' ' HB3' ' A' ' 25' ' ' PHE . 27.4 m -117.29 139.13 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.274 -1.133 . . . . 1.13 110.007 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 75.2 m -88.15 156.64 19.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.889 -1.132 . . . . 0.24 111.1 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 23' ' ' TYR . 8.8 mmtt -148.92 179.64 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.862 -0.608 . . . . 0.65 110.458 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -55.73 -63.63 1.11 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.479 -0.763 . . . . 0.77 110.369 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.627 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.54 110.549 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.506 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.004 0.431 . . . . 1.6 110.445 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.39 119.78 13.64 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.518 -1.433 . . . . 1.26 109.518 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 p -107.25 143.49 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.402 -1.058 . . . . 0.78 110.45 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.1 mm -107.41 130.95 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.36 -0.838 . . . . 1.18 109.556 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -71.62 -39.16 70.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.796 . . . . 0.84 111.671 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.7 133.24 15.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.359 -0.838 . . . . 0.79 111.517 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.53 34.24 54.43 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.931 -0.868 . . . . 0.59 110.931 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.41 -153.16 24.41 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.274 -1.13 . . . . 0.45 110.274 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -140.68 121.64 14.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -1.05 . . . . 0.81 109.989 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 11.4 p -151.51 -168.55 3.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.36 111.31 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -140.86 157.6 45.15 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.493 -0.754 . . . . 0.52 109.63 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.69 66.4 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.357 -0.839 . . . . 1.12 109.765 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 p -101.78 44.57 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 1.52 109.692 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.625 ' HB2' ' HG2' ' A' ' 17' ' ' PRO . . . -83.47 128.49 34.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.332 -0.855 . . . . 1.27 110.916 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.18 -84.34 1.22 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.168 -1.573 . . . . 0.69 109.168 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.73 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.96 -34.2 48.74 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 O-C-N 123.79 1.416 . . . . 0.85 113.674 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.73 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 50.6 Cg_endo -83.76 64.24 7.31 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 CA-C-N 118.912 0.647 . . . . 0.6 110.511 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.506 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 22.5 p90 -91.52 163.99 13.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.241 -0.912 . . . . 1.35 110.994 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 85.9 m -90.28 170.86 9.91 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.023 -1.048 . . . . 0.28 111.292 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 t -92.08 -39.08 11.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.287 -0.883 . . . . 0.4 111.466 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 37.3 m -84.75 -0.14 52.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 1.33 110.463 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 21' ' ' SER . 5.2 t 83.68 -3.17 1.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.002 -0.436 . . . . 1.09 111.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' ' 38' ' ' ARG . 46.8 t80 -101.33 151.33 22.03 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.422 -1.424 . . . . 0.96 110.419 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.26 118.5 5.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.794 -0.566 . . . . 0.29 110.803 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.454 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.3 t80 -104.72 94.71 5.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.328 -0.857 . . . . 0.87 110.227 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.658 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.4 tm0? -120.05 144.94 47.3 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.366 -0.834 . . . . 0.52 110.454 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -114.26 170.06 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.408 -0.807 . . . . 1.56 110.615 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.65 19.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 1.07 110.705 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.64 -43.68 1.43 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.133 -1.587 . . . . 0.6 109.133 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.92 -3.79 2.5 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.859 . . . . 0.79 111.539 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.9 50.94 3.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.149 -0.97 . . . . 0.42 110.31 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -128.33 131.96 48.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.331 -0.856 . . . . 0.92 110.269 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.658 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -140.94 172.73 23.55 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.903 -1.141 . . . . 0.35 111.194 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 25' ' ' PHE . 34.6 m -129.57 148.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.586 -0.95 . . . . 1.08 110.523 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 59.2 m -89.23 153.84 20.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.742 -1.224 . . . . 0.28 111.813 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.97 -171.78 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.344 -0.843 . . . . 0.59 110.068 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.23 -80.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.725 -0.61 . . . . 0.85 111.24 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.569 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 2.39 110.713 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.466 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 109.911 -0.403 . . . . 1.71 109.911 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.69 154.88 26.24 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.282 -1.527 . . . . 0.85 109.282 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.09 150.07 21.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.19 -1.182 . . . . 0.65 110.634 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.402 HG23 ' CA ' ' A' ' 8' ' ' GLY . 3.0 mt -108.48 122.44 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 1.35 110.021 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.52 -48.78 66.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.526 -0.734 . . . . 1.17 110.989 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -143.62 128.28 18.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.053 -1.03 . . . . 0.84 111.185 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.94 24.46 27.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.629 -0.988 . . . . 0.57 110.629 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -84.83 -153.06 18.47 Favored Glycine 0 N--CA 1.498 2.795 0 O-C-N 121.059 -1.26 . . . . 0.45 110.304 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.496 ' NH2' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -141.19 129.8 22.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.7 110.468 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 p -151.7 -178.44 6.72 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.114 -0.991 . . . . 0.41 111.126 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.428 ' HA ' ' CG ' ' A' ' 26' ' ' GLN . 2.6 p-10 -166.41 -169.91 1.52 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.691 -0.63 . . . . 0.61 110.656 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.04 60.45 5.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.177 -0.952 . . . . 1.33 110.406 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.3 m -144.91 133.66 22.28 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.036 -1.04 . . . . 1.08 110.228 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.56 108.83 20.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.296 -0.877 . . . . 1.51 110.663 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.436 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 170.61 -128.01 1.56 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.032 -1.227 . . . . 1.14 110.032 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 38.1 Cg_endo -65.85 -31.56 47.65 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 O-C-N 123.716 1.377 . . . . 1.0 114.35 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.655 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 55.2 Cg_endo -77.69 59.27 6.74 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 118.97 0.668 . . . . 1.08 111.793 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.466 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 52.9 p90 -108.25 146.6 32.61 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 0.69 110.487 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 74.1 m -90.32 170.56 10.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.36 110.452 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.54 -47.35 7.46 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.036 -1.04 . . . . 0.48 112.554 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.641 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -87.95 10.01 20.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.132 -0.98 . . . . 0.74 112.256 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.641 ' HB3' ' O ' ' A' ' 21' ' ' SER . 23.2 t 84.27 -5.04 1.06 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.885 -0.509 . . . . 0.68 112.289 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.654 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.1 t80 -96.04 146.01 24.98 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.069 -1.644 . . . . 0.96 110.743 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -151.04 112.14 4.33 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.085 0.469 . . . . 0.3 110.213 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.596 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.5 t80 -99.61 86.36 3.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.427 -0.796 . . . . 0.72 110.345 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.562 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.18 149.55 41.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.464 -0.773 . . . . 0.51 110.115 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.441 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -109.11 165.42 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.233 -0.917 . . . . 1.18 111.009 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.1 35.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.512 -0.743 . . . . 1.23 110.976 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.47 -55.37 0.49 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.046 -1.622 . . . . 0.68 109.046 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.74 0.21 9.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.678 -0.895 . . . . 1.68 111.398 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.43 54.45 1.96 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.149 -0.969 . . . . 0.6 110.063 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -139.2 138.61 37.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.431 -0.793 . . . . 0.74 110.628 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 26' ' ' GLN . . . -159.82 -166.17 18.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.124 -1.036 . . . . 0.27 110.982 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 25' ' ' PHE . 11.6 m -132.73 143.89 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.673 -0.898 . . . . 1.1 110.268 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 79.3 m -88.67 156.81 18.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.753 -1.217 . . . . 0.34 110.817 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.654 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -151.12 -167.14 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 1.18 111.174 -179.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 21' ' ' SER . 10.4 m120 -68.4 -89.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.701 -0.624 . . . . 0.98 111.402 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.591 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 2.3 tpm_? . . . . . 0 N--CA 1.486 1.359 0 O-C-N 120.439 -1.413 . . . . 0.69 111.666 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 120.942 0.401 . . . . 3.79 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.08 115.42 6.47 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.875 -1.29 . . . . 2.62 109.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.462 ' HB2' ' CA ' ' A' ' 20' ' ' CYS . 19.1 p -126.27 165.99 17.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.42 -1.047 . . . . 1.25 110.351 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 4' ' ' ILE . 41.7 mm -106.63 123.97 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.377 -0.827 . . . . 1.31 110.326 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -55.12 -44.99 75.51 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.345 -0.847 . . . . 0.57 110.57 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -150.44 127.28 11.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.52 110.855 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.83 32.5 7.96 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.452 -1.059 . . . . 0.61 110.452 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -86.92 -156.42 29.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.44 -1.464 . . . . 0.47 109.44 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 122.92 18.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 1.77 110.339 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.0 p -151.08 176.15 11.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.109 -0.995 . . . . 0.41 111.53 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.82 172.35 7.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.889 -0.507 . . . . 0.54 110.448 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.84 83.54 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.501 -0.749 . . . . 1.05 111.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.49 81.97 7.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.174 -0.954 . . . . 1.72 109.64 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -129.79 -70.92 0.62 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 1.21 111.025 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.0 -111.08 4.08 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.988 -1.245 . . . . 0.92 109.988 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.714 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.9 Cg_endo -65.02 -33.41 51.14 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 O-C-N 123.696 1.366 . . . . 1.29 114.107 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.714 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.0 Cg_endo -76.51 76.28 4.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 118.889 0.639 . . . . 0.92 110.578 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -89.59 173.69 8.17 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.201 -0.937 . . . . 1.14 110.914 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 88.8 m -76.74 -178.66 4.92 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.927 -1.108 . . . . 0.41 110.829 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.462 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 t -89.23 -36.85 15.39 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.522 -1.361 . . . . 0.61 112.942 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 28.2 t -109.9 -75.39 0.63 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.984 -1.072 . . . . 0.56 110.526 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.427 ' OG ' ' NH2' ' A' ' 38' ' ' ARG . 29.8 t -170.46 25.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.7 112.154 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.555 ' HD2' ' CB ' ' A' ' 36' ' ' LYS . 3.3 t80 -135.4 150.29 49.85 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.348 -1.47 . . . . 0.7 112.08 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.9 t -150.34 106.15 3.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.799 -0.815 . . . . 0.36 108.799 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.631 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.4 t80 -91.68 90.59 7.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.298 -0.876 . . . . 0.73 110.344 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.622 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.69 147.74 44.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 0.65 110.16 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.77 164.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.24 -0.912 . . . . 1.27 111.103 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.5 143.78 28.33 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.493 -0.754 . . . . 1.3 111.279 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.95 -52.54 0.7 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.693 -1.763 . . . . 0.76 108.693 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.507 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 3.5 tt0 -131.57 -3.27 3.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.668 -0.901 . . . . 2.31 111.579 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER 70.61 60.46 0.21 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.318 -0.864 . . . . 0.53 110.189 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 32.2 p90 -144.55 146.12 32.19 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.82 . . . . 1.61 110.936 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' A' ' 26' ' ' GLN . . . -167.16 -157.36 10.52 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 120.252 -0.975 . . . . 0.34 110.712 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 25' ' ' PHE . 33.4 m -141.98 145.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.518 -0.99 . . . . 1.1 110.901 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 98.2 m -88.99 158.67 17.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.897 -1.127 . . . . 0.34 110.85 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -151.83 179.2 8.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.534 -0.757 . . . . 1.1 110.471 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.573 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 4.5 m120 -63.02 -61.71 2.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.365 -0.834 . . . . 0.54 110.168 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.427 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 O-C-N 121.656 -0.653 . . . . 0.69 110.374 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.491 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.158 0.504 . . . . 1.6 109.936 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.33 163.22 38.92 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.736 -1.346 . . . . 0.55 109.736 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p -162.85 175.21 11.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -1.06 . . . . 0.37 110.721 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.36 120.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.239 -0.913 . . . . 1.14 110.435 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -29.5 70.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.527 -0.733 . . . . 0.72 111.318 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.51 121.86 10.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.093 -1.004 . . . . 0.73 111.082 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 25.04 37.33 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.386 -0.911 . . . . 0.37 110.875 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -73.62 -160.67 6.5 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.838 -1.305 . . . . 0.36 109.838 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -137.87 124.21 20.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.292 . . . . 0.64 110.622 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.9 p -150.55 -180.0 7.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.227 -0.92 . . . . 0.31 111.183 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -160.21 -169.91 2.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.547 . . . . 0.77 110.652 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.07 56.86 1.04 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.326 -0.859 . . . . 1.32 110.835 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.3 t -149.1 132.52 16.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.198 -0.939 . . . . 1.55 110.659 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.89 89.69 4.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.397 -0.814 . . . . 2.11 110.735 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.51 -119.99 0.51 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.323 -1.511 . . . . 1.01 109.323 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.726 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 36.4 Cg_endo -63.6 -33.15 68.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.795 1.418 . . . . 0.79 113.217 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.726 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 56.0 Cg_endo -82.14 58.58 6.7 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 118.946 0.659 . . . . 0.78 110.439 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.491 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 47.8 p90 -96.58 148.55 22.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.068 -1.02 . . . . 0.62 110.155 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 84.4 m -87.05 178.37 6.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.28 110.894 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.62 -43.18 10.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.075 -1.016 . . . . 0.33 112.793 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.545 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -107.46 -73.23 0.69 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.078 -1.014 . . . . 1.74 110.632 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HD3' ' A' ' 38' ' ' ARG . 1.2 m -171.17 15.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.356 -0.84 . . . . 0.41 112.453 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.736 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 18.1 t80 -119.15 147.64 43.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.358 -1.464 . . . . 1.01 110.654 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 34.9 t -151.86 106.17 3.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.99 -0.444 . . . . 0.27 109.933 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.4 t80 -97.9 91.12 5.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 1.05 110.422 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.589 ' HA ' ' CA ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.85 149.12 40.55 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 1.4 110.577 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.417 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -119.86 162.18 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.393 -0.817 . . . . 1.23 110.507 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.28 154.65 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.93 111.107 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.4 -43.95 1.3 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.269 -1.532 . . . . 0.81 109.269 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.562 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -143.47 5.2 1.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.634 -0.921 . . . . 1.9 112.487 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 7.1 t 61.08 51.1 4.6 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.147 -0.971 . . . . 0.65 109.684 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 27.3 p90 -132.03 137.74 47.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 1.24 110.649 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 26' ' ' GLN . . . -156.18 -167.68 17.91 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.584 -1.006 . . . . 0.28 110.584 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 34.0 m -135.27 138.5 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.839 -0.801 . . . . 1.03 110.894 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 71.2 m -88.81 159.08 17.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.958 -1.089 . . . . 0.24 111.863 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.567 ' CB ' ' HB3' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -151.39 -167.07 2.69 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.315 -0.857 . . . . 0.43 110.458 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.545 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 14.5 m120 -75.51 -76.01 0.16 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.364 -0.835 . . . . 0.48 111.447 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.736 ' HB2' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.556 0 C-N-CA 122.436 0.294 . . . . 0.57 110.536 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' PRO . . . . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 120.949 0.404 . . . . 1.06 110.133 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.32 149.67 47.47 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.439 -1.465 . . . . 0.55 109.439 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.8 p -70.02 138.81 52.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.196 -1.179 . . . . 0.43 110.602 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.424 HG23 ' CA ' ' A' ' 8' ' ' GLY . 2.2 mt -106.96 126.86 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 1.22 110.401 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -89.49 -18.48 26.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.621 -0.675 . . . . 2.02 111.017 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 t30 -149.81 113.61 5.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.55 110.448 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.2 33.14 15.16 Favored Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.187 -0.946 . . . . 0.41 110.845 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -75.12 -167.58 20.94 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.081 -1.608 . . . . 0.3 109.081 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.595 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -140.34 114.06 8.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.071 -1.252 . . . . 0.85 110.784 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 p -135.56 176.67 8.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.195 -0.941 . . . . 0.34 111.222 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.571 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 28.4 t-20 -161.19 -141.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.196 -0.668 . . . . 0.87 109.196 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.81 25.51 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.907 -1.12 . . . . 1.15 110.158 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -126.83 -166.52 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.393 -0.817 . . . . 1.06 110.024 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.62 7.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.245 -0.91 . . . . 1.14 110.817 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.96 172.39 39.2 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.955 -1.258 . . . . 0.43 109.955 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.3 Cg_endo -61.78 -33.4 85.28 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 O-C-N 123.511 1.269 . . . . 0.47 113.302 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.7 Cg_endo -96.49 40.62 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 120.943 1.096 . . . . 0.38 109.88 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -53.58 164.29 0.54 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.023 0.916 . . . . 0.61 112.185 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 3.9 m -73.36 160.42 31.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.389 -0.819 . . . . 0.24 110.155 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 6.9 t -90.45 -44.19 9.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.074 -1.016 . . . . 0.29 112.127 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 p -99.28 -72.27 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.301 -0.874 . . . . 0.37 109.965 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -173.37 13.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 112.895 0.702 . . . . 0.37 112.895 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 15.1 t80 -103.64 141.51 35.91 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.01 -1.681 . . . . 0.86 110.856 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.546 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.5 t -152.2 106.99 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 116.008 -0.542 . . . . 0.24 109.981 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.6 t80 -92.47 88.37 6.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.075 -1.016 . . . . 0.84 110.36 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.604 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -113.61 149.52 34.44 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.55 110.91 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.461 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.86 162.82 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.464 -0.772 . . . . 1.18 111.029 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.18 14.69 11.9 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.505 -0.747 . . . . 0.91 112.066 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 -53.54 4.14 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.826 -1.309 . . . . 0.75 109.826 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.24 7.51 10.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.563 -0.963 . . . . 2.9 111.707 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t 65.99 54.5 1.0 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.279 -0.888 . . . . 1.1 109.769 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -148.51 149.08 31.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -0.851 . . . . 0.92 110.675 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -148.78 168.95 29.31 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.174 -1.013 . . . . 0.33 110.988 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 18.3 m -128.71 133.31 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.54 -0.976 . . . . 1.07 110.126 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 75.7 m -87.21 159.53 18.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.2 111.739 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -150.64 174.71 12.69 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.349 -0.842 . . . . 0.6 110.852 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -66.1 -64.54 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.67 109.827 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.854 -0.529 . . . . 0.71 110.245 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.476 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 110.094 -0.335 . . . . 1.58 110.094 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.15 164.97 49.73 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.232 -1.147 . . . . 0.99 110.232 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.5 p -155.46 174.53 15.12 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.288 -1.125 . . . . 0.51 110.325 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.453 ' HB ' ' HA2' ' A' ' 8' ' ' GLY . 47.3 mt -128.62 125.32 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.148 -0.97 . . . . 1.36 110.36 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -51.94 9.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.73 110.746 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.39 61.8 4.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.368 -0.832 . . . . 1.45 110.709 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.35 61.74 0.17 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.14 -1.029 . . . . 0.51 110.747 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.453 ' HA2' ' HB ' ' A' ' 4' ' ' ILE . . . -99.2 156.56 19.99 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.419 -1.473 . . . . 0.33 109.419 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 tpt85 -108.9 131.86 54.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.991 -1.299 . . . . 0.59 110.797 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.9 p -142.19 173.52 11.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.15 -0.969 . . . . 0.35 110.945 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.82 99.16 3.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.591 -0.693 . . . . 0.5 110.45 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . . . -76.05 -11.06 59.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.472 -0.767 . . . . 1.17 110.793 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -93.51 -15.41 25.54 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.291 -0.881 . . . . 0.82 111.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.45 38.53 4.13 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.13 -0.981 . . . . 1.11 111.192 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' O ' ' HD3' ' A' ' 17' ' ' PRO . . . 84.46 78.69 1.12 Allowed Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.138 -1.185 . . . . 0.93 110.138 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 40.2 Cg_endo -67.18 110.1 1.91 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.803 1.423 . . . . 1.03 111.266 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 15' ' ' GLY . 42.5 Cg_endo -75.91 -78.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.58 1.305 . . . . 0.62 110.591 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.476 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 40.0 p90 -169.83 138.65 1.82 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.889 -1.132 . . . . 1.6 110.444 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 7.5 m -91.77 -178.38 5.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.899 -1.125 . . . . 0.24 109.937 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.13 -32.86 61.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.04 -1.037 . . . . 0.28 111.561 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -123.32 27.81 7.35 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.023 -1.048 . . . . 0.49 111.592 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.552 ' HB3' ' O ' ' A' ' 21' ' ' SER . 22.6 t 71.13 -4.14 1.87 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 112.702 0.63 . . . . 0.43 112.702 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 36.0 t80 -105.6 148.91 26.79 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.46 -1.4 . . . . 0.79 110.77 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.585 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 25.9 t -152.4 117.0 5.04 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.382 -0.599 . . . . 0.31 109.382 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.654 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.0 t80 -102.2 109.92 21.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.85 110.196 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.526 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.8 tt0 -125.57 149.07 48.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.4 -0.812 . . . . 0.82 110.254 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.28 164.71 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.478 -0.764 . . . . 1.26 110.722 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.56 91.43 8.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.43 110.7 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.29 -69.73 0.02 OUTLIER Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.556 -1.418 . . . . 0.9 109.556 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -111.09 5.33 20.08 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.551 -0.97 . . . . 1.4 111.191 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.59 58.0 0.53 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.283 -0.885 . . . . 0.99 109.515 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.437 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 45.7 p90 -137.56 136.42 37.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.428 -0.795 . . . . 1.13 111.193 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -129.63 151.88 19.41 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.145 -1.182 . . . . 0.31 110.145 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.654 HG23 ' HB3' ' A' ' 25' ' ' PHE . 34.1 m -117.98 136.97 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.455 -1.027 . . . . 1.13 109.462 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 36.0 m -88.32 152.8 21.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.714 -1.241 . . . . 0.24 111.602 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -151.69 -173.03 4.39 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.46 -0.791 . . . . 0.5 111.024 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 21' ' ' SER . 7.6 m120 -76.66 -167.3 0.8 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.261 0.553 . . . . 0.7 110.714 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.469 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.813 . . . . 0.92 110.098 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 120.94 0.4 . . . . 1.68 110.004 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.29 167.55 40.26 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 109.658 -1.377 . . . . 0.88 109.658 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 10.2 p -160.7 153.75 21.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.251 -1.146 . . . . 0.7 110.434 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 32.1 mm -96.07 131.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.997 -1.064 . . . . 1.5 109.468 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -72.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.81 111.583 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.48 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 69.0 m-80 -125.28 101.5 7.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.872 -1.143 . . . . 0.73 110.5 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.91 62.33 0.49 Allowed Glycine 0 N--CA 1.499 2.842 0 N-CA-C 110.14 -1.184 . . . . 0.54 110.14 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -116.78 -157.82 11.04 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.707 -1.357 . . . . 0.57 109.707 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -139.2 132.76 30.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.348 -1.089 . . . . 0.75 110.431 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -128.37 165.71 20.06 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.935 -1.103 . . . . 0.33 111.508 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -115.72 178.1 4.43 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 0.74 110.574 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 -8.99 59.72 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.213 -0.929 . . . . 1.03 111.575 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 t -121.1 -171.09 2.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.927 -1.108 . . . . 1.11 110.603 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.86 144.59 27.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.872 . . . . 1.21 110.493 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 164.55 -154.69 25.66 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.727 -1.349 . . . . 0.69 109.727 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.717 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.29 -32.92 61.11 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 O-C-N 123.801 1.422 . . . . 0.55 113.789 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.717 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.5 Cg_endo -78.43 66.03 8.5 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-N 118.868 0.631 . . . . 0.71 111.072 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.443 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 42.6 p90 -109.29 161.83 14.89 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.049 -1.032 . . . . 0.5 110.919 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 32.6 m -88.67 173.5 8.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.177 -0.952 . . . . 0.32 110.849 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 11.0 t -89.41 -48.64 7.2 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.728 -1.233 . . . . 0.41 113.049 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 37' ' ' ASN . 74.4 m -98.93 -73.49 0.62 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.103 -0.998 . . . . 0.87 110.695 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -174.33 23.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.39 111.702 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 12.6 t80 -119.24 139.36 52.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.675 -1.266 . . . . 0.83 110.772 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.9 t -153.03 108.62 3.28 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.744 -0.662 . . . . 0.26 109.315 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' HB3' HG21 ' A' ' 34' ' ' VAL . 4.9 t80 -89.11 79.8 7.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.77 109.445 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.557 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 5.0 tt0 -109.43 154.17 22.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.776 -0.577 . . . . 0.52 110.474 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.01 168.99 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.381 -0.825 . . . . 1.19 110.592 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.91 128.07 35.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.227 -0.92 . . . . 0.77 110.75 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.92 -53.4 0.49 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.204 -1.158 . . . . 0.76 110.204 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.444 ' O ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -127.82 7.45 6.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.358 -1.084 . . . . 2.68 111.949 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 11.3 t 59.57 52.19 5.88 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.249 -0.907 . . . . 0.52 110.011 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -138.78 139.7 38.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.669 0.747 . . . . 1.35 110.846 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.557 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -162.5 178.45 38.27 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.635 -1.386 . . . . 0.31 109.635 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 16.1 m -114.58 136.02 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.332 -1.099 . . . . 1.18 110.822 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.9 m -88.6 158.66 18.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.3 111.215 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -151.6 166.18 32.01 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.229 -0.896 . . . . 0.5 110.109 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.607 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 24.5 m-20 -83.38 -61.22 1.9 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.122 -1.066 . . . . 0.78 108.122 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.306 0 CA-C-N 116.313 -0.403 . . . . 0.88 109.989 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.492 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.823 0.344 . . . . 1.27 110.428 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.55 145.15 19.39 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.803 -1.319 . . . . 0.76 109.803 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 p -141.0 159.72 41.61 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.255 -1.144 . . . . 0.69 111.086 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 7' ' ' GLY . 51.6 mt -128.3 106.01 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.414 -0.804 . . . . 1.41 109.687 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.473 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 3.2 mptt -54.63 -32.54 59.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.523 -0.736 . . . . 0.89 111.6 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -97.41 8.58 44.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.103 -0.998 . . . . 0.97 112.25 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 4' ' ' ILE . . . 167.02 58.76 0.03 OUTLIER Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.11 -1.519 . . . . 0.58 111.591 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.8 -178.04 47.86 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 109.027 -1.629 . . . . 0.42 109.027 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -135.44 141.01 45.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.856 -1.379 . . . . 0.97 110.769 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.74 -167.15 2.74 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.253 -0.904 . . . . 0.47 111.117 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -151.09 -164.69 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.788 -0.57 . . . . 1.23 110.676 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.52 60.7 4.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 1.16 110.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 m -147.59 120.59 8.8 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.233 -0.917 . . . . 1.79 110.373 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.47 72.57 4.02 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.822 -1.174 . . . . 1.74 110.47 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . -140.64 -137.77 3.49 Favored Glycine 0 N--CA 1.499 2.875 0 C-N-CA 120.192 -1.004 . . . . 1.87 110.728 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.7 Cg_endo -65.44 -33.1 48.26 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 O-C-N 123.814 1.428 . . . . 1.74 114.602 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.666 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 48.5 Cg_endo -74.07 62.79 5.05 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 CA-C-N 118.96 0.664 . . . . 1.6 111.155 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.492 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 6.8 p90 -97.31 160.03 14.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.077 -1.015 . . . . 0.85 110.324 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 90.8 m -80.7 175.86 10.31 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.043 -1.036 . . . . 0.4 111.336 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.442 ' SG ' ' HD2' ' A' ' 5' ' ' LYS . 1.5 t -87.44 -31.38 20.06 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.24 -0.912 . . . . 0.53 112.697 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.473 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -112.9 -75.46 0.6 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.154 -0.967 . . . . 0.43 109.95 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -172.38 14.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.345 -0.847 . . . . 1.19 112.706 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 40.3 t80 -132.01 152.0 51.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.312 -1.493 . . . . 0.97 111.981 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 2.0 t -153.57 115.74 4.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 120.92 0.391 . . . . 0.26 110.239 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' HG21 ' A' ' 34' ' ' VAL . 3.2 t80 -93.83 98.33 11.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.302 -0.874 . . . . 0.75 109.496 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.665 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.6 tt0 -111.34 155.87 22.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.88 110.442 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -125.34 168.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.414 -0.804 . . . . 1.25 110.569 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.73 24.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 1.1 111.846 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.36 0.89 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.625 -1.79 . . . . 0.54 108.625 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 31' ' ' SER . 1.7 tt0 -151.79 -80.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.892 -0.769 . . . . 1.56 110.082 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.9 OUTLIER 174.33 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.957 -0.757 . . . . 1.17 108.957 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -138.14 126.97 23.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.005 -1.06 . . . . 0.68 110.972 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.665 ' HA2' ' HA ' ' A' ' 26' ' ' GLN . . . -141.18 163.45 26.7 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.191 -1.004 . . . . 0.42 110.635 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.7 HG21 ' HB3' ' A' ' 25' ' ' PHE . 15.3 m -109.38 134.89 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.61 -0.935 . . . . 1.07 109.309 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 82.4 m -88.39 155.03 19.92 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.435 1.112 . . . . 0.35 112.192 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.415 ' CE ' ' HA ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -151.21 -166.28 2.49 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.042 -0.981 . . . . 0.5 109.834 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 21' ' ' SER . 7.3 m120 -60.6 -76.81 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.38 -0.825 . . . . 0.75 111.348 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.187 -0.946 . . . . 1.61 111.101 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.479 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.116 0.484 . . . . 1.33 109.925 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.32 163.54 38.68 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.943 -1.263 . . . . 0.67 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 4.7 p -153.7 168.43 26.28 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.56 110.202 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.505 ' HB ' ' HA3' ' A' ' 8' ' ' GLY . 4.7 mt -128.49 87.69 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.099 -1.001 . . . . 1.47 110.267 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -68.42 -17.77 64.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.556 -0.715 . . . . 1.24 111.642 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -97.42 51.37 1.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.198 -0.939 . . . . 0.93 111.083 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.21 55.25 1.86 Allowed Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.072 -1.018 . . . . 0.52 110.671 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -70.03 -170.4 8.27 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.554 -1.418 . . . . 0.42 109.554 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.478 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -126.38 136.0 52.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.077 -1.249 . . . . 0.76 110.919 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -149.43 173.9 13.06 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.718 0.77 . . . . 0.28 111.171 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 20.9 t-20 -155.62 143.44 19.76 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.436 -0.579 . . . . 0.59 109.436 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.33 -20.71 66.16 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.409 -0.807 . . . . 1.13 111.811 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -122.2 45.96 2.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.84 -1.163 . . . . 1.47 111.169 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 11' ' ' ASN . . . -121.16 -71.38 0.74 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.003 . . . . 1.02 110.722 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.69 -75.49 0.3 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.022 -1.085 . . . . 0.59 110.71 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.725 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.8 Cg_endo -61.58 -37.05 72.75 Favored 'Trans proline' 0 CA--C 1.552 1.408 0 O-C-N 123.708 1.373 . . . . 0.6 114.315 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.725 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 53.6 Cg_endo -73.94 65.82 5.03 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.168 0.738 . . . . 0.46 110.299 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.479 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 28.2 p90 -83.4 160.13 21.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.3 -0.875 . . . . 0.46 110.629 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 81.1 m -90.86 173.23 8.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.224 -0.922 . . . . 0.28 111.402 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 6.6 t -78.47 -54.84 5.73 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.163 -0.961 . . . . 0.45 113.023 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 70.0 m -101.1 -73.36 0.65 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 1.14 110.827 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -168.9 18.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.177 -0.952 . . . . 0.56 112.386 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.8 t80 -117.22 144.17 45.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.524 -1.36 . . . . 0.97 110.715 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.626 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 17.6 t -152.54 108.06 3.3 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.521 -0.548 . . . . 0.31 109.521 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.2 t80 -95.71 90.11 5.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.101 -1.0 . . . . 1.08 110.13 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.679 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.9 tm0? -117.98 144.83 45.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.92 110.937 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 163.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.486 -0.759 . . . . 1.18 110.737 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.46 0.53 57.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.5 -0.75 . . . . 1.12 111.757 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.85 45.36 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.642 -1.383 . . . . 0.69 109.642 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.96 5.59 9.32 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -1.061 . . . . 1.33 111.147 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.81 48.71 3.12 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.477 -0.764 . . . . 1.0 110.764 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -138.88 144.17 39.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.8 110.182 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.679 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -144.21 168.63 26.55 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.431 -1.366 . . . . 0.35 111.757 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 26.9 m -123.32 134.66 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.862 -0.787 . . . . 1.16 110.201 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 77.3 m -88.78 158.21 18.23 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.29 111.894 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -151.54 -162.38 1.52 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.333 -0.849 . . . . 0.64 110.187 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.466 ' H ' ' HD3' ' A' ' 36' ' ' LYS . 7.6 m120 -69.34 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.568 -0.707 . . . . 0.62 110.48 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.153 -0.967 . . . . 1.08 110.408 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.857 0.361 . . . . 3.1 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.89 85.54 0.59 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.243 -1.143 . . . . 1.04 110.243 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 p -152.19 165.0 36.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.167 -1.196 . . . . 0.43 110.48 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.3 mt -120.59 122.24 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 1.42 109.433 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -52.33 -43.27 64.49 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.528 -0.732 . . . . 0.6 111.573 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -130.42 99.96 5.19 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.514 -0.741 . . . . 1.59 110.604 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.84 68.21 0.78 Allowed Glycine 0 N--CA 1.499 2.833 0 N-CA-C 109.928 -1.269 . . . . 0.52 109.928 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.35 172.72 14.77 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.551 -1.42 . . . . 0.35 109.551 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.61 132.7 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.139 -1.212 . . . . 1.09 110.719 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p -150.34 -171.14 3.84 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.124 -0.985 . . . . 0.28 111.268 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.19 138.48 11.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.67 109.593 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 60.55 6.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.333 -0.855 . . . . 1.23 110.276 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -136.81 -162.96 1.34 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.427 -0.796 . . . . 0.85 110.663 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.56 101.53 13.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.165 -0.959 . . . . 1.08 110.428 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.9 0.21 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.193 -1.163 . . . . 0.63 110.193 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.91 120.14 7.21 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.914 1.481 . . . . 0.61 111.046 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.16 -164.52 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.945 1.497 . . . . 0.64 110.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -58.05 153.09 15.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.286 -0.884 . . . . 1.45 111.051 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 m -72.51 -171.87 0.87 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.26 -0.9 . . . . 0.26 110.7 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -70.77 -39.31 73.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.656 -1.278 . . . . 0.27 112.436 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 10.1 m -101.11 -75.0 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.36 109.333 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.627 ' HB3' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -175.64 18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.726 -0.609 . . . . 0.35 111.92 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 23.3 t80 -137.93 154.19 49.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.504 -1.372 . . . . 0.67 111.791 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.512 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -151.33 120.62 6.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.407 -0.96 . . . . 0.32 108.407 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t80 -113.44 114.8 27.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.8 110.981 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.571 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 41.4 tt0 -126.59 147.64 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 1.18 111.174 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.18 169.7 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.724 . . . . 1.28 110.892 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.05 155.32 26.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.486 -0.759 . . . . 1.48 111.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.54 -47.33 1.03 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.472 -1.851 . . . . 1.17 108.472 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.37 -2.94 1.76 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.761 -0.846 . . . . 1.97 111.9 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t 64.96 51.98 1.64 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.012 -1.055 . . . . 1.11 110.15 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -126.06 134.53 51.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.339 -0.851 . . . . 1.11 110.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 26' ' ' GLN . . . -121.61 149.5 17.21 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.007 -1.237 . . . . 0.54 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.503 ' CG2' ' HB3' ' A' ' 25' ' ' PHE . 27.4 m -117.29 139.13 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.274 -1.133 . . . . 1.13 110.007 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 75.2 m -88.15 156.64 19.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.889 -1.132 . . . . 0.24 111.1 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 23' ' ' TYR . 8.8 mmtt -148.92 179.64 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.862 -0.608 . . . . 0.65 110.458 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -55.73 -63.63 1.11 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.479 -0.763 . . . . 0.77 110.369 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.627 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.54 110.549 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.506 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.004 0.431 . . . . 1.6 110.445 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.39 119.78 13.64 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.518 -1.433 . . . . 1.26 109.518 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 p -107.25 143.49 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.402 -1.058 . . . . 0.78 110.45 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.1 mm -107.41 130.95 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.36 -0.838 . . . . 1.18 109.556 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -71.62 -39.16 70.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.796 . . . . 0.84 111.671 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.7 133.24 15.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.359 -0.838 . . . . 0.79 111.517 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.53 34.24 54.43 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.931 -0.868 . . . . 0.59 110.931 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.41 -153.16 24.41 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.274 -1.13 . . . . 0.45 110.274 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -140.68 121.64 14.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -1.05 . . . . 0.81 109.989 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 11.4 p -151.51 -168.55 3.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.36 111.31 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -140.86 157.6 45.15 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.493 -0.754 . . . . 0.52 109.63 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.69 66.4 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.357 -0.839 . . . . 1.12 109.765 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 p -101.78 44.57 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 1.52 109.692 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.625 ' HB2' ' HG2' ' A' ' 17' ' ' PRO . . . -83.47 128.49 34.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.332 -0.855 . . . . 1.27 110.916 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.18 -84.34 1.22 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.168 -1.573 . . . . 0.69 109.168 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.73 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.96 -34.2 48.74 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 O-C-N 123.79 1.416 . . . . 0.85 113.674 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.73 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 50.6 Cg_endo -83.76 64.24 7.31 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 CA-C-N 118.912 0.647 . . . . 0.6 110.511 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.506 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 22.5 p90 -91.52 163.99 13.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.241 -0.912 . . . . 1.35 110.994 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 85.9 m -90.28 170.86 9.91 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.023 -1.048 . . . . 0.28 111.292 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 t -92.08 -39.08 11.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.287 -0.883 . . . . 0.4 111.466 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 37.3 m -84.75 -0.14 52.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 1.33 110.463 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 21' ' ' SER . 5.2 t 83.68 -3.17 1.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.002 -0.436 . . . . 1.09 111.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' ' 38' ' ' ARG . 46.8 t80 -101.33 151.33 22.03 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.422 -1.424 . . . . 0.96 110.419 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.26 118.5 5.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.794 -0.566 . . . . 0.29 110.803 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.3 t80 -104.72 94.71 5.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.328 -0.857 . . . . 0.87 110.227 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.658 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.4 tm0? -120.05 144.94 47.3 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.366 -0.834 . . . . 0.52 110.454 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -114.26 170.06 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.408 -0.807 . . . . 1.56 110.615 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.65 19.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 1.07 110.705 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.64 -43.68 1.43 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.133 -1.587 . . . . 0.6 109.133 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.92 -3.79 2.5 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.859 . . . . 0.79 111.539 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.9 50.94 3.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.149 -0.97 . . . . 0.42 110.31 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -128.33 131.96 48.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.331 -0.856 . . . . 0.92 110.269 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.658 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -140.94 172.73 23.55 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.903 -1.141 . . . . 0.35 111.194 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 25' ' ' PHE . 34.6 m -129.57 148.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.586 -0.95 . . . . 1.08 110.523 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 59.2 m -89.23 153.84 20.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.742 -1.224 . . . . 0.28 111.813 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.97 -171.78 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.344 -0.843 . . . . 0.59 110.068 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.23 -80.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.725 -0.61 . . . . 0.85 111.24 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.569 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 2.39 110.713 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.466 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 109.911 -0.403 . . . . 1.71 109.911 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.69 154.88 26.24 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.282 -1.527 . . . . 0.85 109.282 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.09 150.07 21.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.19 -1.182 . . . . 0.65 110.634 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.402 HG23 ' CA ' ' A' ' 8' ' ' GLY . 3.0 mt -108.48 122.44 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 1.35 110.021 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.52 -48.78 66.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.526 -0.734 . . . . 1.17 110.989 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -143.62 128.28 18.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.053 -1.03 . . . . 0.84 111.185 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.94 24.46 27.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.629 -0.988 . . . . 0.57 110.629 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -84.83 -153.06 18.47 Favored Glycine 0 N--CA 1.498 2.795 0 O-C-N 121.059 -1.26 . . . . 0.45 110.304 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.496 ' NH2' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -141.19 129.8 22.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.7 110.468 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 p -151.7 -178.44 6.72 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.114 -0.991 . . . . 0.41 111.126 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.428 ' HA ' ' CG ' ' A' ' 26' ' ' GLN . 2.6 p-10 -166.41 -169.91 1.52 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.691 -0.63 . . . . 0.61 110.656 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.04 60.45 5.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.177 -0.952 . . . . 1.33 110.406 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.3 m -144.91 133.66 22.28 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.036 -1.04 . . . . 1.08 110.228 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.56 108.83 20.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.296 -0.877 . . . . 1.51 110.663 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.436 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 170.61 -128.01 1.56 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.032 -1.227 . . . . 1.14 110.032 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 38.1 Cg_endo -65.85 -31.56 47.65 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 O-C-N 123.716 1.377 . . . . 1.0 114.35 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.655 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 55.2 Cg_endo -77.69 59.27 6.74 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 118.97 0.668 . . . . 1.08 111.793 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.466 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 52.9 p90 -108.25 146.6 32.61 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 0.69 110.487 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 74.1 m -90.32 170.56 10.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.36 110.452 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.54 -47.35 7.46 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.036 -1.04 . . . . 0.48 112.554 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.641 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -87.95 10.01 20.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.132 -0.98 . . . . 0.74 112.256 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.641 ' HB3' ' O ' ' A' ' 21' ' ' SER . 23.2 t 84.27 -5.04 1.06 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.885 -0.509 . . . . 0.68 112.289 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.654 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.1 t80 -96.04 146.01 24.98 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.069 -1.644 . . . . 0.96 110.743 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -151.04 112.14 4.33 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.085 0.469 . . . . 0.3 110.213 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.596 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.5 t80 -99.61 86.36 3.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.427 -0.796 . . . . 0.72 110.345 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.562 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.18 149.55 41.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.464 -0.773 . . . . 0.51 110.115 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.441 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -109.11 165.42 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.233 -0.917 . . . . 1.18 111.009 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.1 35.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.512 -0.743 . . . . 1.23 110.976 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.47 -55.37 0.49 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.046 -1.622 . . . . 0.68 109.046 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.74 0.21 9.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.678 -0.895 . . . . 1.68 111.398 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.43 54.45 1.96 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.149 -0.969 . . . . 0.6 110.063 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -139.2 138.61 37.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.431 -0.793 . . . . 0.74 110.628 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 26' ' ' GLN . . . -159.82 -166.17 18.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.124 -1.036 . . . . 0.27 110.982 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 25' ' ' PHE . 11.6 m -132.73 143.89 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.673 -0.898 . . . . 1.1 110.268 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 79.3 m -88.67 156.81 18.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.753 -1.217 . . . . 0.34 110.817 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.654 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -151.12 -167.14 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 1.18 111.174 -179.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 21' ' ' SER . 10.4 m120 -68.4 -89.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.701 -0.624 . . . . 0.98 111.402 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.591 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 2.3 tpm_? . . . . . 0 N--CA 1.486 1.359 0 O-C-N 120.439 -1.413 . . . . 0.69 111.666 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 120.942 0.401 . . . . 3.79 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.08 115.42 6.47 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.875 -1.29 . . . . 2.62 109.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.462 ' HB2' ' CA ' ' A' ' 20' ' ' CYS . 19.1 p -126.27 165.99 17.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.42 -1.047 . . . . 1.25 110.351 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 4' ' ' ILE . 41.7 mm -106.63 123.97 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.377 -0.827 . . . . 1.31 110.326 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -55.12 -44.99 75.51 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.345 -0.847 . . . . 0.57 110.57 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -150.44 127.28 11.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.52 110.855 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.83 32.5 7.96 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.452 -1.059 . . . . 0.61 110.452 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -86.92 -156.42 29.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.44 -1.464 . . . . 0.47 109.44 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 122.92 18.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 1.77 110.339 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.0 p -151.08 176.15 11.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.109 -0.995 . . . . 0.41 111.53 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.82 172.35 7.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.889 -0.507 . . . . 0.54 110.448 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.84 83.54 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.501 -0.749 . . . . 1.05 111.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.49 81.97 7.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.174 -0.954 . . . . 1.72 109.64 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -129.79 -70.92 0.62 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 1.21 111.025 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.0 -111.08 4.08 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.988 -1.245 . . . . 0.92 109.988 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.714 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.9 Cg_endo -65.02 -33.41 51.14 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 O-C-N 123.696 1.366 . . . . 1.29 114.107 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.714 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.0 Cg_endo -76.51 76.28 4.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 118.889 0.639 . . . . 0.92 110.578 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -89.59 173.69 8.17 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.201 -0.937 . . . . 1.14 110.914 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 88.8 m -76.74 -178.66 4.92 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.927 -1.108 . . . . 0.41 110.829 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.462 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 t -89.23 -36.85 15.39 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.522 -1.361 . . . . 0.61 112.942 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 28.2 t -109.9 -75.39 0.63 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.984 -1.072 . . . . 0.56 110.526 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.427 ' OG ' ' NH2' ' A' ' 38' ' ' ARG . 29.8 t -170.46 25.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.7 112.154 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.555 ' HD2' ' CB ' ' A' ' 36' ' ' LYS . 3.3 t80 -135.4 150.29 49.85 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.348 -1.47 . . . . 0.7 112.08 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.9 t -150.34 106.15 3.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.799 -0.815 . . . . 0.36 108.799 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.631 ' HB3' HG23 ' A' ' 34' ' ' VAL . 3.4 t80 -91.68 90.59 7.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.298 -0.876 . . . . 0.73 110.344 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.622 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.69 147.74 44.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 0.65 110.16 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.77 164.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.24 -0.912 . . . . 1.27 111.103 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.5 143.78 28.33 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.493 -0.754 . . . . 1.3 111.279 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.95 -52.54 0.7 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.693 -1.763 . . . . 0.76 108.693 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.507 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 3.5 tt0 -131.57 -3.27 3.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.668 -0.901 . . . . 2.31 111.579 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER 70.61 60.46 0.21 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.318 -0.864 . . . . 0.53 110.189 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 32.2 p90 -144.55 146.12 32.19 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.82 . . . . 1.61 110.936 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.622 ' HA3' ' HA ' ' A' ' 26' ' ' GLN . . . -167.16 -157.36 10.52 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 120.252 -0.975 . . . . 0.34 110.712 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 25' ' ' PHE . 33.4 m -141.98 145.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.518 -0.99 . . . . 1.1 110.901 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 98.2 m -88.99 158.67 17.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.897 -1.127 . . . . 0.34 110.85 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -151.83 179.2 8.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.534 -0.757 . . . . 1.1 110.471 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.573 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 4.5 m120 -63.02 -61.71 2.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.365 -0.834 . . . . 0.54 110.168 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.427 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 O-C-N 121.656 -0.653 . . . . 0.69 110.374 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' N ' ' OH ' ' A' ' 18' ' ' TYR . . . . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.158 0.504 . . . . 1.6 109.936 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.33 163.22 38.92 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.736 -1.346 . . . . 0.55 109.736 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p -162.85 175.21 11.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -1.06 . . . . 0.37 110.721 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.36 120.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.239 -0.913 . . . . 1.14 110.435 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -29.5 70.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.527 -0.733 . . . . 0.72 111.318 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.51 121.86 10.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.093 -1.004 . . . . 0.73 111.082 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 25.04 37.33 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.386 -0.911 . . . . 0.37 110.875 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -73.62 -160.67 6.5 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.838 -1.305 . . . . 0.36 109.838 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -137.87 124.21 20.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.292 . . . . 0.64 110.622 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.9 p -150.55 -180.0 7.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.227 -0.92 . . . . 0.31 111.183 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -160.21 -169.91 2.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.547 . . . . 0.77 110.652 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.07 56.86 1.04 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.326 -0.859 . . . . 1.32 110.835 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.3 t -149.1 132.52 16.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.198 -0.939 . . . . 1.55 110.659 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.89 89.69 4.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.397 -0.814 . . . . 2.11 110.735 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.51 -119.99 0.51 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.323 -1.511 . . . . 1.01 109.323 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.726 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 36.4 Cg_endo -63.6 -33.15 68.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.795 1.418 . . . . 0.79 113.217 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.726 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 56.0 Cg_endo -82.14 58.58 6.7 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 118.946 0.659 . . . . 0.78 110.439 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.491 ' OH ' ' N ' ' A' ' 1' ' ' ALA . 47.8 p90 -96.58 148.55 22.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.068 -1.02 . . . . 0.62 110.155 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 84.4 m -87.05 178.37 6.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.28 110.894 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.62 -43.18 10.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.075 -1.016 . . . . 0.33 112.793 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.545 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -107.46 -73.23 0.69 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.078 -1.014 . . . . 1.74 110.632 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HD3' ' A' ' 38' ' ' ARG . 1.2 m -171.17 15.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.356 -0.84 . . . . 0.41 112.453 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.736 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 18.1 t80 -119.15 147.64 43.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.358 -1.464 . . . . 1.01 110.654 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.483 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 34.9 t -151.86 106.17 3.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.99 -0.444 . . . . 0.27 109.933 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.4 t80 -97.9 91.12 5.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 1.05 110.422 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.589 ' HA ' ' CA ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.85 149.12 40.55 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 1.4 110.577 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.417 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -119.86 162.18 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.393 -0.817 . . . . 1.23 110.507 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.28 154.65 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.93 111.107 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.4 -43.95 1.3 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.269 -1.532 . . . . 0.81 109.269 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.562 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -143.47 5.2 1.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.634 -0.921 . . . . 1.9 112.487 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 7.1 t 61.08 51.1 4.6 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.147 -0.971 . . . . 0.65 109.684 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 27.3 p90 -132.03 137.74 47.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 1.24 110.649 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 26' ' ' GLN . . . -156.18 -167.68 17.91 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.584 -1.006 . . . . 0.28 110.584 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 34.0 m -135.27 138.5 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.839 -0.801 . . . . 1.03 110.894 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 71.2 m -88.81 159.08 17.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.958 -1.089 . . . . 0.24 111.863 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.567 ' CB ' ' HB3' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -151.39 -167.07 2.69 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.315 -0.857 . . . . 0.43 110.458 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.545 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 14.5 m120 -75.51 -76.01 0.16 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.364 -0.835 . . . . 0.48 111.447 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.736 ' HB2' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.556 0 C-N-CA 122.436 0.294 . . . . 0.57 110.536 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' PRO . . . . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 120.949 0.404 . . . . 1.06 110.133 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.32 149.67 47.47 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.439 -1.465 . . . . 0.55 109.439 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.62 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.8 p -70.02 138.81 52.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.196 -1.179 . . . . 0.43 110.602 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.424 HG23 ' CA ' ' A' ' 8' ' ' GLY . 2.2 mt -106.96 126.86 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 1.22 110.401 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -89.49 -18.48 26.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.621 -0.675 . . . . 2.02 111.017 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 t30 -149.81 113.61 5.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.55 110.448 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.2 33.14 15.16 Favored Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.187 -0.946 . . . . 0.41 110.845 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -75.12 -167.58 20.94 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.081 -1.608 . . . . 0.3 109.081 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.595 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -140.34 114.06 8.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.071 -1.252 . . . . 0.85 110.784 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 p -135.56 176.67 8.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.195 -0.941 . . . . 0.34 111.222 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.571 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 28.4 t-20 -161.19 -141.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.196 -0.668 . . . . 0.87 109.196 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.81 25.51 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.907 -1.12 . . . . 1.15 110.158 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -126.83 -166.52 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.393 -0.817 . . . . 1.06 110.024 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.62 7.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.245 -0.91 . . . . 1.14 110.817 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.96 172.39 39.2 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.955 -1.258 . . . . 0.43 109.955 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.3 Cg_endo -61.78 -33.4 85.28 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 O-C-N 123.511 1.269 . . . . 0.47 113.302 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.7 Cg_endo -96.49 40.62 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 120.943 1.096 . . . . 0.38 109.88 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -53.58 164.29 0.54 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.023 0.916 . . . . 0.61 112.185 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 3.9 m -73.36 160.42 31.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.389 -0.819 . . . . 0.24 110.155 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 6.9 t -90.45 -44.19 9.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.074 -1.016 . . . . 0.29 112.127 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 p -99.28 -72.27 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.301 -0.874 . . . . 0.37 109.965 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -173.37 13.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 112.895 0.702 . . . . 0.37 112.895 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 15.1 t80 -103.64 141.51 35.91 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.01 -1.681 . . . . 0.86 110.856 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.546 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.5 t -152.2 106.99 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 116.008 -0.542 . . . . 0.24 109.981 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.6 t80 -92.47 88.37 6.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.075 -1.016 . . . . 0.84 110.36 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.604 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -113.61 149.52 34.44 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.55 110.91 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.461 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.86 162.82 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.464 -0.772 . . . . 1.18 111.029 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.18 14.69 11.9 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.505 -0.747 . . . . 0.91 112.066 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 -53.54 4.14 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.826 -1.309 . . . . 0.75 109.826 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.24 7.51 10.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.563 -0.963 . . . . 2.9 111.707 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t 65.99 54.5 1.0 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.279 -0.888 . . . . 1.1 109.769 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -148.51 149.08 31.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -0.851 . . . . 0.92 110.675 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -148.78 168.95 29.31 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.174 -1.013 . . . . 0.33 110.988 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 18.3 m -128.71 133.31 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.54 -0.976 . . . . 1.07 110.126 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 75.7 m -87.21 159.53 18.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.2 111.739 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -150.64 174.71 12.69 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.349 -0.842 . . . . 0.6 110.852 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -66.1 -64.54 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.67 109.827 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.854 -0.529 . . . . 0.71 110.245 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 110.094 -0.335 . . . . 1.04 110.094 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.15 164.97 49.73 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.232 -1.147 . . . . 0.81999999999999995 110.232 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.5 p -155.46 174.53 15.12 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.288 -1.125 . . . . 0.46000000000000002 110.325 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' HB ' ' HA2' ' A' ' 8' ' ' GLY . 47.3 mt -128.62 125.32 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.148 -0.97 . . . . 0.76000000000000001 110.36 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -51.94 9.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.46000000000000002 110.746 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.39 61.8 4.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.368 -0.832 . . . . 1.1200000000000001 110.709 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.35 61.74 0.17 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.14 -1.029 . . . . 0.42999999999999999 110.747 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 4' ' ' ILE . . . -99.2 156.56 19.99 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.419 -1.473 . . . . 0.28999999999999998 109.419 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.4 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 21.5 tpt85 -108.9 131.86 54.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.991 -1.299 . . . . 0.46000000000000002 110.797 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.9 p -142.19 173.52 11.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.15 -0.969 . . . . 0.29999999999999999 110.945 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.4 ' OD1' ' NH1' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -146.82 99.16 3.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.591 -0.693 . . . . 0.5 110.45 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . . . -76.05 -11.06 59.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.472 -0.767 . . . . 0.60999999999999999 110.793 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -93.51 -15.41 25.54 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.291 -0.881 . . . . 0.81999999999999995 111.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.45 38.53 4.13 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.13 -0.981 . . . . 1.03 111.192 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 17' ' ' PRO . . . 84.46 78.69 1.12 Allowed Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.138 -1.185 . . . . 0.76000000000000001 110.138 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 40.2 Cg_endo -67.18 110.1 1.91 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.803 1.423 . . . . 0.87 111.266 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 15' ' ' GLY . 42.5 Cg_endo -75.91 -78.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.58 1.305 . . . . 0.48999999999999999 110.591 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -169.83 138.65 1.82 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.889 -1.132 . . . . 1.01 110.444 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 7.5 m -91.77 -178.38 5.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.899 -1.125 . . . . 0.22 109.937 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.13 -32.86 61.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.04 -1.037 . . . . 0.28000000000000003 111.561 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.68 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -123.32 27.81 7.35 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.023 -1.048 . . . . 0.28000000000000003 111.592 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.555 ' HB3' ' O ' ' A' ' 21' ' ' SER . 22.6 t 71.13 -4.14 1.87 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 112.702 0.63 . . . . 0.31 112.702 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 36.0 t80 -105.6 148.91 26.79 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.46 -1.4 . . . . 0.56999999999999995 110.77 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.583 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 25.9 t -152.4 117.0 5.04 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.382 -0.599 . . . . 0.31 109.382 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.604 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.0 t80 -102.2 109.92 21.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.65000000000000002 110.196 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.551 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.8 tt0 -125.57 149.07 48.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.4 -0.812 . . . . 0.66000000000000003 110.254 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.28 164.71 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.478 -0.764 . . . . 0.71999999999999997 110.722 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.56 91.43 8.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.24 110.7 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.29 -69.73 0.02 OUTLIER Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.556 -1.418 . . . . 0.72999999999999998 109.556 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -111.09 5.33 20.08 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.551 -0.97 . . . . 1.1799999999999999 111.191 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.59 58.0 0.53 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.283 -0.885 . . . . 0.59999999999999998 109.515 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 45.7 p90 -137.56 136.42 37.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.428 -0.795 . . . . 0.66000000000000003 111.193 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -129.63 151.88 19.41 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.145 -1.182 . . . . 0.25 110.145 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.1 m -117.98 136.97 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.455 -1.027 . . . . 0.39000000000000001 109.462 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.0 m -88.32 152.8 21.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.714 -1.241 . . . . 0.23000000000000001 111.602 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -151.69 -173.03 4.39 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.46 -0.791 . . . . 0.35999999999999999 111.024 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.68 ' HA ' ' HB3' ' A' ' 21' ' ' SER . 7.6 m120 -76.66 -167.3 0.8 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.261 0.553 . . . . 0.69999999999999996 110.714 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.469 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.813 . . . . 0.92000000000000004 110.098 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 120.94 0.4 . . . . 1.3100000000000001 110.004 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.29 167.55 40.26 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 109.658 -1.377 . . . . 0.77000000000000002 109.658 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 p -160.7 153.75 21.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.251 -1.146 . . . . 0.58999999999999997 110.434 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.792 HG21 ' CA ' ' A' ' 8' ' ' GLY . 32.1 mm -96.07 131.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.997 -1.064 . . . . 1.05 109.468 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -72.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.67000000000000004 111.583 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.48 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 69.0 m-80 -125.28 101.5 7.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.872 -1.143 . . . . 0.67000000000000004 110.5 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.91 62.33 0.49 Allowed Glycine 0 N--CA 1.499 2.842 0 N-CA-C 110.14 -1.184 . . . . 0.51000000000000001 110.14 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.792 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -116.78 -157.82 11.04 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.707 -1.357 . . . . 0.46000000000000002 109.707 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -139.2 132.76 30.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.348 -1.089 . . . . 0.58999999999999997 110.431 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -128.37 165.71 20.06 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.935 -1.103 . . . . 0.28999999999999998 111.508 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -115.72 178.1 4.43 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 0.57999999999999996 110.574 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 -8.99 59.72 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.213 -0.929 . . . . 0.68999999999999995 111.575 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 t -121.1 -171.09 2.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.927 -1.108 . . . . 0.82999999999999996 110.603 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.86 144.59 27.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.872 . . . . 0.64000000000000001 110.493 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 164.55 -154.69 25.66 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.727 -1.349 . . . . 0.56000000000000005 109.727 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.721 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.29 -32.92 61.11 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 O-C-N 123.801 1.422 . . . . 0.47999999999999998 113.789 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.721 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.5 Cg_endo -78.43 66.03 8.5 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-N 118.868 0.631 . . . . 0.58999999999999997 111.072 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -109.29 161.83 14.89 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.049 -1.032 . . . . 0.42999999999999999 110.919 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 32.6 m -88.67 173.5 8.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.177 -0.952 . . . . 0.28000000000000003 110.849 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 11.0 t -89.41 -48.64 7.2 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.728 -1.233 . . . . 0.40999999999999998 113.049 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.636 ' HB2' ' HA ' ' A' ' 37' ' ' ASN . 74.4 m -98.93 -73.49 0.62 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.103 -0.998 . . . . 0.38 110.695 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -174.33 23.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.39000000000000001 111.702 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 12.6 t80 -119.24 139.36 52.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.675 -1.266 . . . . 0.39000000000000001 110.772 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.9 t -153.03 108.62 3.28 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.744 -0.662 . . . . 0.25 109.315 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.782 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.9 t80 -89.11 79.8 7.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.56000000000000005 109.445 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.586 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 5.0 tt0 -109.43 154.17 22.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.776 -0.577 . . . . 0.5 110.474 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.01 168.99 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.381 -0.825 . . . . 0.53000000000000003 110.592 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.91 128.07 35.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.227 -0.92 . . . . 0.70999999999999996 110.75 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.92 -53.4 0.49 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.204 -1.158 . . . . 0.64000000000000001 110.204 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -127.82 7.45 6.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.358 -1.084 . . . . 2.27 111.949 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 11.3 t 59.57 52.19 5.88 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.249 -0.907 . . . . 0.48999999999999999 110.011 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -138.78 139.7 38.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.669 0.747 . . . . 1.03 110.846 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.586 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -162.5 178.45 38.27 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.635 -1.386 . . . . 0.28000000000000003 109.635 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.782 HG22 ' HB3' ' A' ' 25' ' ' PHE . 16.1 m -114.58 136.02 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.332 -1.099 . . . . 0.44 110.822 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.9 m -88.6 158.66 18.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.28000000000000003 111.215 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -151.6 166.18 32.01 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.229 -0.896 . . . . 0.40999999999999998 110.109 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 24.5 m-20 -83.38 -61.22 1.9 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.122 -1.066 . . . . 0.51000000000000001 108.122 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.306 0 CA-C-N 116.313 -0.403 . . . . 0.78000000000000003 109.989 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.823 0.344 . . . . 0.73999999999999999 110.428 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.55 145.15 19.39 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.803 -1.319 . . . . 0.76000000000000001 109.803 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 p -141.0 159.72 41.61 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.255 -1.144 . . . . 0.53000000000000003 111.086 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.6 mt -128.3 106.01 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.414 -0.804 . . . . 0.79000000000000004 109.687 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 3.2 mptt -54.63 -32.54 59.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.523 -0.736 . . . . 0.68999999999999995 111.6 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.474 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -97.41 8.58 44.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.103 -0.998 . . . . 0.78000000000000003 112.25 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 58.76 0.03 OUTLIER Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.11 -1.519 . . . . 0.5 111.591 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.8 -178.04 47.86 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 109.027 -1.629 . . . . 0.37 109.027 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -135.44 141.01 45.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.856 -1.379 . . . . 0.82999999999999996 110.769 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.74 -167.15 2.74 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.253 -0.904 . . . . 0.37 111.117 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 31' ' ' SER . 20.1 p-10 -151.09 -164.69 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.788 -0.57 . . . . 1.05 110.676 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.52 60.7 4.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.93000000000000005 110.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 m -147.59 120.59 8.8 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.233 -0.917 . . . . 1.55 110.373 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.47 72.57 4.02 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.822 -1.174 . . . . 1.3999999999999999 110.47 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . -140.64 -137.77 3.49 Favored Glycine 0 N--CA 1.499 2.875 0 C-N-CA 120.192 -1.004 . . . . 1.5700000000000001 110.728 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.7 Cg_endo -65.44 -33.1 48.26 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 O-C-N 123.814 1.428 . . . . 1.5900000000000001 114.602 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.673 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 48.5 Cg_endo -74.07 62.79 5.05 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 CA-C-N 118.96 0.664 . . . . 1.3999999999999999 111.155 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -97.31 160.03 14.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.077 -1.015 . . . . 0.71999999999999997 110.324 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 90.8 m -80.7 175.86 10.31 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.043 -1.036 . . . . 0.33000000000000002 111.336 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 5' ' ' LYS . 1.5 t -87.44 -31.38 20.06 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.24 -0.912 . . . . 0.53000000000000003 112.697 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.495 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -112.9 -75.46 0.6 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.154 -0.967 . . . . 0.42999999999999999 109.95 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -172.38 14.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.345 -0.847 . . . . 0.73999999999999999 112.706 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 40.3 t80 -132.01 152.0 51.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.312 -1.493 . . . . 0.56000000000000005 111.981 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 2.0 t -153.57 115.74 4.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 120.92 0.391 . . . . 0.25 110.239 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.735 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.2 t80 -93.83 98.33 11.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.302 -0.874 . . . . 0.52000000000000002 109.496 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.641 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.6 tt0 -111.34 155.87 22.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.68999999999999995 110.442 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.34 168.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.414 -0.804 . . . . 0.59999999999999998 110.569 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.73 24.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.57999999999999996 111.846 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.36 0.89 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.625 -1.79 . . . . 0.46000000000000002 108.625 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' SER . 1.7 tt0 -151.79 -80.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.892 -0.769 . . . . 1.21 110.082 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.9 OUTLIER 174.33 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.957 -0.757 . . . . 0.72999999999999998 108.957 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -138.14 126.97 23.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.005 -1.06 . . . . 0.56999999999999995 110.972 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.641 ' HA2' ' HA ' ' A' ' 26' ' ' GLN . . . -141.18 163.45 26.7 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.191 -1.004 . . . . 0.38 110.635 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 25' ' ' PHE . 15.3 m -109.38 134.89 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.61 -0.935 . . . . 0.40999999999999998 109.309 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 82.4 m -88.39 155.03 19.92 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.435 1.112 . . . . 0.34999999999999998 112.192 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.474 ' CE ' ' HA ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -151.21 -166.28 2.49 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.042 -0.981 . . . . 0.40999999999999998 109.834 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 21' ' ' SER . 7.3 m120 -60.6 -76.81 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.38 -0.825 . . . . 0.65000000000000002 111.348 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.187 -0.946 . . . . 1.48 111.101 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.116 0.484 . . . . 1.01 109.925 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.32 163.54 38.68 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.943 -1.263 . . . . 0.54000000000000004 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 p -153.7 168.43 26.28 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.44 110.202 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.538 ' HB ' ' HA3' ' A' ' 8' ' ' GLY . 4.7 mt -128.49 87.69 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.099 -1.001 . . . . 0.80000000000000004 110.267 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.451 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 15.6 pttp -68.42 -17.77 64.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.556 -0.715 . . . . 0.92000000000000004 111.642 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.414 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 5.7 m120 -97.42 51.37 1.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.198 -0.939 . . . . 0.76000000000000001 111.083 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.21 55.25 1.86 Allowed Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.072 -1.018 . . . . 0.41999999999999998 110.671 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -70.03 -170.4 8.27 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.554 -1.418 . . . . 0.41999999999999998 109.554 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -126.38 136.0 52.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.077 -1.249 . . . . 0.63 110.919 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -149.43 173.9 13.06 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.718 0.77 . . . . 0.28000000000000003 111.171 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 20.9 t-20 -155.62 143.44 19.76 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.436 -0.579 . . . . 0.48999999999999999 109.436 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.33 -20.71 66.16 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.409 -0.807 . . . . 0.57999999999999996 111.811 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -122.2 45.96 2.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.84 -1.163 . . . . 0.93999999999999995 111.169 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 11' ' ' ASN . . . -121.16 -71.38 0.74 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.003 . . . . 0.63 110.722 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.69 -75.49 0.3 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.022 -1.085 . . . . 0.51000000000000001 110.71 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.744 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.8 Cg_endo -61.58 -37.05 72.75 Favored 'Trans proline' 0 CA--C 1.552 1.408 0 O-C-N 123.708 1.373 . . . . 0.52000000000000002 114.315 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.744 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 53.6 Cg_endo -73.94 65.82 5.03 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.168 0.738 . . . . 0.39000000000000001 110.299 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -83.4 160.13 21.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.3 -0.875 . . . . 0.40999999999999998 110.629 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 81.1 m -90.86 173.23 8.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 111.402 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -78.47 -54.84 5.73 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.163 -0.961 . . . . 0.45000000000000001 113.023 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 70.0 m -101.1 -73.36 0.65 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.81999999999999995 110.827 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -168.9 18.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.177 -0.952 . . . . 0.52000000000000002 112.386 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.8 t80 -117.22 144.17 45.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.524 -1.36 . . . . 0.44 110.715 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.624 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 17.6 t -152.54 108.06 3.3 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.521 -0.548 . . . . 0.31 109.521 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.644 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.2 t80 -95.71 90.11 5.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.101 -1.0 . . . . 0.81000000000000005 110.13 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.677 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.9 tm0? -117.98 144.83 45.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.68000000000000005 110.937 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 163.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.486 -0.759 . . . . 0.56000000000000005 110.737 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.46 0.53 57.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.5 -0.75 . . . . 0.76000000000000001 111.757 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.85 45.36 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.642 -1.383 . . . . 0.68999999999999995 109.642 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -122.96 5.59 9.32 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -1.061 . . . . 1.0800000000000001 111.147 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.81 48.71 3.12 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.477 -0.764 . . . . 0.54000000000000004 110.764 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 15.4 p90 -138.88 144.17 39.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.66000000000000003 110.182 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -144.21 168.63 26.55 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.431 -1.366 . . . . 0.31 111.757 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 25' ' ' PHE . 26.9 m -123.32 134.66 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.862 -0.787 . . . . 0.44 110.201 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 77.3 m -88.78 158.21 18.23 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.27000000000000002 111.894 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -151.54 -162.38 1.52 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.333 -0.849 . . . . 0.45000000000000001 110.187 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.482 ' H ' ' HD3' ' A' ' 36' ' ' LYS . 7.6 m120 -69.34 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.568 -0.707 . . . . 0.54000000000000004 110.48 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.153 -0.967 . . . . 0.95999999999999996 110.408 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.857 0.361 . . . . 3.1000000000000001 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.89 85.54 0.59 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.243 -1.143 . . . . 0.71999999999999997 110.243 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 p -152.19 165.0 36.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.167 -1.196 . . . . 0.37 110.48 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 20' ' ' CYS . 30.3 mt -120.59 122.24 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.80000000000000004 109.433 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -52.33 -43.27 64.49 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.528 -0.732 . . . . 0.46000000000000002 111.573 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -130.42 99.96 5.19 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.514 -0.741 . . . . 1.3 110.604 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.84 68.21 0.78 Allowed Glycine 0 N--CA 1.499 2.833 0 N-CA-C 109.928 -1.269 . . . . 0.52000000000000002 109.928 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.35 172.72 14.77 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.551 -1.42 . . . . 0.28999999999999998 109.551 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.61 132.7 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.139 -1.212 . . . . 0.91000000000000003 110.719 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p -150.34 -171.14 3.84 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.124 -0.985 . . . . 0.26000000000000001 111.268 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.19 138.48 11.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.57999999999999996 109.593 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 60.55 6.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.333 -0.855 . . . . 0.58999999999999997 110.276 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -136.81 -162.96 1.34 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.427 -0.796 . . . . 0.71999999999999997 110.663 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.56 101.53 13.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.165 -0.959 . . . . 0.93000000000000005 110.428 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.9 0.21 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.193 -1.163 . . . . 0.51000000000000001 110.193 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.91 120.14 7.21 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.914 1.481 . . . . 0.52000000000000002 111.046 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.16 -164.52 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.945 1.497 . . . . 0.53000000000000003 110.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -58.05 153.09 15.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.286 -0.884 . . . . 1.0700000000000001 111.051 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 m -72.51 -171.87 0.87 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.26 -0.9 . . . . 0.23000000000000001 110.7 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 1.8 t -70.77 -39.31 73.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.656 -1.278 . . . . 0.27000000000000002 112.436 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 10.1 m -101.11 -75.0 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.32000000000000001 109.333 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.67 ' HB3' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -175.64 18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.726 -0.609 . . . . 0.34999999999999998 111.92 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 23.3 t80 -137.93 154.19 49.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.504 -1.372 . . . . 0.47999999999999998 111.791 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -151.33 120.62 6.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.407 -0.96 . . . . 0.32000000000000001 108.407 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.547 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t80 -113.44 114.8 27.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.60999999999999999 110.981 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.524 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 41.4 tt0 -126.59 147.64 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.87 111.174 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.18 169.7 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.724 . . . . 0.72999999999999998 110.892 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.05 155.32 26.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.486 -0.759 . . . . 1.01 111.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.54 -47.33 1.03 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.472 -1.851 . . . . 0.97999999999999998 108.472 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.37 -2.94 1.76 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.761 -0.846 . . . . 1.47 111.9 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t 64.96 51.98 1.64 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.012 -1.055 . . . . 0.72999999999999998 110.15 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -126.06 134.53 51.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.339 -0.851 . . . . 0.67000000000000004 110.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 25' ' ' PHE . . . -121.61 149.5 17.21 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.007 -1.237 . . . . 0.53000000000000003 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 25' ' ' PHE . 27.4 m -117.29 139.13 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.274 -1.133 . . . . 0.46000000000000002 110.007 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 75.2 m -88.15 156.64 19.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.889 -1.132 . . . . 0.23000000000000001 111.1 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.523 ' HB2' ' HD2' ' A' ' 23' ' ' TYR . 8.8 mmtt -148.92 179.64 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.862 -0.608 . . . . 0.47999999999999998 110.458 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 17.9 m-80 -55.73 -63.63 1.11 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.479 -0.763 . . . . 0.63 110.369 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.67 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.46999999999999997 110.549 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.004 0.431 . . . . 1.0900000000000001 110.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.39 119.78 13.64 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.518 -1.433 . . . . 1.26 109.518 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 p -107.25 143.49 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.402 -1.058 . . . . 0.51000000000000001 110.45 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.496 HG21 ' CA ' ' A' ' 8' ' ' GLY . 48.1 mm -107.41 130.95 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.36 -0.838 . . . . 0.56000000000000005 109.556 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -71.62 -39.16 70.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.796 . . . . 0.65000000000000002 111.671 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.7 133.24 15.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.359 -0.838 . . . . 0.57999999999999996 111.517 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.53 34.24 54.43 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.931 -0.868 . . . . 0.58999999999999997 110.931 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.496 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -87.41 -153.16 24.41 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.274 -1.13 . . . . 0.45000000000000001 110.274 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 tpp180 -140.68 121.64 14.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -1.05 . . . . 0.70999999999999996 109.989 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 11.4 p -151.51 -168.55 3.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.32000000000000001 111.31 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -140.86 157.6 45.15 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.493 -0.754 . . . . 0.52000000000000002 109.63 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.69 66.4 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.357 -0.839 . . . . 0.54000000000000004 109.765 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 p -101.78 44.57 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 1.0700000000000001 109.692 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -83.47 128.49 34.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.332 -0.855 . . . . 0.76000000000000001 110.916 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.18 -84.34 1.22 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.168 -1.573 . . . . 0.58999999999999997 109.168 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.96 -34.2 48.74 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 O-C-N 123.79 1.416 . . . . 0.75 113.674 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 50.6 Cg_endo -83.76 64.24 7.31 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 CA-C-N 118.912 0.647 . . . . 0.5 110.511 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -91.52 163.99 13.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.241 -0.912 . . . . 0.87 110.994 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 85.9 m -90.28 170.86 9.91 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.023 -1.048 . . . . 0.26000000000000001 111.292 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' HB2' ' N ' ' A' ' 4' ' ' ILE . 2.0 t -92.08 -39.08 11.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.287 -0.883 . . . . 0.40000000000000002 111.466 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 37.3 m -84.75 -0.14 52.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.81000000000000005 110.463 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 21' ' ' SER . 5.2 t 83.68 -3.17 1.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.002 -0.436 . . . . 0.65000000000000002 111.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 38' ' ' ARG . 46.8 t80 -101.33 151.33 22.03 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.422 -1.424 . . . . 0.38 110.419 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.26 118.5 5.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.794 -0.566 . . . . 0.28999999999999998 110.803 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.591 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.3 t80 -104.72 94.71 5.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.328 -0.857 . . . . 0.62 110.227 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.669 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.4 tm0? -120.05 144.94 47.3 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.366 -0.834 . . . . 0.40999999999999998 110.454 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.563 HD13 ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -114.26 170.06 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.408 -0.807 . . . . 0.87 110.615 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.65 19.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.55000000000000004 110.705 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.64 -43.68 1.43 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.133 -1.587 . . . . 0.5 109.133 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.92 -3.79 2.5 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.859 . . . . 0.79000000000000004 111.539 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.9 50.94 3.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.149 -0.97 . . . . 0.40000000000000002 110.31 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 13.2 p90 -128.33 131.96 48.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.331 -0.856 . . . . 0.83999999999999997 110.269 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.669 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -140.94 172.73 23.55 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.903 -1.141 . . . . 0.33000000000000002 111.194 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.6 m -129.57 148.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.586 -0.95 . . . . 0.35999999999999999 110.523 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 59.2 m -89.23 153.84 20.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.742 -1.224 . . . . 0.27000000000000002 111.813 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.97 -171.78 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.344 -0.843 . . . . 0.45000000000000001 110.068 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.23 -80.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.725 -0.61 . . . . 0.70999999999999996 111.24 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 1.75 110.713 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 109.911 -0.403 . . . . 1.3 109.911 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.69 154.88 26.24 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.282 -1.527 . . . . 0.77000000000000002 109.282 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.09 150.07 21.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.19 -1.182 . . . . 0.58999999999999997 110.634 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.507 HG21 ' CA ' ' A' ' 8' ' ' GLY . 3.0 mt -108.48 122.44 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.65000000000000002 110.021 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.52 -48.78 66.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.526 -0.734 . . . . 0.88 110.989 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -143.62 128.28 18.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.053 -1.03 . . . . 0.71999999999999997 111.185 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.94 24.46 27.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.629 -0.988 . . . . 0.56999999999999995 110.629 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.507 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -84.83 -153.06 18.47 Favored Glycine 0 N--CA 1.498 2.795 0 O-C-N 121.059 -1.26 . . . . 0.37 110.304 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.523 ' NH2' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -141.19 129.8 22.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.56999999999999995 110.468 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 p -151.7 -178.44 6.72 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.114 -0.991 . . . . 0.32000000000000001 111.126 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.422 ' HA ' ' CG ' ' A' ' 26' ' ' GLN . 2.6 p-10 -166.41 -169.91 1.52 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.691 -0.63 . . . . 0.56000000000000005 110.656 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.04 60.45 5.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.177 -0.952 . . . . 0.76000000000000001 110.406 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.3 m -144.91 133.66 22.28 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.036 -1.04 . . . . 0.84999999999999998 110.228 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.56 108.83 20.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.296 -0.877 . . . . 1.1100000000000001 110.663 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 170.61 -128.01 1.56 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.032 -1.227 . . . . 0.78000000000000003 110.032 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.65 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 38.1 Cg_endo -65.85 -31.56 47.65 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 O-C-N 123.716 1.377 . . . . 0.87 114.35 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.65 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 55.2 Cg_endo -77.69 59.27 6.74 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 118.97 0.668 . . . . 0.94999999999999996 111.793 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -108.25 146.6 32.61 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 0.68999999999999995 110.487 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 74.1 m -90.32 170.56 10.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.28999999999999998 110.452 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.54 -47.35 7.46 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.036 -1.04 . . . . 0.47999999999999998 112.554 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -87.95 10.01 20.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.132 -0.98 . . . . 0.46999999999999997 112.256 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 21' ' ' SER . 23.2 t 84.27 -5.04 1.06 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.885 -0.509 . . . . 0.41999999999999998 112.289 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.695 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.1 t80 -96.04 146.01 24.98 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.069 -1.644 . . . . 0.41999999999999998 110.743 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -151.04 112.14 4.33 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.085 0.469 . . . . 0.28999999999999998 110.213 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.786 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.5 t80 -99.61 86.36 3.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.427 -0.796 . . . . 0.51000000000000001 110.345 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.527 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.18 149.55 41.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.464 -0.773 . . . . 0.42999999999999999 110.115 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.435 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -109.11 165.42 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.233 -0.917 . . . . 0.55000000000000004 111.009 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.1 35.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.512 -0.743 . . . . 0.68999999999999995 110.976 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.47 -55.37 0.49 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.046 -1.622 . . . . 0.58999999999999997 109.046 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -122.74 0.21 9.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.678 -0.895 . . . . 1.3600000000000001 111.398 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.43 54.45 1.96 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.149 -0.969 . . . . 0.35999999999999999 110.063 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 30' ' ' GLN . 33.0 p90 -139.2 138.61 37.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.431 -0.793 . . . . 0.55000000000000004 110.628 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -159.82 -166.17 18.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.124 -1.036 . . . . 0.26000000000000001 110.982 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.786 HG22 ' HB3' ' A' ' 25' ' ' PHE . 11.6 m -132.73 143.89 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.673 -0.898 . . . . 0.34999999999999998 110.268 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 79.3 m -88.67 156.81 18.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.753 -1.217 . . . . 0.31 110.817 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.695 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -151.12 -167.14 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.67000000000000004 111.174 -179.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' A' ' 21' ' ' SER . 10.4 m120 -68.4 -89.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.701 -0.624 . . . . 0.81000000000000005 111.402 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.583 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 2.3 tpm_? . . . . . 0 N--CA 1.486 1.359 0 O-C-N 120.439 -1.413 . . . . 0.55000000000000004 111.666 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 120.942 0.401 . . . . 3.4700000000000002 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.08 115.42 6.47 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.875 -1.29 . . . . 2.2999999999999998 109.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 20' ' ' CYS . 19.1 p -126.27 165.99 17.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.42 -1.047 . . . . 1.0900000000000001 110.351 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 41.7 mm -106.63 123.97 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.377 -0.827 . . . . 0.76000000000000001 110.326 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -55.12 -44.99 75.51 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.345 -0.847 . . . . 0.45000000000000001 110.57 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.605 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -150.44 127.28 11.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.48999999999999999 110.855 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.83 32.5 7.96 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.452 -1.059 . . . . 0.60999999999999999 110.452 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -86.92 -156.42 29.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.44 -1.464 . . . . 0.46999999999999997 109.44 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 122.92 18.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 1.46 110.339 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.0 p -151.08 176.15 11.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.109 -0.995 . . . . 0.39000000000000001 111.53 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.82 172.35 7.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.889 -0.507 . . . . 0.46000000000000002 110.448 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.84 83.54 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.501 -0.749 . . . . 0.51000000000000001 111.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.49 81.97 7.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.174 -0.954 . . . . 1.1799999999999999 109.64 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -129.79 -70.92 0.62 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.82999999999999996 111.025 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 94.0 -111.08 4.08 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.988 -1.245 . . . . 0.83999999999999997 109.988 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.9 Cg_endo -65.02 -33.41 51.14 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 O-C-N 123.696 1.366 . . . . 1.1499999999999999 114.107 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.0 Cg_endo -76.51 76.28 4.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 118.889 0.639 . . . . 0.80000000000000004 110.578 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -89.59 173.69 8.17 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.201 -0.937 . . . . 0.87 110.914 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 88.8 m -76.74 -178.66 4.92 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.927 -1.108 . . . . 0.37 110.829 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 1.3 t -89.23 -36.85 15.39 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.522 -1.361 . . . . 0.60999999999999999 112.942 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.617 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 28.2 t -109.9 -75.39 0.63 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.984 -1.072 . . . . 0.56000000000000005 110.526 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.512 ' OG ' ' NH2' ' A' ' 38' ' ' ARG . 29.8 t -170.46 25.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.52000000000000002 112.154 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.562 ' HD2' ' CB ' ' A' ' 36' ' ' LYS . 3.3 t80 -135.4 150.29 49.85 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.348 -1.47 . . . . 0.39000000000000001 112.08 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.9 t -150.34 106.15 3.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.799 -0.815 . . . . 0.33000000000000002 108.799 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.4 t80 -91.68 90.59 7.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.298 -0.876 . . . . 0.57999999999999996 110.344 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.584 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.69 147.74 44.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 0.5 110.16 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -113.77 164.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.24 -0.912 . . . . 0.59999999999999998 111.103 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.5 143.78 28.33 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.493 -0.754 . . . . 0.79000000000000004 111.279 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.95 -52.54 0.7 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.693 -1.763 . . . . 0.62 108.693 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 3.5 tt0 -131.57 -3.27 3.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.668 -0.901 . . . . 1.8300000000000001 111.579 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER 70.61 60.46 0.21 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.318 -0.864 . . . . 0.39000000000000001 110.189 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 32.2 p90 -144.55 146.12 32.19 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.82 . . . . 1.0700000000000001 110.936 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 26' ' ' GLN . . . -167.16 -157.36 10.52 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 120.252 -0.975 . . . . 0.34000000000000002 110.712 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 25' ' ' PHE . 33.4 m -141.98 145.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.518 -0.99 . . . . 0.48999999999999999 110.901 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 98.2 m -88.99 158.67 17.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.897 -1.127 . . . . 0.34000000000000002 110.85 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -151.83 179.2 8.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.534 -0.757 . . . . 0.54000000000000004 110.471 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.617 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 4.5 m120 -63.02 -61.71 2.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.365 -0.834 . . . . 0.46000000000000002 110.168 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 O-C-N 121.656 -0.653 . . . . 0.55000000000000004 110.374 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.158 0.504 . . . . 1.1399999999999999 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.33 163.22 38.92 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.736 -1.346 . . . . 0.42999999999999999 109.736 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p -162.85 175.21 11.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -1.06 . . . . 0.33000000000000002 110.721 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.36 120.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.239 -0.913 . . . . 0.46999999999999997 110.435 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -29.5 70.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.527 -0.733 . . . . 0.47999999999999998 111.318 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.51 121.86 10.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.093 -1.004 . . . . 0.57999999999999996 111.082 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 25.04 37.33 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.386 -0.911 . . . . 0.35999999999999999 110.875 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -73.62 -160.67 6.5 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.838 -1.305 . . . . 0.35999999999999999 109.838 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -137.87 124.21 20.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.292 . . . . 0.54000000000000004 110.622 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.9 p -150.55 -180.0 7.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.227 -0.92 . . . . 0.28999999999999998 111.183 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -160.21 -169.91 2.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.547 . . . . 0.58999999999999997 110.652 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.07 56.86 1.04 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.326 -0.859 . . . . 0.64000000000000001 110.835 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.3 t -149.1 132.52 16.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.198 -0.939 . . . . 1.4099999999999999 110.659 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.89 89.69 4.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.397 -0.814 . . . . 2.1099999999999999 110.735 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.51 -119.99 0.51 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.323 -1.511 . . . . 0.75 109.323 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 36.4 Cg_endo -63.6 -33.15 68.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.795 1.418 . . . . 0.67000000000000004 113.217 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 56.0 Cg_endo -82.14 58.58 6.7 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 118.946 0.659 . . . . 0.72999999999999998 110.439 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -96.58 148.55 22.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.068 -1.02 . . . . 0.45000000000000001 110.155 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 84.4 m -87.05 178.37 6.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.25 110.894 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.62 -43.18 10.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.075 -1.016 . . . . 0.33000000000000002 112.793 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.588 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -107.46 -73.23 0.69 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.078 -1.014 . . . . 1.22 110.632 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.406 ' HB3' ' HD3' ' A' ' 38' ' ' ARG . 1.2 m -171.17 15.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.356 -0.84 . . . . 0.39000000000000001 112.453 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.76 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 18.1 t80 -119.15 147.64 43.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.358 -1.464 . . . . 0.39000000000000001 110.654 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 34.9 t -151.86 106.17 3.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.99 -0.444 . . . . 0.27000000000000002 109.933 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.4 t80 -97.9 91.12 5.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.68000000000000005 110.422 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.548 ' HA ' ' CA ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.85 149.12 40.55 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.89000000000000001 110.577 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.413 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -119.86 162.18 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.393 -0.817 . . . . 0.58999999999999997 110.507 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.28 154.65 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.80000000000000004 111.107 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.4 -43.95 1.3 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.269 -1.532 . . . . 0.68000000000000005 109.269 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.583 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -143.47 5.2 1.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.634 -0.921 . . . . 1.47 112.487 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 7.1 t 61.08 51.1 4.6 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.147 -0.971 . . . . 0.60999999999999999 109.684 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 27.3 p90 -132.03 137.74 47.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.80000000000000004 110.649 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 26' ' ' GLN . . . -156.18 -167.68 17.91 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.584 -1.006 . . . . 0.25 110.584 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.0 m -135.27 138.5 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.839 -0.801 . . . . 0.38 110.894 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 71.2 m -88.81 159.08 17.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.958 -1.089 . . . . 0.23999999999999999 111.863 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.592 ' CB ' ' HB3' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -151.39 -167.07 2.69 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.315 -0.857 . . . . 0.33000000000000002 110.458 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.588 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 14.5 m120 -75.51 -76.01 0.16 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.364 -0.835 . . . . 0.40999999999999998 111.447 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.76 ' HB2' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.556 0 C-N-CA 122.436 0.294 . . . . 0.5 110.536 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 120.949 0.404 . . . . 0.52000000000000002 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.32 149.67 47.47 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.439 -1.465 . . . . 0.55000000000000004 109.439 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.8 p -70.02 138.81 52.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.196 -1.179 . . . . 0.34000000000000002 110.602 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.412 HD13 ' HA2' ' A' ' 8' ' ' GLY . 2.2 mt -106.96 126.86 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.54000000000000004 110.401 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -89.49 -18.48 26.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.621 -0.675 . . . . 1.25 111.017 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 t30 -149.81 113.61 5.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.5 110.448 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.2 33.14 15.16 Favored Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.187 -0.946 . . . . 0.33000000000000002 110.845 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -75.12 -167.58 20.94 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.081 -1.608 . . . . 0.25 109.081 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -140.34 114.06 8.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.071 -1.252 . . . . 0.67000000000000004 110.784 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 p -135.56 176.67 8.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.195 -0.941 . . . . 0.28999999999999998 111.222 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.575 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 28.4 t-20 -161.19 -141.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.196 -0.668 . . . . 0.69999999999999996 109.196 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.81 25.51 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.907 -1.12 . . . . 0.56999999999999995 110.158 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -126.83 -166.52 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.393 -0.817 . . . . 0.75 110.024 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.62 7.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.245 -0.91 . . . . 0.46000000000000002 110.817 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.96 172.39 39.2 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.955 -1.258 . . . . 0.32000000000000001 109.955 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.718 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.3 Cg_endo -61.78 -33.4 85.28 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 O-C-N 123.511 1.269 . . . . 0.39000000000000001 113.302 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.718 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.7 Cg_endo -96.49 40.62 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 120.943 1.096 . . . . 0.32000000000000001 109.88 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -53.58 164.29 0.54 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.023 0.916 . . . . 0.56000000000000005 112.185 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 3.9 m -73.36 160.42 31.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.389 -0.819 . . . . 0.23000000000000001 110.155 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 6.9 t -90.45 -44.19 9.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.074 -1.016 . . . . 0.28999999999999998 112.127 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 p -99.28 -72.27 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.301 -0.874 . . . . 0.27000000000000002 109.965 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -173.37 13.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 112.895 0.702 . . . . 0.35999999999999999 112.895 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 15.1 t80 -103.64 141.51 35.91 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.01 -1.681 . . . . 0.33000000000000002 110.856 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.5 t -152.2 106.99 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 116.008 -0.542 . . . . 0.23999999999999999 109.981 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.547 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.6 t80 -92.47 88.37 6.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.075 -1.016 . . . . 0.59999999999999998 110.36 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.605 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -113.61 149.52 34.44 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.55000000000000004 110.91 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.86 162.82 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.464 -0.772 . . . . 0.58999999999999997 111.029 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.18 14.69 11.9 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.505 -0.747 . . . . 0.84999999999999998 112.066 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 -53.54 4.14 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.826 -1.309 . . . . 0.69999999999999996 109.826 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.24 7.51 10.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.563 -0.963 . . . . 2.25 111.707 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t 65.99 54.5 1.0 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.279 -0.888 . . . . 0.67000000000000004 109.769 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -148.51 149.08 31.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -0.851 . . . . 0.66000000000000003 110.675 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -148.78 168.95 29.31 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.174 -1.013 . . . . 0.29999999999999999 110.988 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 18.3 m -128.71 133.31 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.54 -0.976 . . . . 0.35999999999999999 110.126 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 75.7 m -87.21 159.53 18.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.20000000000000001 111.739 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -150.64 174.71 12.69 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.349 -0.842 . . . . 0.45000000000000001 110.852 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -66.1 -64.54 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.53000000000000003 109.827 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.854 -0.529 . . . . 0.60999999999999999 110.245 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 110.094 -0.335 . . . . 1.04 110.094 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.15 164.97 49.73 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.232 -1.147 . . . . 0.81999999999999995 110.232 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.5 p -155.46 174.53 15.12 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.288 -1.125 . . . . 0.46000000000000002 110.325 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' HB ' ' HA2' ' A' ' 8' ' ' GLY . 47.3 mt -128.62 125.32 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.148 -0.97 . . . . 0.76000000000000001 110.36 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -51.94 9.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.46000000000000002 110.746 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.39 61.8 4.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.368 -0.832 . . . . 1.1200000000000001 110.709 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.35 61.74 0.17 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.14 -1.029 . . . . 0.42999999999999999 110.747 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 4' ' ' ILE . . . -99.2 156.56 19.99 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.419 -1.473 . . . . 0.28999999999999998 109.419 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.4 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 21.5 tpt85 -108.9 131.86 54.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.991 -1.299 . . . . 0.46000000000000002 110.797 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.9 p -142.19 173.52 11.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.15 -0.969 . . . . 0.29999999999999999 110.945 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.4 ' OD1' ' NH1' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -146.82 99.16 3.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.591 -0.693 . . . . 0.5 110.45 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . . . -76.05 -11.06 59.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.472 -0.767 . . . . 0.60999999999999999 110.793 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -93.51 -15.41 25.54 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.291 -0.881 . . . . 0.81999999999999995 111.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.45 38.53 4.13 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.13 -0.981 . . . . 1.03 111.192 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 17' ' ' PRO . . . 84.46 78.69 1.12 Allowed Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.138 -1.185 . . . . 0.76000000000000001 110.138 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 40.2 Cg_endo -67.18 110.1 1.91 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.803 1.423 . . . . 0.87 111.266 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 15' ' ' GLY . 42.5 Cg_endo -75.91 -78.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.58 1.305 . . . . 0.48999999999999999 110.591 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -169.83 138.65 1.82 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.889 -1.132 . . . . 1.01 110.444 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 7.5 m -91.77 -178.38 5.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.899 -1.125 . . . . 0.22 109.937 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.13 -32.86 61.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.04 -1.037 . . . . 0.28000000000000003 111.561 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.68 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -123.32 27.81 7.35 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.023 -1.048 . . . . 0.28000000000000003 111.592 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.555 ' HB3' ' O ' ' A' ' 21' ' ' SER . 22.6 t 71.13 -4.14 1.87 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 112.702 0.63 . . . . 0.31 112.702 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 36.0 t80 -105.6 148.91 26.79 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.46 -1.4 . . . . 0.56999999999999995 110.77 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.583 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 25.9 t -152.4 117.0 5.04 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.382 -0.599 . . . . 0.31 109.382 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.604 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.0 t80 -102.2 109.92 21.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.65000000000000002 110.196 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.551 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.8 tt0 -125.57 149.07 48.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.4 -0.812 . . . . 0.66000000000000003 110.254 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.28 164.71 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.478 -0.764 . . . . 0.71999999999999997 110.722 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.56 91.43 8.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.24 110.7 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.29 -69.73 0.02 OUTLIER Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.556 -1.418 . . . . 0.72999999999999998 109.556 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -111.09 5.33 20.08 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.551 -0.97 . . . . 1.1799999999999999 111.191 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.59 58.0 0.53 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.283 -0.885 . . . . 0.59999999999999998 109.515 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 45.7 p90 -137.56 136.42 37.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.428 -0.795 . . . . 0.66000000000000003 111.193 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -129.63 151.88 19.41 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.145 -1.182 . . . . 0.25 110.145 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.1 m -117.98 136.97 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.455 -1.027 . . . . 0.39000000000000001 109.462 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.0 m -88.32 152.8 21.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.714 -1.241 . . . . 0.23000000000000001 111.602 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -151.69 -173.03 4.39 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.46 -0.791 . . . . 0.35999999999999999 111.024 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.68 ' HA ' ' HB3' ' A' ' 21' ' ' SER . 7.6 m120 -76.66 -167.3 0.8 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.261 0.553 . . . . 0.69999999999999996 110.714 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.469 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.813 . . . . 0.92000000000000004 110.098 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 120.94 0.4 . . . . 1.3100000000000001 110.004 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.29 167.55 40.26 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 109.658 -1.377 . . . . 0.77000000000000002 109.658 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 p -160.7 153.75 21.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.251 -1.146 . . . . 0.58999999999999997 110.434 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.792 HG21 ' CA ' ' A' ' 8' ' ' GLY . 32.1 mm -96.07 131.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.997 -1.064 . . . . 1.05 109.468 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -72.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.67000000000000004 111.583 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.48 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 69.0 m-80 -125.28 101.5 7.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.872 -1.143 . . . . 0.67000000000000004 110.5 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.91 62.33 0.49 Allowed Glycine 0 N--CA 1.499 2.842 0 N-CA-C 110.14 -1.184 . . . . 0.51000000000000001 110.14 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.792 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -116.78 -157.82 11.04 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.707 -1.357 . . . . 0.46000000000000002 109.707 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -139.2 132.76 30.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.348 -1.089 . . . . 0.58999999999999997 110.431 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -128.37 165.71 20.06 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.935 -1.103 . . . . 0.28999999999999998 111.508 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -115.72 178.1 4.43 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 0.57999999999999996 110.574 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 -8.99 59.72 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.213 -0.929 . . . . 0.68999999999999995 111.575 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 t -121.1 -171.09 2.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.927 -1.108 . . . . 0.82999999999999996 110.603 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.86 144.59 27.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.872 . . . . 0.64000000000000001 110.493 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 164.55 -154.69 25.66 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.727 -1.349 . . . . 0.56000000000000005 109.727 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.721 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.29 -32.92 61.11 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 O-C-N 123.801 1.422 . . . . 0.47999999999999998 113.789 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.721 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.5 Cg_endo -78.43 66.03 8.5 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-N 118.868 0.631 . . . . 0.58999999999999997 111.072 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -109.29 161.83 14.89 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.049 -1.032 . . . . 0.42999999999999999 110.919 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 32.6 m -88.67 173.5 8.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.177 -0.952 . . . . 0.28000000000000003 110.849 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 11.0 t -89.41 -48.64 7.2 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.728 -1.233 . . . . 0.40999999999999998 113.049 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.636 ' HB2' ' HA ' ' A' ' 37' ' ' ASN . 74.4 m -98.93 -73.49 0.62 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.103 -0.998 . . . . 0.38 110.695 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -174.33 23.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.39000000000000001 111.702 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 12.6 t80 -119.24 139.36 52.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.675 -1.266 . . . . 0.39000000000000001 110.772 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.9 t -153.03 108.62 3.28 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.744 -0.662 . . . . 0.25 109.315 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.782 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.9 t80 -89.11 79.8 7.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.56000000000000005 109.445 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.586 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 5.0 tt0 -109.43 154.17 22.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.776 -0.577 . . . . 0.5 110.474 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.01 168.99 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.381 -0.825 . . . . 0.53000000000000003 110.592 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.91 128.07 35.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.227 -0.92 . . . . 0.70999999999999996 110.75 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.92 -53.4 0.49 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.204 -1.158 . . . . 0.64000000000000001 110.204 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -127.82 7.45 6.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.358 -1.084 . . . . 2.27 111.949 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 11.3 t 59.57 52.19 5.88 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.249 -0.907 . . . . 0.48999999999999999 110.011 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -138.78 139.7 38.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.669 0.747 . . . . 1.03 110.846 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.586 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -162.5 178.45 38.27 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.635 -1.386 . . . . 0.28000000000000003 109.635 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.782 HG22 ' HB3' ' A' ' 25' ' ' PHE . 16.1 m -114.58 136.02 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.332 -1.099 . . . . 0.44 110.822 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.9 m -88.6 158.66 18.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.28000000000000003 111.215 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -151.6 166.18 32.01 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.229 -0.896 . . . . 0.40999999999999998 110.109 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 24.5 m-20 -83.38 -61.22 1.9 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.122 -1.066 . . . . 0.51000000000000001 108.122 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.306 0 CA-C-N 116.313 -0.403 . . . . 0.78000000000000003 109.989 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.823 0.344 . . . . 0.73999999999999999 110.428 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.55 145.15 19.39 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.803 -1.319 . . . . 0.76000000000000001 109.803 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 p -141.0 159.72 41.61 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.255 -1.144 . . . . 0.53000000000000003 111.086 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.6 mt -128.3 106.01 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.414 -0.804 . . . . 0.79000000000000004 109.687 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 3.2 mptt -54.63 -32.54 59.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.523 -0.736 . . . . 0.68999999999999995 111.6 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.474 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -97.41 8.58 44.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.103 -0.998 . . . . 0.78000000000000003 112.25 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 58.76 0.03 OUTLIER Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.11 -1.519 . . . . 0.5 111.591 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.8 -178.04 47.86 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 109.027 -1.629 . . . . 0.37 109.027 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -135.44 141.01 45.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.856 -1.379 . . . . 0.82999999999999996 110.769 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.74 -167.15 2.74 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.253 -0.904 . . . . 0.37 111.117 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 31' ' ' SER . 20.1 p-10 -151.09 -164.69 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.788 -0.57 . . . . 1.05 110.676 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.52 60.7 4.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.93000000000000005 110.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 m -147.59 120.59 8.8 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.233 -0.917 . . . . 1.55 110.373 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.47 72.57 4.02 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.822 -1.174 . . . . 1.3999999999999999 110.47 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . -140.64 -137.77 3.49 Favored Glycine 0 N--CA 1.499 2.875 0 C-N-CA 120.192 -1.004 . . . . 1.5700000000000001 110.728 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.7 Cg_endo -65.44 -33.1 48.26 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 O-C-N 123.814 1.428 . . . . 1.5900000000000001 114.602 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.673 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 48.5 Cg_endo -74.07 62.79 5.05 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 CA-C-N 118.96 0.664 . . . . 1.3999999999999999 111.155 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -97.31 160.03 14.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.077 -1.015 . . . . 0.71999999999999997 110.324 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 90.8 m -80.7 175.86 10.31 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.043 -1.036 . . . . 0.33000000000000002 111.336 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 5' ' ' LYS . 1.5 t -87.44 -31.38 20.06 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.24 -0.912 . . . . 0.53000000000000003 112.697 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.495 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -112.9 -75.46 0.6 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.154 -0.967 . . . . 0.42999999999999999 109.95 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -172.38 14.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.345 -0.847 . . . . 0.73999999999999999 112.706 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 40.3 t80 -132.01 152.0 51.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.312 -1.493 . . . . 0.56000000000000005 111.981 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 2.0 t -153.57 115.74 4.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 120.92 0.391 . . . . 0.25 110.239 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.735 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.2 t80 -93.83 98.33 11.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.302 -0.874 . . . . 0.52000000000000002 109.496 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.641 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.6 tt0 -111.34 155.87 22.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.68999999999999995 110.442 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.34 168.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.414 -0.804 . . . . 0.59999999999999998 110.569 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.73 24.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.57999999999999996 111.846 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.36 0.89 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.625 -1.79 . . . . 0.46000000000000002 108.625 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' SER . 1.7 tt0 -151.79 -80.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.892 -0.769 . . . . 1.21 110.082 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.9 OUTLIER 174.33 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.957 -0.757 . . . . 0.72999999999999998 108.957 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -138.14 126.97 23.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.005 -1.06 . . . . 0.56999999999999995 110.972 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.641 ' HA2' ' HA ' ' A' ' 26' ' ' GLN . . . -141.18 163.45 26.7 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.191 -1.004 . . . . 0.38 110.635 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 25' ' ' PHE . 15.3 m -109.38 134.89 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.61 -0.935 . . . . 0.40999999999999998 109.309 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 82.4 m -88.39 155.03 19.92 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.435 1.112 . . . . 0.34999999999999998 112.192 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.474 ' CE ' ' HA ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -151.21 -166.28 2.49 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.042 -0.981 . . . . 0.40999999999999998 109.834 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 21' ' ' SER . 7.3 m120 -60.6 -76.81 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.38 -0.825 . . . . 0.65000000000000002 111.348 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.187 -0.946 . . . . 1.48 111.101 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.116 0.484 . . . . 1.01 109.925 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.32 163.54 38.68 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.943 -1.263 . . . . 0.54000000000000004 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 p -153.7 168.43 26.28 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.44 110.202 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.538 ' HB ' ' HA3' ' A' ' 8' ' ' GLY . 4.7 mt -128.49 87.69 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.099 -1.001 . . . . 0.80000000000000004 110.267 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 15.6 pttp -68.42 -17.77 64.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.556 -0.715 . . . . 0.92000000000000004 111.642 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 5.7 m120 -97.42 51.37 1.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.198 -0.939 . . . . 0.76000000000000001 111.083 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.21 55.25 1.86 Allowed Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.072 -1.018 . . . . 0.41999999999999998 110.671 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -70.03 -170.4 8.27 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.554 -1.418 . . . . 0.41999999999999998 109.554 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -126.38 136.0 52.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.077 -1.249 . . . . 0.63 110.919 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -149.43 173.9 13.06 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.718 0.77 . . . . 0.28000000000000003 111.171 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 20.9 t-20 -155.62 143.44 19.76 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.436 -0.579 . . . . 0.48999999999999999 109.436 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.33 -20.71 66.16 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.409 -0.807 . . . . 0.57999999999999996 111.811 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -122.2 45.96 2.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.84 -1.163 . . . . 0.93999999999999995 111.169 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 11' ' ' ASN . . . -121.16 -71.38 0.74 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.003 . . . . 0.63 110.722 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.69 -75.49 0.3 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.022 -1.085 . . . . 0.51000000000000001 110.71 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.744 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.8 Cg_endo -61.58 -37.05 72.75 Favored 'Trans proline' 0 CA--C 1.552 1.408 0 O-C-N 123.708 1.373 . . . . 0.52000000000000002 114.315 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.744 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 53.6 Cg_endo -73.94 65.82 5.03 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.168 0.738 . . . . 0.39000000000000001 110.299 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -83.4 160.13 21.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.3 -0.875 . . . . 0.40999999999999998 110.629 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 81.1 m -90.86 173.23 8.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 111.402 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -78.47 -54.84 5.73 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.163 -0.961 . . . . 0.45000000000000001 113.023 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 70.0 m -101.1 -73.36 0.65 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.81999999999999995 110.827 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -168.9 18.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.177 -0.952 . . . . 0.52000000000000002 112.386 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.8 t80 -117.22 144.17 45.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.524 -1.36 . . . . 0.44 110.715 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.624 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 17.6 t -152.54 108.06 3.3 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.521 -0.548 . . . . 0.31 109.521 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.644 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.2 t80 -95.71 90.11 5.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.101 -1.0 . . . . 0.81000000000000005 110.13 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.677 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.9 tm0? -117.98 144.83 45.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.68000000000000005 110.937 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 163.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.486 -0.759 . . . . 0.56000000000000005 110.737 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.46 0.53 57.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.5 -0.75 . . . . 0.76000000000000001 111.757 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.85 45.36 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.642 -1.383 . . . . 0.68999999999999995 109.642 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -122.96 5.59 9.32 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -1.061 . . . . 1.0800000000000001 111.147 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.81 48.71 3.12 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.477 -0.764 . . . . 0.54000000000000004 110.764 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 15.4 p90 -138.88 144.17 39.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.66000000000000003 110.182 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -144.21 168.63 26.55 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.431 -1.366 . . . . 0.31 111.757 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 25' ' ' PHE . 26.9 m -123.32 134.66 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.862 -0.787 . . . . 0.44 110.201 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 77.3 m -88.78 158.21 18.23 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.27000000000000002 111.894 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -151.54 -162.38 1.52 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.333 -0.849 . . . . 0.45000000000000001 110.187 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' H ' ' HD3' ' A' ' 36' ' ' LYS . 7.6 m120 -69.34 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.568 -0.707 . . . . 0.54000000000000004 110.48 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.153 -0.967 . . . . 0.95999999999999996 110.408 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.857 0.361 . . . . 3.1000000000000001 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.89 85.54 0.59 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.243 -1.143 . . . . 0.71999999999999997 110.243 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 p -152.19 165.0 36.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.167 -1.196 . . . . 0.37 110.48 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 20' ' ' CYS . 30.3 mt -120.59 122.24 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.80000000000000004 109.433 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -52.33 -43.27 64.49 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.528 -0.732 . . . . 0.46000000000000002 111.573 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -130.42 99.96 5.19 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.514 -0.741 . . . . 1.3 110.604 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.84 68.21 0.78 Allowed Glycine 0 N--CA 1.499 2.833 0 N-CA-C 109.928 -1.269 . . . . 0.52000000000000002 109.928 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.35 172.72 14.77 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.551 -1.42 . . . . 0.28999999999999998 109.551 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.61 132.7 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.139 -1.212 . . . . 0.91000000000000003 110.719 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p -150.34 -171.14 3.84 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.124 -0.985 . . . . 0.26000000000000001 111.268 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.19 138.48 11.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.57999999999999996 109.593 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 60.55 6.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.333 -0.855 . . . . 0.58999999999999997 110.276 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -136.81 -162.96 1.34 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.427 -0.796 . . . . 0.71999999999999997 110.663 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.56 101.53 13.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.165 -0.959 . . . . 0.93000000000000005 110.428 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.9 0.21 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.193 -1.163 . . . . 0.51000000000000001 110.193 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.91 120.14 7.21 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.914 1.481 . . . . 0.52000000000000002 111.046 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.16 -164.52 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.945 1.497 . . . . 0.53000000000000003 110.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -58.05 153.09 15.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.286 -0.884 . . . . 1.0700000000000001 111.051 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 m -72.51 -171.87 0.87 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.26 -0.9 . . . . 0.23000000000000001 110.7 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 1.8 t -70.77 -39.31 73.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.656 -1.278 . . . . 0.27000000000000002 112.436 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 10.1 m -101.11 -75.0 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.32000000000000001 109.333 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.67 ' HB3' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -175.64 18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.726 -0.609 . . . . 0.34999999999999998 111.92 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 23.3 t80 -137.93 154.19 49.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.504 -1.372 . . . . 0.47999999999999998 111.791 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -151.33 120.62 6.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.407 -0.96 . . . . 0.32000000000000001 108.407 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.547 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t80 -113.44 114.8 27.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.60999999999999999 110.981 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.524 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 41.4 tt0 -126.59 147.64 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.87 111.174 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.18 169.7 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.724 . . . . 0.72999999999999998 110.892 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.05 155.32 26.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.486 -0.759 . . . . 1.01 111.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.54 -47.33 1.03 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.472 -1.851 . . . . 0.97999999999999998 108.472 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.37 -2.94 1.76 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.761 -0.846 . . . . 1.47 111.9 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t 64.96 51.98 1.64 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.012 -1.055 . . . . 0.72999999999999998 110.15 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -126.06 134.53 51.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.339 -0.851 . . . . 0.67000000000000004 110.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 25' ' ' PHE . . . -121.61 149.5 17.21 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.007 -1.237 . . . . 0.53000000000000003 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 25' ' ' PHE . 27.4 m -117.29 139.13 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.274 -1.133 . . . . 0.46000000000000002 110.007 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 75.2 m -88.15 156.64 19.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.889 -1.132 . . . . 0.23000000000000001 111.1 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.523 ' HB2' ' HD2' ' A' ' 23' ' ' TYR . 8.8 mmtt -148.92 179.64 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.862 -0.608 . . . . 0.47999999999999998 110.458 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 17.9 m-80 -55.73 -63.63 1.11 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.479 -0.763 . . . . 0.63 110.369 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.67 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.46999999999999997 110.549 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.004 0.431 . . . . 1.0900000000000001 110.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.39 119.78 13.64 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.518 -1.433 . . . . 1.26 109.518 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 p -107.25 143.49 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.402 -1.058 . . . . 0.51000000000000001 110.45 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.496 HG21 ' CA ' ' A' ' 8' ' ' GLY . 48.1 mm -107.41 130.95 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.36 -0.838 . . . . 0.56000000000000005 109.556 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -71.62 -39.16 70.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.796 . . . . 0.65000000000000002 111.671 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.7 133.24 15.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.359 -0.838 . . . . 0.57999999999999996 111.517 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.53 34.24 54.43 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.931 -0.868 . . . . 0.58999999999999997 110.931 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -87.41 -153.16 24.41 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.274 -1.13 . . . . 0.45000000000000001 110.274 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 tpp180 -140.68 121.64 14.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -1.05 . . . . 0.70999999999999996 109.989 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 11.4 p -151.51 -168.55 3.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.32000000000000001 111.31 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -140.86 157.6 45.15 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.493 -0.754 . . . . 0.52000000000000002 109.63 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.69 66.4 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.357 -0.839 . . . . 0.54000000000000004 109.765 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 p -101.78 44.57 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 1.0700000000000001 109.692 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -83.47 128.49 34.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.332 -0.855 . . . . 0.76000000000000001 110.916 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.18 -84.34 1.22 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.168 -1.573 . . . . 0.58999999999999997 109.168 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.96 -34.2 48.74 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 O-C-N 123.79 1.416 . . . . 0.75 113.674 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 50.6 Cg_endo -83.76 64.24 7.31 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 CA-C-N 118.912 0.647 . . . . 0.5 110.511 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -91.52 163.99 13.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.241 -0.912 . . . . 0.87 110.994 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 85.9 m -90.28 170.86 9.91 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.023 -1.048 . . . . 0.26000000000000001 111.292 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' HB2' ' N ' ' A' ' 4' ' ' ILE . 2.0 t -92.08 -39.08 11.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.287 -0.883 . . . . 0.40000000000000002 111.466 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 37.3 m -84.75 -0.14 52.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.81000000000000005 110.463 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 21' ' ' SER . 5.2 t 83.68 -3.17 1.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.002 -0.436 . . . . 0.65000000000000002 111.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 38' ' ' ARG . 46.8 t80 -101.33 151.33 22.03 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.422 -1.424 . . . . 0.38 110.419 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.26 118.5 5.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.794 -0.566 . . . . 0.28999999999999998 110.803 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.3 t80 -104.72 94.71 5.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.328 -0.857 . . . . 0.62 110.227 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.669 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.4 tm0? -120.05 144.94 47.3 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.366 -0.834 . . . . 0.40999999999999998 110.454 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.563 HD13 ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -114.26 170.06 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.408 -0.807 . . . . 0.87 110.615 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.65 19.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.55000000000000004 110.705 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.64 -43.68 1.43 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.133 -1.587 . . . . 0.5 109.133 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.92 -3.79 2.5 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.859 . . . . 0.79000000000000004 111.539 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.9 50.94 3.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.149 -0.97 . . . . 0.40000000000000002 110.31 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 13.2 p90 -128.33 131.96 48.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.331 -0.856 . . . . 0.83999999999999997 110.269 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.669 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -140.94 172.73 23.55 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.903 -1.141 . . . . 0.33000000000000002 111.194 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.6 m -129.57 148.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.586 -0.95 . . . . 0.35999999999999999 110.523 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 59.2 m -89.23 153.84 20.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.742 -1.224 . . . . 0.27000000000000002 111.813 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.97 -171.78 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.344 -0.843 . . . . 0.45000000000000001 110.068 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.23 -80.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.725 -0.61 . . . . 0.70999999999999996 111.24 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 1.75 110.713 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 109.911 -0.403 . . . . 1.3 109.911 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.69 154.88 26.24 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.282 -1.527 . . . . 0.77000000000000002 109.282 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.09 150.07 21.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.19 -1.182 . . . . 0.58999999999999997 110.634 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.507 HG21 ' CA ' ' A' ' 8' ' ' GLY . 3.0 mt -108.48 122.44 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.65000000000000002 110.021 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.52 -48.78 66.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.526 -0.734 . . . . 0.88 110.989 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -143.62 128.28 18.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.053 -1.03 . . . . 0.71999999999999997 111.185 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.94 24.46 27.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.629 -0.988 . . . . 0.56999999999999995 110.629 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.507 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -84.83 -153.06 18.47 Favored Glycine 0 N--CA 1.498 2.795 0 O-C-N 121.059 -1.26 . . . . 0.37 110.304 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.523 ' NH2' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -141.19 129.8 22.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.56999999999999995 110.468 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 p -151.7 -178.44 6.72 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.114 -0.991 . . . . 0.32000000000000001 111.126 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' HA ' ' CG ' ' A' ' 26' ' ' GLN . 2.6 p-10 -166.41 -169.91 1.52 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.691 -0.63 . . . . 0.56000000000000005 110.656 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.04 60.45 5.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.177 -0.952 . . . . 0.76000000000000001 110.406 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.3 m -144.91 133.66 22.28 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.036 -1.04 . . . . 0.84999999999999998 110.228 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.56 108.83 20.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.296 -0.877 . . . . 1.1100000000000001 110.663 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 170.61 -128.01 1.56 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.032 -1.227 . . . . 0.78000000000000003 110.032 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.65 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 38.1 Cg_endo -65.85 -31.56 47.65 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 O-C-N 123.716 1.377 . . . . 0.87 114.35 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.65 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 55.2 Cg_endo -77.69 59.27 6.74 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 118.97 0.668 . . . . 0.94999999999999996 111.793 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -108.25 146.6 32.61 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 0.68999999999999995 110.487 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 74.1 m -90.32 170.56 10.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.28999999999999998 110.452 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.54 -47.35 7.46 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.036 -1.04 . . . . 0.47999999999999998 112.554 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -87.95 10.01 20.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.132 -0.98 . . . . 0.46999999999999997 112.256 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 21' ' ' SER . 23.2 t 84.27 -5.04 1.06 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.885 -0.509 . . . . 0.41999999999999998 112.289 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.695 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.1 t80 -96.04 146.01 24.98 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.069 -1.644 . . . . 0.41999999999999998 110.743 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -151.04 112.14 4.33 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.085 0.469 . . . . 0.28999999999999998 110.213 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.786 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.5 t80 -99.61 86.36 3.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.427 -0.796 . . . . 0.51000000000000001 110.345 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.527 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.18 149.55 41.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.464 -0.773 . . . . 0.42999999999999999 110.115 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.435 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -109.11 165.42 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.233 -0.917 . . . . 0.55000000000000004 111.009 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.1 35.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.512 -0.743 . . . . 0.68999999999999995 110.976 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.47 -55.37 0.49 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.046 -1.622 . . . . 0.58999999999999997 109.046 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -122.74 0.21 9.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.678 -0.895 . . . . 1.3600000000000001 111.398 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.43 54.45 1.96 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.149 -0.969 . . . . 0.35999999999999999 110.063 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 30' ' ' GLN . 33.0 p90 -139.2 138.61 37.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.431 -0.793 . . . . 0.55000000000000004 110.628 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -159.82 -166.17 18.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.124 -1.036 . . . . 0.26000000000000001 110.982 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.786 HG22 ' HB3' ' A' ' 25' ' ' PHE . 11.6 m -132.73 143.89 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.673 -0.898 . . . . 0.34999999999999998 110.268 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 79.3 m -88.67 156.81 18.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.753 -1.217 . . . . 0.31 110.817 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.695 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -151.12 -167.14 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.67000000000000004 111.174 -179.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' A' ' 21' ' ' SER . 10.4 m120 -68.4 -89.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.701 -0.624 . . . . 0.81000000000000005 111.402 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.583 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 2.3 tpm_? . . . . . 0 N--CA 1.486 1.359 0 O-C-N 120.439 -1.413 . . . . 0.55000000000000004 111.666 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 120.942 0.401 . . . . 3.4700000000000002 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.08 115.42 6.47 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.875 -1.29 . . . . 2.2999999999999998 109.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 20' ' ' CYS . 19.1 p -126.27 165.99 17.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.42 -1.047 . . . . 1.0900000000000001 110.351 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 41.7 mm -106.63 123.97 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.377 -0.827 . . . . 0.76000000000000001 110.326 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -55.12 -44.99 75.51 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.345 -0.847 . . . . 0.45000000000000001 110.57 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.605 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -150.44 127.28 11.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.48999999999999999 110.855 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.83 32.5 7.96 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.452 -1.059 . . . . 0.60999999999999999 110.452 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -86.92 -156.42 29.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.44 -1.464 . . . . 0.46999999999999997 109.44 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 122.92 18.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 1.46 110.339 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.0 p -151.08 176.15 11.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.109 -0.995 . . . . 0.39000000000000001 111.53 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.82 172.35 7.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.889 -0.507 . . . . 0.46000000000000002 110.448 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.84 83.54 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.501 -0.749 . . . . 0.51000000000000001 111.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.49 81.97 7.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.174 -0.954 . . . . 1.1799999999999999 109.64 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -129.79 -70.92 0.62 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.82999999999999996 111.025 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 94.0 -111.08 4.08 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.988 -1.245 . . . . 0.83999999999999997 109.988 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.9 Cg_endo -65.02 -33.41 51.14 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 O-C-N 123.696 1.366 . . . . 1.1499999999999999 114.107 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.0 Cg_endo -76.51 76.28 4.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 118.889 0.639 . . . . 0.80000000000000004 110.578 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -89.59 173.69 8.17 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.201 -0.937 . . . . 0.87 110.914 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 88.8 m -76.74 -178.66 4.92 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.927 -1.108 . . . . 0.37 110.829 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 1.3 t -89.23 -36.85 15.39 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.522 -1.361 . . . . 0.60999999999999999 112.942 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.617 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 28.2 t -109.9 -75.39 0.63 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.984 -1.072 . . . . 0.56000000000000005 110.526 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.512 ' OG ' ' NH2' ' A' ' 38' ' ' ARG . 29.8 t -170.46 25.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.52000000000000002 112.154 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.562 ' HD2' ' CB ' ' A' ' 36' ' ' LYS . 3.3 t80 -135.4 150.29 49.85 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.348 -1.47 . . . . 0.39000000000000001 112.08 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.9 t -150.34 106.15 3.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.799 -0.815 . . . . 0.33000000000000002 108.799 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.4 t80 -91.68 90.59 7.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.298 -0.876 . . . . 0.57999999999999996 110.344 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.584 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.69 147.74 44.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 0.5 110.16 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -113.77 164.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.24 -0.912 . . . . 0.59999999999999998 111.103 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.5 143.78 28.33 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.493 -0.754 . . . . 0.79000000000000004 111.279 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.95 -52.54 0.7 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.693 -1.763 . . . . 0.62 108.693 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 3.5 tt0 -131.57 -3.27 3.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.668 -0.901 . . . . 1.8300000000000001 111.579 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER 70.61 60.46 0.21 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.318 -0.864 . . . . 0.39000000000000001 110.189 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 32.2 p90 -144.55 146.12 32.19 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.82 . . . . 1.0700000000000001 110.936 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 26' ' ' GLN . . . -167.16 -157.36 10.52 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 120.252 -0.975 . . . . 0.34000000000000002 110.712 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 25' ' ' PHE . 33.4 m -141.98 145.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.518 -0.99 . . . . 0.48999999999999999 110.901 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 98.2 m -88.99 158.67 17.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.897 -1.127 . . . . 0.34000000000000002 110.85 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -151.83 179.2 8.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.534 -0.757 . . . . 0.54000000000000004 110.471 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.617 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 4.5 m120 -63.02 -61.71 2.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.365 -0.834 . . . . 0.46000000000000002 110.168 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 O-C-N 121.656 -0.653 . . . . 0.55000000000000004 110.374 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.158 0.504 . . . . 1.1399999999999999 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.33 163.22 38.92 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.736 -1.346 . . . . 0.42999999999999999 109.736 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p -162.85 175.21 11.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -1.06 . . . . 0.33000000000000002 110.721 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.36 120.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.239 -0.913 . . . . 0.46999999999999997 110.435 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -29.5 70.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.527 -0.733 . . . . 0.47999999999999998 111.318 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.51 121.86 10.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.093 -1.004 . . . . 0.57999999999999996 111.082 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 25.04 37.33 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.386 -0.911 . . . . 0.35999999999999999 110.875 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -73.62 -160.67 6.5 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.838 -1.305 . . . . 0.35999999999999999 109.838 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -137.87 124.21 20.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.292 . . . . 0.54000000000000004 110.622 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.9 p -150.55 -180.0 7.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.227 -0.92 . . . . 0.28999999999999998 111.183 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -160.21 -169.91 2.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.547 . . . . 0.58999999999999997 110.652 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.07 56.86 1.04 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.326 -0.859 . . . . 0.64000000000000001 110.835 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.3 t -149.1 132.52 16.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.198 -0.939 . . . . 1.4099999999999999 110.659 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.89 89.69 4.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.397 -0.814 . . . . 2.1099999999999999 110.735 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.51 -119.99 0.51 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.323 -1.511 . . . . 0.75 109.323 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 36.4 Cg_endo -63.6 -33.15 68.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.795 1.418 . . . . 0.67000000000000004 113.217 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 56.0 Cg_endo -82.14 58.58 6.7 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 118.946 0.659 . . . . 0.72999999999999998 110.439 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -96.58 148.55 22.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.068 -1.02 . . . . 0.45000000000000001 110.155 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 84.4 m -87.05 178.37 6.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.25 110.894 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.62 -43.18 10.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.075 -1.016 . . . . 0.33000000000000002 112.793 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.588 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -107.46 -73.23 0.69 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.078 -1.014 . . . . 1.22 110.632 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.406 ' HB3' ' HD3' ' A' ' 38' ' ' ARG . 1.2 m -171.17 15.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.356 -0.84 . . . . 0.39000000000000001 112.453 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.76 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 18.1 t80 -119.15 147.64 43.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.358 -1.464 . . . . 0.39000000000000001 110.654 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 34.9 t -151.86 106.17 3.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.99 -0.444 . . . . 0.27000000000000002 109.933 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.4 t80 -97.9 91.12 5.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.68000000000000005 110.422 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.548 ' HA ' ' CA ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.85 149.12 40.55 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.89000000000000001 110.577 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.413 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -119.86 162.18 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.393 -0.817 . . . . 0.58999999999999997 110.507 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.28 154.65 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.80000000000000004 111.107 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.4 -43.95 1.3 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.269 -1.532 . . . . 0.68000000000000005 109.269 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.583 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -143.47 5.2 1.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.634 -0.921 . . . . 1.47 112.487 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 7.1 t 61.08 51.1 4.6 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.147 -0.971 . . . . 0.60999999999999999 109.684 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 27.3 p90 -132.03 137.74 47.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.80000000000000004 110.649 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 26' ' ' GLN . . . -156.18 -167.68 17.91 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.584 -1.006 . . . . 0.25 110.584 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.0 m -135.27 138.5 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.839 -0.801 . . . . 0.38 110.894 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 71.2 m -88.81 159.08 17.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.958 -1.089 . . . . 0.23999999999999999 111.863 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.592 ' CB ' ' HB3' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -151.39 -167.07 2.69 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.315 -0.857 . . . . 0.33000000000000002 110.458 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.588 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 14.5 m120 -75.51 -76.01 0.16 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.364 -0.835 . . . . 0.40999999999999998 111.447 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.76 ' HB2' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.556 0 C-N-CA 122.436 0.294 . . . . 0.5 110.536 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 120.949 0.404 . . . . 0.52000000000000002 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.32 149.67 47.47 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.439 -1.465 . . . . 0.55000000000000004 109.439 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.8 p -70.02 138.81 52.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.196 -1.179 . . . . 0.34000000000000002 110.602 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.412 HD13 ' HA2' ' A' ' 8' ' ' GLY . 2.2 mt -106.96 126.86 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.54000000000000004 110.401 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -89.49 -18.48 26.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.621 -0.675 . . . . 1.25 111.017 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 t30 -149.81 113.61 5.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.5 110.448 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.2 33.14 15.16 Favored Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.187 -0.946 . . . . 0.33000000000000002 110.845 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -75.12 -167.58 20.94 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.081 -1.608 . . . . 0.25 109.081 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -140.34 114.06 8.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.071 -1.252 . . . . 0.67000000000000004 110.784 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 p -135.56 176.67 8.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.195 -0.941 . . . . 0.28999999999999998 111.222 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.575 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 28.4 t-20 -161.19 -141.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.196 -0.668 . . . . 0.69999999999999996 109.196 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.81 25.51 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.907 -1.12 . . . . 0.56999999999999995 110.158 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -126.83 -166.52 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.393 -0.817 . . . . 0.75 110.024 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.62 7.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.245 -0.91 . . . . 0.46000000000000002 110.817 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.96 172.39 39.2 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.955 -1.258 . . . . 0.32000000000000001 109.955 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.718 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.3 Cg_endo -61.78 -33.4 85.28 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 O-C-N 123.511 1.269 . . . . 0.39000000000000001 113.302 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.718 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.7 Cg_endo -96.49 40.62 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 120.943 1.096 . . . . 0.32000000000000001 109.88 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -53.58 164.29 0.54 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.023 0.916 . . . . 0.56000000000000005 112.185 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 3.9 m -73.36 160.42 31.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.389 -0.819 . . . . 0.23000000000000001 110.155 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 6.9 t -90.45 -44.19 9.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.074 -1.016 . . . . 0.28999999999999998 112.127 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 p -99.28 -72.27 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.301 -0.874 . . . . 0.27000000000000002 109.965 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -173.37 13.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 112.895 0.702 . . . . 0.35999999999999999 112.895 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 15.1 t80 -103.64 141.51 35.91 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.01 -1.681 . . . . 0.33000000000000002 110.856 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.5 t -152.2 106.99 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 116.008 -0.542 . . . . 0.23999999999999999 109.981 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.547 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.6 t80 -92.47 88.37 6.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.075 -1.016 . . . . 0.59999999999999998 110.36 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.605 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -113.61 149.52 34.44 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.55000000000000004 110.91 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.86 162.82 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.464 -0.772 . . . . 0.58999999999999997 111.029 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.18 14.69 11.9 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.505 -0.747 . . . . 0.84999999999999998 112.066 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 -53.54 4.14 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.826 -1.309 . . . . 0.69999999999999996 109.826 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.24 7.51 10.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.563 -0.963 . . . . 2.25 111.707 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t 65.99 54.5 1.0 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.279 -0.888 . . . . 0.67000000000000004 109.769 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -148.51 149.08 31.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -0.851 . . . . 0.66000000000000003 110.675 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -148.78 168.95 29.31 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.174 -1.013 . . . . 0.29999999999999999 110.988 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 18.3 m -128.71 133.31 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.54 -0.976 . . . . 0.35999999999999999 110.126 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 75.7 m -87.21 159.53 18.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.20000000000000001 111.739 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -150.64 174.71 12.69 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.349 -0.842 . . . . 0.45000000000000001 110.852 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -66.1 -64.54 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.53000000000000003 109.827 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.854 -0.529 . . . . 0.60999999999999999 110.245 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 110.094 -0.335 . . . . 1.04 110.094 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.15 164.97 49.73 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.232 -1.147 . . . . 0.81999999999999995 110.232 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.5 p -155.46 174.53 15.12 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.288 -1.125 . . . . 0.46000000000000002 110.325 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' HB ' ' HA2' ' A' ' 8' ' ' GLY . 47.3 mt -128.62 125.32 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.148 -0.97 . . . . 0.76000000000000001 110.36 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -51.94 9.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.46000000000000002 110.746 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.39 61.8 4.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.368 -0.832 . . . . 1.1200000000000001 110.709 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.35 61.74 0.17 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.14 -1.029 . . . . 0.42999999999999999 110.747 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 4' ' ' ILE . . . -99.2 156.56 19.99 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.419 -1.473 . . . . 0.28999999999999998 109.419 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.4 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 21.5 tpt85 -108.9 131.86 54.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.991 -1.299 . . . . 0.46000000000000002 110.797 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.443 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.9 p -142.19 173.52 11.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.15 -0.969 . . . . 0.29999999999999999 110.945 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.4 ' OD1' ' NH1' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -146.82 99.16 3.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.591 -0.693 . . . . 0.5 110.45 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . . . -76.05 -11.06 59.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.472 -0.767 . . . . 0.60999999999999999 110.793 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -93.51 -15.41 25.54 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.291 -0.881 . . . . 0.81999999999999995 111.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.45 38.53 4.13 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.13 -0.981 . . . . 1.03 111.192 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 17' ' ' PRO . . . 84.46 78.69 1.12 Allowed Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.138 -1.185 . . . . 0.76000000000000001 110.138 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 40.2 Cg_endo -67.18 110.1 1.91 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.803 1.423 . . . . 0.87 111.266 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 15' ' ' GLY . 42.5 Cg_endo -75.91 -78.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.58 1.305 . . . . 0.48999999999999999 110.591 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -169.83 138.65 1.82 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.889 -1.132 . . . . 1.01 110.444 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 7.5 m -91.77 -178.38 5.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.899 -1.125 . . . . 0.22 109.937 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.13 -32.86 61.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.04 -1.037 . . . . 0.28000000000000003 111.561 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.68 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -123.32 27.81 7.35 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.023 -1.048 . . . . 0.28000000000000003 111.592 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.555 ' HB3' ' O ' ' A' ' 21' ' ' SER . 22.6 t 71.13 -4.14 1.87 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 112.702 0.63 . . . . 0.31 112.702 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 36.0 t80 -105.6 148.91 26.79 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.46 -1.4 . . . . 0.56999999999999995 110.77 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.583 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 25.9 t -152.4 117.0 5.04 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.382 -0.599 . . . . 0.31 109.382 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.604 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.0 t80 -102.2 109.92 21.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.65000000000000002 110.196 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.551 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.8 tt0 -125.57 149.07 48.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.4 -0.812 . . . . 0.66000000000000003 110.254 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.28 164.71 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.478 -0.764 . . . . 0.71999999999999997 110.722 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.56 91.43 8.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.24 110.7 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.29 -69.73 0.02 OUTLIER Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.556 -1.418 . . . . 0.72999999999999998 109.556 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -111.09 5.33 20.08 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.551 -0.97 . . . . 1.1799999999999999 111.191 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.59 58.0 0.53 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.283 -0.885 . . . . 0.59999999999999998 109.515 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 45.7 p90 -137.56 136.42 37.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.428 -0.795 . . . . 0.66000000000000003 111.193 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -129.63 151.88 19.41 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.145 -1.182 . . . . 0.25 110.145 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.1 m -117.98 136.97 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.455 -1.027 . . . . 0.39000000000000001 109.462 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.0 m -88.32 152.8 21.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.714 -1.241 . . . . 0.23000000000000001 111.602 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -151.69 -173.03 4.39 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.46 -0.791 . . . . 0.35999999999999999 111.024 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.68 ' HA ' ' HB3' ' A' ' 21' ' ' SER . 7.6 m120 -76.66 -167.3 0.8 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.261 0.553 . . . . 0.69999999999999996 110.714 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.469 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.813 . . . . 0.92000000000000004 110.098 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 120.94 0.4 . . . . 1.3100000000000001 110.004 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.29 167.55 40.26 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 109.658 -1.377 . . . . 0.77000000000000002 109.658 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 p -160.7 153.75 21.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.251 -1.146 . . . . 0.58999999999999997 110.434 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.792 HG21 ' CA ' ' A' ' 8' ' ' GLY . 32.1 mm -96.07 131.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.997 -1.064 . . . . 1.05 109.468 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -72.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.67000000000000004 111.583 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.48 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 69.0 m-80 -125.28 101.5 7.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.872 -1.143 . . . . 0.67000000000000004 110.5 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.91 62.33 0.49 Allowed Glycine 0 N--CA 1.499 2.842 0 N-CA-C 110.14 -1.184 . . . . 0.51000000000000001 110.14 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.792 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -116.78 -157.82 11.04 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.707 -1.357 . . . . 0.46000000000000002 109.707 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -139.2 132.76 30.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.348 -1.089 . . . . 0.58999999999999997 110.431 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -128.37 165.71 20.06 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.935 -1.103 . . . . 0.28999999999999998 111.508 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -115.72 178.1 4.43 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 0.57999999999999996 110.574 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 -8.99 59.72 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.213 -0.929 . . . . 0.68999999999999995 111.575 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 t -121.1 -171.09 2.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.927 -1.108 . . . . 0.82999999999999996 110.603 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.86 144.59 27.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.872 . . . . 0.64000000000000001 110.493 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 164.55 -154.69 25.66 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.727 -1.349 . . . . 0.56000000000000005 109.727 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.721 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.29 -32.92 61.11 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 O-C-N 123.801 1.422 . . . . 0.47999999999999998 113.789 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.721 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.5 Cg_endo -78.43 66.03 8.5 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-N 118.868 0.631 . . . . 0.58999999999999997 111.072 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -109.29 161.83 14.89 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.049 -1.032 . . . . 0.42999999999999999 110.919 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 32.6 m -88.67 173.5 8.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.177 -0.952 . . . . 0.28000000000000003 110.849 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 11.0 t -89.41 -48.64 7.2 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.728 -1.233 . . . . 0.40999999999999998 113.049 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.636 ' HB2' ' HA ' ' A' ' 37' ' ' ASN . 74.4 m -98.93 -73.49 0.62 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.103 -0.998 . . . . 0.38 110.695 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -174.33 23.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.39000000000000001 111.702 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 12.6 t80 -119.24 139.36 52.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.675 -1.266 . . . . 0.39000000000000001 110.772 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.9 t -153.03 108.62 3.28 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.744 -0.662 . . . . 0.25 109.315 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.782 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.9 t80 -89.11 79.8 7.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.56000000000000005 109.445 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.586 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 5.0 tt0 -109.43 154.17 22.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.776 -0.577 . . . . 0.5 110.474 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.01 168.99 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.381 -0.825 . . . . 0.53000000000000003 110.592 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.91 128.07 35.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.227 -0.92 . . . . 0.70999999999999996 110.75 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.92 -53.4 0.49 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.204 -1.158 . . . . 0.64000000000000001 110.204 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -127.82 7.45 6.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.358 -1.084 . . . . 2.27 111.949 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 11.3 t 59.57 52.19 5.88 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.249 -0.907 . . . . 0.48999999999999999 110.011 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -138.78 139.7 38.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.669 0.747 . . . . 1.03 110.846 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.586 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -162.5 178.45 38.27 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.635 -1.386 . . . . 0.28000000000000003 109.635 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.782 HG22 ' HB3' ' A' ' 25' ' ' PHE . 16.1 m -114.58 136.02 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.332 -1.099 . . . . 0.44 110.822 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.9 m -88.6 158.66 18.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.28000000000000003 111.215 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -151.6 166.18 32.01 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.229 -0.896 . . . . 0.40999999999999998 110.109 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 24.5 m-20 -83.38 -61.22 1.9 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.122 -1.066 . . . . 0.51000000000000001 108.122 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.306 0 CA-C-N 116.313 -0.403 . . . . 0.78000000000000003 109.989 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.823 0.344 . . . . 0.73999999999999999 110.428 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.55 145.15 19.39 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.803 -1.319 . . . . 0.76000000000000001 109.803 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 p -141.0 159.72 41.61 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.255 -1.144 . . . . 0.53000000000000003 111.086 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.6 mt -128.3 106.01 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.414 -0.804 . . . . 0.79000000000000004 109.687 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 3.2 mptt -54.63 -32.54 59.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.523 -0.736 . . . . 0.68999999999999995 111.6 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.474 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -97.41 8.58 44.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.103 -0.998 . . . . 0.78000000000000003 112.25 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 58.76 0.03 OUTLIER Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.11 -1.519 . . . . 0.5 111.591 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.8 -178.04 47.86 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 109.027 -1.629 . . . . 0.37 109.027 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -135.44 141.01 45.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.856 -1.379 . . . . 0.82999999999999996 110.769 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.74 -167.15 2.74 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.253 -0.904 . . . . 0.37 111.117 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 31' ' ' SER . 20.1 p-10 -151.09 -164.69 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.788 -0.57 . . . . 1.05 110.676 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.52 60.7 4.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.93000000000000005 110.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 m -147.59 120.59 8.8 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.233 -0.917 . . . . 1.55 110.373 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.47 72.57 4.02 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.822 -1.174 . . . . 1.3999999999999999 110.47 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . -140.64 -137.77 3.49 Favored Glycine 0 N--CA 1.499 2.875 0 C-N-CA 120.192 -1.004 . . . . 1.5700000000000001 110.728 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.7 Cg_endo -65.44 -33.1 48.26 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 O-C-N 123.814 1.428 . . . . 1.5900000000000001 114.602 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.673 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 48.5 Cg_endo -74.07 62.79 5.05 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 CA-C-N 118.96 0.664 . . . . 1.3999999999999999 111.155 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -97.31 160.03 14.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.077 -1.015 . . . . 0.71999999999999997 110.324 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 90.8 m -80.7 175.86 10.31 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.043 -1.036 . . . . 0.33000000000000002 111.336 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 5' ' ' LYS . 1.5 t -87.44 -31.38 20.06 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.24 -0.912 . . . . 0.53000000000000003 112.697 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.495 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -112.9 -75.46 0.6 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.154 -0.967 . . . . 0.42999999999999999 109.95 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -172.38 14.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.345 -0.847 . . . . 0.73999999999999999 112.706 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 40.3 t80 -132.01 152.0 51.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.312 -1.493 . . . . 0.56000000000000005 111.981 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 2.0 t -153.57 115.74 4.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 120.92 0.391 . . . . 0.25 110.239 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.735 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.2 t80 -93.83 98.33 11.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.302 -0.874 . . . . 0.52000000000000002 109.496 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.641 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.6 tt0 -111.34 155.87 22.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.68999999999999995 110.442 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.34 168.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.414 -0.804 . . . . 0.59999999999999998 110.569 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.73 24.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.57999999999999996 111.846 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.36 0.89 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.625 -1.79 . . . . 0.46000000000000002 108.625 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' SER . 1.7 tt0 -151.79 -80.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.892 -0.769 . . . . 1.21 110.082 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.9 OUTLIER 174.33 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.957 -0.757 . . . . 0.72999999999999998 108.957 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -138.14 126.97 23.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.005 -1.06 . . . . 0.56999999999999995 110.972 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.641 ' HA2' ' HA ' ' A' ' 26' ' ' GLN . . . -141.18 163.45 26.7 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.191 -1.004 . . . . 0.38 110.635 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 25' ' ' PHE . 15.3 m -109.38 134.89 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.61 -0.935 . . . . 0.40999999999999998 109.309 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 82.4 m -88.39 155.03 19.92 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.435 1.112 . . . . 0.34999999999999998 112.192 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.474 ' CE ' ' HA ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -151.21 -166.28 2.49 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.042 -0.981 . . . . 0.40999999999999998 109.834 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 21' ' ' SER . 7.3 m120 -60.6 -76.81 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.38 -0.825 . . . . 0.65000000000000002 111.348 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.187 -0.946 . . . . 1.48 111.101 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.116 0.484 . . . . 1.01 109.925 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.32 163.54 38.68 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.943 -1.263 . . . . 0.54000000000000004 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 p -153.7 168.43 26.28 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.44 110.202 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.538 ' HB ' ' HA3' ' A' ' 8' ' ' GLY . 4.7 mt -128.49 87.69 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.099 -1.001 . . . . 0.80000000000000004 110.267 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.451 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 15.6 pttp -68.42 -17.77 64.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.556 -0.715 . . . . 0.92000000000000004 111.642 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.414 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 5.7 m120 -97.42 51.37 1.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.198 -0.939 . . . . 0.76000000000000001 111.083 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.21 55.25 1.86 Allowed Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.072 -1.018 . . . . 0.41999999999999998 110.671 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -70.03 -170.4 8.27 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.554 -1.418 . . . . 0.41999999999999998 109.554 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -126.38 136.0 52.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.077 -1.249 . . . . 0.63 110.919 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -149.43 173.9 13.06 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.718 0.77 . . . . 0.28000000000000003 111.171 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 20.9 t-20 -155.62 143.44 19.76 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.436 -0.579 . . . . 0.48999999999999999 109.436 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.33 -20.71 66.16 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.409 -0.807 . . . . 0.57999999999999996 111.811 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -122.2 45.96 2.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.84 -1.163 . . . . 0.93999999999999995 111.169 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 11' ' ' ASN . . . -121.16 -71.38 0.74 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.003 . . . . 0.63 110.722 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.69 -75.49 0.3 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.022 -1.085 . . . . 0.51000000000000001 110.71 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.744 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.8 Cg_endo -61.58 -37.05 72.75 Favored 'Trans proline' 0 CA--C 1.552 1.408 0 O-C-N 123.708 1.373 . . . . 0.52000000000000002 114.315 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.744 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 53.6 Cg_endo -73.94 65.82 5.03 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.168 0.738 . . . . 0.39000000000000001 110.299 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -83.4 160.13 21.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.3 -0.875 . . . . 0.40999999999999998 110.629 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 81.1 m -90.86 173.23 8.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 111.402 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -78.47 -54.84 5.73 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.163 -0.961 . . . . 0.45000000000000001 113.023 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 70.0 m -101.1 -73.36 0.65 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.81999999999999995 110.827 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -168.9 18.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.177 -0.952 . . . . 0.52000000000000002 112.386 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.8 t80 -117.22 144.17 45.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.524 -1.36 . . . . 0.44 110.715 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.624 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 17.6 t -152.54 108.06 3.3 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.521 -0.548 . . . . 0.31 109.521 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.644 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.2 t80 -95.71 90.11 5.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.101 -1.0 . . . . 0.81000000000000005 110.13 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.677 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.9 tm0? -117.98 144.83 45.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.68000000000000005 110.937 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 163.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.486 -0.759 . . . . 0.56000000000000005 110.737 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.46 0.53 57.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.5 -0.75 . . . . 0.76000000000000001 111.757 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.85 45.36 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.642 -1.383 . . . . 0.68999999999999995 109.642 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -122.96 5.59 9.32 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -1.061 . . . . 1.0800000000000001 111.147 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.81 48.71 3.12 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.477 -0.764 . . . . 0.54000000000000004 110.764 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 15.4 p90 -138.88 144.17 39.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.66000000000000003 110.182 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -144.21 168.63 26.55 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.431 -1.366 . . . . 0.31 111.757 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 25' ' ' PHE . 26.9 m -123.32 134.66 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.862 -0.787 . . . . 0.44 110.201 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 77.3 m -88.78 158.21 18.23 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.27000000000000002 111.894 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -151.54 -162.38 1.52 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.333 -0.849 . . . . 0.45000000000000001 110.187 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.482 ' H ' ' HD3' ' A' ' 36' ' ' LYS . 7.6 m120 -69.34 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.568 -0.707 . . . . 0.54000000000000004 110.48 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.153 -0.967 . . . . 0.95999999999999996 110.408 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.857 0.361 . . . . 3.1000000000000001 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.89 85.54 0.59 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.243 -1.143 . . . . 0.71999999999999997 110.243 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 p -152.19 165.0 36.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.167 -1.196 . . . . 0.37 110.48 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 20' ' ' CYS . 30.3 mt -120.59 122.24 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.80000000000000004 109.433 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -52.33 -43.27 64.49 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.528 -0.732 . . . . 0.46000000000000002 111.573 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -130.42 99.96 5.19 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.514 -0.741 . . . . 1.3 110.604 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.84 68.21 0.78 Allowed Glycine 0 N--CA 1.499 2.833 0 N-CA-C 109.928 -1.269 . . . . 0.52000000000000002 109.928 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.35 172.72 14.77 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.551 -1.42 . . . . 0.28999999999999998 109.551 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.61 132.7 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.139 -1.212 . . . . 0.91000000000000003 110.719 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p -150.34 -171.14 3.84 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.124 -0.985 . . . . 0.26000000000000001 111.268 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.19 138.48 11.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.57999999999999996 109.593 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 60.55 6.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.333 -0.855 . . . . 0.58999999999999997 110.276 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -136.81 -162.96 1.34 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.427 -0.796 . . . . 0.71999999999999997 110.663 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.56 101.53 13.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.165 -0.959 . . . . 0.93000000000000005 110.428 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.9 0.21 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.193 -1.163 . . . . 0.51000000000000001 110.193 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.91 120.14 7.21 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.914 1.481 . . . . 0.52000000000000002 111.046 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.16 -164.52 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.945 1.497 . . . . 0.53000000000000003 110.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -58.05 153.09 15.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.286 -0.884 . . . . 1.0700000000000001 111.051 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 m -72.51 -171.87 0.87 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.26 -0.9 . . . . 0.23000000000000001 110.7 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 1.8 t -70.77 -39.31 73.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.656 -1.278 . . . . 0.27000000000000002 112.436 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 10.1 m -101.11 -75.0 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.32000000000000001 109.333 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.67 ' HB3' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -175.64 18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.726 -0.609 . . . . 0.34999999999999998 111.92 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 23.3 t80 -137.93 154.19 49.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.504 -1.372 . . . . 0.47999999999999998 111.791 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -151.33 120.62 6.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.407 -0.96 . . . . 0.32000000000000001 108.407 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.547 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t80 -113.44 114.8 27.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.60999999999999999 110.981 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.524 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 41.4 tt0 -126.59 147.64 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.87 111.174 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.18 169.7 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.724 . . . . 0.72999999999999998 110.892 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.05 155.32 26.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.486 -0.759 . . . . 1.01 111.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.54 -47.33 1.03 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.472 -1.851 . . . . 0.97999999999999998 108.472 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.37 -2.94 1.76 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.761 -0.846 . . . . 1.47 111.9 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t 64.96 51.98 1.64 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.012 -1.055 . . . . 0.72999999999999998 110.15 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -126.06 134.53 51.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.339 -0.851 . . . . 0.67000000000000004 110.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 25' ' ' PHE . . . -121.61 149.5 17.21 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.007 -1.237 . . . . 0.53000000000000003 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 25' ' ' PHE . 27.4 m -117.29 139.13 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.274 -1.133 . . . . 0.46000000000000002 110.007 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 75.2 m -88.15 156.64 19.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.889 -1.132 . . . . 0.23000000000000001 111.1 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.523 ' HB2' ' HD2' ' A' ' 23' ' ' TYR . 8.8 mmtt -148.92 179.64 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.862 -0.608 . . . . 0.47999999999999998 110.458 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 17.9 m-80 -55.73 -63.63 1.11 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.479 -0.763 . . . . 0.63 110.369 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.67 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.46999999999999997 110.549 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.004 0.431 . . . . 1.0900000000000001 110.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.39 119.78 13.64 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.518 -1.433 . . . . 1.26 109.518 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 p -107.25 143.49 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.402 -1.058 . . . . 0.51000000000000001 110.45 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.496 HG21 ' CA ' ' A' ' 8' ' ' GLY . 48.1 mm -107.41 130.95 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.36 -0.838 . . . . 0.56000000000000005 109.556 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -71.62 -39.16 70.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.796 . . . . 0.65000000000000002 111.671 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.7 133.24 15.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.359 -0.838 . . . . 0.57999999999999996 111.517 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.53 34.24 54.43 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.931 -0.868 . . . . 0.58999999999999997 110.931 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.496 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -87.41 -153.16 24.41 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.274 -1.13 . . . . 0.45000000000000001 110.274 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 tpp180 -140.68 121.64 14.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -1.05 . . . . 0.70999999999999996 109.989 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 11.4 p -151.51 -168.55 3.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.32000000000000001 111.31 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -140.86 157.6 45.15 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.493 -0.754 . . . . 0.52000000000000002 109.63 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.69 66.4 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.357 -0.839 . . . . 0.54000000000000004 109.765 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 p -101.78 44.57 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 1.0700000000000001 109.692 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -83.47 128.49 34.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.332 -0.855 . . . . 0.76000000000000001 110.916 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.18 -84.34 1.22 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.168 -1.573 . . . . 0.58999999999999997 109.168 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.96 -34.2 48.74 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 O-C-N 123.79 1.416 . . . . 0.75 113.674 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 50.6 Cg_endo -83.76 64.24 7.31 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 CA-C-N 118.912 0.647 . . . . 0.5 110.511 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -91.52 163.99 13.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.241 -0.912 . . . . 0.87 110.994 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 85.9 m -90.28 170.86 9.91 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.023 -1.048 . . . . 0.26000000000000001 111.292 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' HB2' ' N ' ' A' ' 4' ' ' ILE . 2.0 t -92.08 -39.08 11.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.287 -0.883 . . . . 0.40000000000000002 111.466 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 37.3 m -84.75 -0.14 52.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.81000000000000005 110.463 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 21' ' ' SER . 5.2 t 83.68 -3.17 1.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.002 -0.436 . . . . 0.65000000000000002 111.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 38' ' ' ARG . 46.8 t80 -101.33 151.33 22.03 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.422 -1.424 . . . . 0.38 110.419 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.26 118.5 5.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.794 -0.566 . . . . 0.28999999999999998 110.803 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.591 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.3 t80 -104.72 94.71 5.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.328 -0.857 . . . . 0.62 110.227 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.669 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.4 tm0? -120.05 144.94 47.3 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.366 -0.834 . . . . 0.40999999999999998 110.454 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.563 HD13 ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -114.26 170.06 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.408 -0.807 . . . . 0.87 110.615 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.65 19.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.55000000000000004 110.705 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.64 -43.68 1.43 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.133 -1.587 . . . . 0.5 109.133 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.92 -3.79 2.5 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.859 . . . . 0.79000000000000004 111.539 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.9 50.94 3.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.149 -0.97 . . . . 0.40000000000000002 110.31 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 13.2 p90 -128.33 131.96 48.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.331 -0.856 . . . . 0.83999999999999997 110.269 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.669 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -140.94 172.73 23.55 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.903 -1.141 . . . . 0.33000000000000002 111.194 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.6 m -129.57 148.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.586 -0.95 . . . . 0.35999999999999999 110.523 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 59.2 m -89.23 153.84 20.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.742 -1.224 . . . . 0.27000000000000002 111.813 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.97 -171.78 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.344 -0.843 . . . . 0.45000000000000001 110.068 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.23 -80.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.725 -0.61 . . . . 0.70999999999999996 111.24 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 1.75 110.713 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 109.911 -0.403 . . . . 1.3 109.911 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.69 154.88 26.24 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.282 -1.527 . . . . 0.77000000000000002 109.282 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.09 150.07 21.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.19 -1.182 . . . . 0.58999999999999997 110.634 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.507 HG21 ' CA ' ' A' ' 8' ' ' GLY . 3.0 mt -108.48 122.44 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.65000000000000002 110.021 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.52 -48.78 66.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.526 -0.734 . . . . 0.88 110.989 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -143.62 128.28 18.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.053 -1.03 . . . . 0.71999999999999997 111.185 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.94 24.46 27.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.629 -0.988 . . . . 0.56999999999999995 110.629 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.507 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -84.83 -153.06 18.47 Favored Glycine 0 N--CA 1.498 2.795 0 O-C-N 121.059 -1.26 . . . . 0.37 110.304 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.523 ' NH2' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -141.19 129.8 22.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.56999999999999995 110.468 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 p -151.7 -178.44 6.72 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.114 -0.991 . . . . 0.32000000000000001 111.126 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.422 ' HA ' ' CG ' ' A' ' 26' ' ' GLN . 2.6 p-10 -166.41 -169.91 1.52 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.691 -0.63 . . . . 0.56000000000000005 110.656 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.04 60.45 5.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.177 -0.952 . . . . 0.76000000000000001 110.406 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.3 m -144.91 133.66 22.28 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.036 -1.04 . . . . 0.84999999999999998 110.228 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.56 108.83 20.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.296 -0.877 . . . . 1.1100000000000001 110.663 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 170.61 -128.01 1.56 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.032 -1.227 . . . . 0.78000000000000003 110.032 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.65 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 38.1 Cg_endo -65.85 -31.56 47.65 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 O-C-N 123.716 1.377 . . . . 0.87 114.35 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.65 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 55.2 Cg_endo -77.69 59.27 6.74 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 118.97 0.668 . . . . 0.94999999999999996 111.793 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -108.25 146.6 32.61 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 0.68999999999999995 110.487 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 74.1 m -90.32 170.56 10.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.28999999999999998 110.452 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.54 -47.35 7.46 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.036 -1.04 . . . . 0.47999999999999998 112.554 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -87.95 10.01 20.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.132 -0.98 . . . . 0.46999999999999997 112.256 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 21' ' ' SER . 23.2 t 84.27 -5.04 1.06 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.885 -0.509 . . . . 0.41999999999999998 112.289 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.695 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.1 t80 -96.04 146.01 24.98 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.069 -1.644 . . . . 0.41999999999999998 110.743 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -151.04 112.14 4.33 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.085 0.469 . . . . 0.28999999999999998 110.213 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.786 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.5 t80 -99.61 86.36 3.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.427 -0.796 . . . . 0.51000000000000001 110.345 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.527 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.18 149.55 41.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.464 -0.773 . . . . 0.42999999999999999 110.115 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.435 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -109.11 165.42 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.233 -0.917 . . . . 0.55000000000000004 111.009 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.1 35.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.512 -0.743 . . . . 0.68999999999999995 110.976 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.47 -55.37 0.49 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.046 -1.622 . . . . 0.58999999999999997 109.046 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -122.74 0.21 9.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.678 -0.895 . . . . 1.3600000000000001 111.398 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.43 54.45 1.96 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.149 -0.969 . . . . 0.35999999999999999 110.063 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 30' ' ' GLN . 33.0 p90 -139.2 138.61 37.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.431 -0.793 . . . . 0.55000000000000004 110.628 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -159.82 -166.17 18.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.124 -1.036 . . . . 0.26000000000000001 110.982 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.786 HG22 ' HB3' ' A' ' 25' ' ' PHE . 11.6 m -132.73 143.89 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.673 -0.898 . . . . 0.34999999999999998 110.268 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 79.3 m -88.67 156.81 18.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.753 -1.217 . . . . 0.31 110.817 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.695 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -151.12 -167.14 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.67000000000000004 111.174 -179.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' A' ' 21' ' ' SER . 10.4 m120 -68.4 -89.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.701 -0.624 . . . . 0.81000000000000005 111.402 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.583 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 2.3 tpm_? . . . . . 0 N--CA 1.486 1.359 0 O-C-N 120.439 -1.413 . . . . 0.55000000000000004 111.666 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 120.942 0.401 . . . . 3.4700000000000002 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.08 115.42 6.47 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.875 -1.29 . . . . 2.2999999999999998 109.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 20' ' ' CYS . 19.1 p -126.27 165.99 17.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.42 -1.047 . . . . 1.0900000000000001 110.351 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 41.7 mm -106.63 123.97 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.377 -0.827 . . . . 0.76000000000000001 110.326 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -55.12 -44.99 75.51 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.345 -0.847 . . . . 0.45000000000000001 110.57 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.605 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -150.44 127.28 11.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.48999999999999999 110.855 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.83 32.5 7.96 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.452 -1.059 . . . . 0.60999999999999999 110.452 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -86.92 -156.42 29.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.44 -1.464 . . . . 0.46999999999999997 109.44 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 122.92 18.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 1.46 110.339 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.0 p -151.08 176.15 11.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.109 -0.995 . . . . 0.39000000000000001 111.53 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.82 172.35 7.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.889 -0.507 . . . . 0.46000000000000002 110.448 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.84 83.54 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.501 -0.749 . . . . 0.51000000000000001 111.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.49 81.97 7.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.174 -0.954 . . . . 1.1799999999999999 109.64 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -129.79 -70.92 0.62 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.82999999999999996 111.025 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 94.0 -111.08 4.08 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.988 -1.245 . . . . 0.83999999999999997 109.988 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.9 Cg_endo -65.02 -33.41 51.14 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 O-C-N 123.696 1.366 . . . . 1.1499999999999999 114.107 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.0 Cg_endo -76.51 76.28 4.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 118.889 0.639 . . . . 0.80000000000000004 110.578 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -89.59 173.69 8.17 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.201 -0.937 . . . . 0.87 110.914 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 88.8 m -76.74 -178.66 4.92 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.927 -1.108 . . . . 0.37 110.829 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 1.3 t -89.23 -36.85 15.39 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.522 -1.361 . . . . 0.60999999999999999 112.942 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.617 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 28.2 t -109.9 -75.39 0.63 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.984 -1.072 . . . . 0.56000000000000005 110.526 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.512 ' OG ' ' NH2' ' A' ' 38' ' ' ARG . 29.8 t -170.46 25.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.52000000000000002 112.154 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.562 ' HD2' ' CB ' ' A' ' 36' ' ' LYS . 3.3 t80 -135.4 150.29 49.85 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.348 -1.47 . . . . 0.39000000000000001 112.08 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.9 t -150.34 106.15 3.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.799 -0.815 . . . . 0.33000000000000002 108.799 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.4 t80 -91.68 90.59 7.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.298 -0.876 . . . . 0.57999999999999996 110.344 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.584 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.69 147.74 44.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 0.5 110.16 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -113.77 164.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.24 -0.912 . . . . 0.59999999999999998 111.103 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.5 143.78 28.33 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.493 -0.754 . . . . 0.79000000000000004 111.279 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.95 -52.54 0.7 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.693 -1.763 . . . . 0.62 108.693 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 3.5 tt0 -131.57 -3.27 3.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.668 -0.901 . . . . 1.8300000000000001 111.579 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER 70.61 60.46 0.21 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.318 -0.864 . . . . 0.39000000000000001 110.189 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 32.2 p90 -144.55 146.12 32.19 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.82 . . . . 1.0700000000000001 110.936 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 26' ' ' GLN . . . -167.16 -157.36 10.52 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 120.252 -0.975 . . . . 0.34000000000000002 110.712 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 25' ' ' PHE . 33.4 m -141.98 145.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.518 -0.99 . . . . 0.48999999999999999 110.901 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 98.2 m -88.99 158.67 17.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.897 -1.127 . . . . 0.34000000000000002 110.85 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -151.83 179.2 8.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.534 -0.757 . . . . 0.54000000000000004 110.471 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.617 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 4.5 m120 -63.02 -61.71 2.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.365 -0.834 . . . . 0.46000000000000002 110.168 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.512 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 O-C-N 121.656 -0.653 . . . . 0.55000000000000004 110.374 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.158 0.504 . . . . 1.1399999999999999 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.33 163.22 38.92 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.736 -1.346 . . . . 0.42999999999999999 109.736 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p -162.85 175.21 11.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -1.06 . . . . 0.33000000000000002 110.721 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.36 120.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.239 -0.913 . . . . 0.46999999999999997 110.435 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -29.5 70.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.527 -0.733 . . . . 0.47999999999999998 111.318 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.51 121.86 10.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.093 -1.004 . . . . 0.57999999999999996 111.082 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 25.04 37.33 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.386 -0.911 . . . . 0.35999999999999999 110.875 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -73.62 -160.67 6.5 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.838 -1.305 . . . . 0.35999999999999999 109.838 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -137.87 124.21 20.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.292 . . . . 0.54000000000000004 110.622 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.9 p -150.55 -180.0 7.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.227 -0.92 . . . . 0.28999999999999998 111.183 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -160.21 -169.91 2.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.547 . . . . 0.58999999999999997 110.652 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.07 56.86 1.04 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.326 -0.859 . . . . 0.64000000000000001 110.835 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.3 t -149.1 132.52 16.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.198 -0.939 . . . . 1.4099999999999999 110.659 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.89 89.69 4.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.397 -0.814 . . . . 2.1099999999999999 110.735 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.51 -119.99 0.51 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.323 -1.511 . . . . 0.75 109.323 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 36.4 Cg_endo -63.6 -33.15 68.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.795 1.418 . . . . 0.67000000000000004 113.217 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 56.0 Cg_endo -82.14 58.58 6.7 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 118.946 0.659 . . . . 0.72999999999999998 110.439 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -96.58 148.55 22.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.068 -1.02 . . . . 0.45000000000000001 110.155 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 84.4 m -87.05 178.37 6.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.25 110.894 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.62 -43.18 10.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.075 -1.016 . . . . 0.33000000000000002 112.793 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.588 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -107.46 -73.23 0.69 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.078 -1.014 . . . . 1.22 110.632 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.406 ' HB3' ' HD3' ' A' ' 38' ' ' ARG . 1.2 m -171.17 15.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.356 -0.84 . . . . 0.39000000000000001 112.453 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.76 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 18.1 t80 -119.15 147.64 43.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.358 -1.464 . . . . 0.39000000000000001 110.654 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 34.9 t -151.86 106.17 3.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.99 -0.444 . . . . 0.27000000000000002 109.933 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.4 t80 -97.9 91.12 5.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.68000000000000005 110.422 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.548 ' HA ' ' CA ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.85 149.12 40.55 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.89000000000000001 110.577 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.413 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -119.86 162.18 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.393 -0.817 . . . . 0.58999999999999997 110.507 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.28 154.65 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.80000000000000004 111.107 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.4 -43.95 1.3 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.269 -1.532 . . . . 0.68000000000000005 109.269 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.583 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -143.47 5.2 1.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.634 -0.921 . . . . 1.47 112.487 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 7.1 t 61.08 51.1 4.6 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.147 -0.971 . . . . 0.60999999999999999 109.684 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 27.3 p90 -132.03 137.74 47.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.80000000000000004 110.649 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 26' ' ' GLN . . . -156.18 -167.68 17.91 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.584 -1.006 . . . . 0.25 110.584 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.0 m -135.27 138.5 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.839 -0.801 . . . . 0.38 110.894 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 71.2 m -88.81 159.08 17.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.958 -1.089 . . . . 0.23999999999999999 111.863 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.592 ' CB ' ' HB3' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -151.39 -167.07 2.69 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.315 -0.857 . . . . 0.33000000000000002 110.458 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.588 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 14.5 m120 -75.51 -76.01 0.16 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.364 -0.835 . . . . 0.40999999999999998 111.447 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.76 ' HB2' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.556 0 C-N-CA 122.436 0.294 . . . . 0.5 110.536 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 120.949 0.404 . . . . 0.52000000000000002 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.32 149.67 47.47 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.439 -1.465 . . . . 0.55000000000000004 109.439 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.8 p -70.02 138.81 52.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.196 -1.179 . . . . 0.34000000000000002 110.602 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.412 HD13 ' HA2' ' A' ' 8' ' ' GLY . 2.2 mt -106.96 126.86 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.54000000000000004 110.401 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -89.49 -18.48 26.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.621 -0.675 . . . . 1.25 111.017 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 t30 -149.81 113.61 5.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.5 110.448 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.2 33.14 15.16 Favored Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.187 -0.946 . . . . 0.33000000000000002 110.845 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -75.12 -167.58 20.94 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.081 -1.608 . . . . 0.25 109.081 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -140.34 114.06 8.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.071 -1.252 . . . . 0.67000000000000004 110.784 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 p -135.56 176.67 8.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.195 -0.941 . . . . 0.28999999999999998 111.222 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.575 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 28.4 t-20 -161.19 -141.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.196 -0.668 . . . . 0.69999999999999996 109.196 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.81 25.51 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.907 -1.12 . . . . 0.56999999999999995 110.158 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -126.83 -166.52 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.393 -0.817 . . . . 0.75 110.024 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.62 7.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.245 -0.91 . . . . 0.46000000000000002 110.817 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.96 172.39 39.2 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.955 -1.258 . . . . 0.32000000000000001 109.955 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.718 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.3 Cg_endo -61.78 -33.4 85.28 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 O-C-N 123.511 1.269 . . . . 0.39000000000000001 113.302 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.718 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.7 Cg_endo -96.49 40.62 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 120.943 1.096 . . . . 0.32000000000000001 109.88 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -53.58 164.29 0.54 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.023 0.916 . . . . 0.56000000000000005 112.185 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 3.9 m -73.36 160.42 31.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.389 -0.819 . . . . 0.23000000000000001 110.155 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 6.9 t -90.45 -44.19 9.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.074 -1.016 . . . . 0.28999999999999998 112.127 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 p -99.28 -72.27 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.301 -0.874 . . . . 0.27000000000000002 109.965 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -173.37 13.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 112.895 0.702 . . . . 0.35999999999999999 112.895 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 15.1 t80 -103.64 141.51 35.91 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.01 -1.681 . . . . 0.33000000000000002 110.856 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.5 t -152.2 106.99 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 116.008 -0.542 . . . . 0.23999999999999999 109.981 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.547 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.6 t80 -92.47 88.37 6.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.075 -1.016 . . . . 0.59999999999999998 110.36 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.605 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -113.61 149.52 34.44 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.55000000000000004 110.91 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.86 162.82 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.464 -0.772 . . . . 0.58999999999999997 111.029 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.18 14.69 11.9 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.505 -0.747 . . . . 0.84999999999999998 112.066 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 -53.54 4.14 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.826 -1.309 . . . . 0.69999999999999996 109.826 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.24 7.51 10.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.563 -0.963 . . . . 2.25 111.707 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t 65.99 54.5 1.0 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.279 -0.888 . . . . 0.67000000000000004 109.769 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -148.51 149.08 31.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -0.851 . . . . 0.66000000000000003 110.675 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -148.78 168.95 29.31 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.174 -1.013 . . . . 0.29999999999999999 110.988 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 18.3 m -128.71 133.31 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.54 -0.976 . . . . 0.35999999999999999 110.126 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 75.7 m -87.21 159.53 18.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.20000000000000001 111.739 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -150.64 174.71 12.69 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.349 -0.842 . . . . 0.45000000000000001 110.852 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -66.1 -64.54 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.53000000000000003 109.827 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.854 -0.529 . . . . 0.60999999999999999 110.245 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 110.094 -0.335 . . . . 1.04 110.094 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.15 164.97 49.73 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.232 -1.147 . . . . 0.81999999999999995 110.232 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.5 p -155.46 174.53 15.12 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.288 -1.125 . . . . 0.46000000000000002 110.325 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' HB ' ' HA2' ' A' ' 8' ' ' GLY . 47.3 mt -128.62 125.32 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.148 -0.97 . . . . 0.76000000000000001 110.36 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -51.94 9.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.503 -0.748 . . . . 0.46000000000000002 110.746 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.39 61.8 4.48 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.368 -0.832 . . . . 1.1200000000000001 110.709 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.35 61.74 0.17 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 120.14 -1.029 . . . . 0.42999999999999999 110.747 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 4' ' ' ILE . . . -99.2 156.56 19.99 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 109.419 -1.473 . . . . 0.28999999999999998 109.419 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.4 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 21.5 tpt85 -108.9 131.86 54.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.991 -1.299 . . . . 0.46000000000000002 110.797 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.443 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 2.9 p -142.19 173.52 11.44 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.15 -0.969 . . . . 0.29999999999999999 110.945 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.4 ' OD1' ' NH1' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -146.82 99.16 3.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.591 -0.693 . . . . 0.5 110.45 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . . . -76.05 -11.06 59.88 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.472 -0.767 . . . . 0.60999999999999999 110.793 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -93.51 -15.41 25.54 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.291 -0.881 . . . . 0.81999999999999995 111.347 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.45 38.53 4.13 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.13 -0.981 . . . . 1.03 111.192 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.422 ' O ' ' HD3' ' A' ' 17' ' ' PRO . . . 84.46 78.69 1.12 Allowed Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.138 -1.185 . . . . 0.76000000000000001 110.138 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 12' ' ' ALA . 40.2 Cg_endo -67.18 110.1 1.91 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.803 1.423 . . . . 0.87 111.266 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 15' ' ' GLY . 42.5 Cg_endo -75.91 -78.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 O-C-N 123.58 1.305 . . . . 0.48999999999999999 110.591 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -169.83 138.65 1.82 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.889 -1.132 . . . . 1.01 110.444 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 7.5 m -91.77 -178.38 5.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.899 -1.125 . . . . 0.22 109.937 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -75.13 -32.86 61.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.04 -1.037 . . . . 0.28000000000000003 111.561 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.68 ' HB3' ' HA ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -123.32 27.81 7.35 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.023 -1.048 . . . . 0.28000000000000003 111.592 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.555 ' HB3' ' O ' ' A' ' 21' ' ' SER . 22.6 t 71.13 -4.14 1.87 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 112.702 0.63 . . . . 0.31 112.702 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 36.0 t80 -105.6 148.91 26.79 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.46 -1.4 . . . . 0.56999999999999995 110.77 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.583 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 25.9 t -152.4 117.0 5.04 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.382 -0.599 . . . . 0.31 109.382 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.604 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.0 t80 -102.2 109.92 21.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.455 -0.778 . . . . 0.65000000000000002 110.196 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.551 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.8 tt0 -125.57 149.07 48.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.4 -0.812 . . . . 0.66000000000000003 110.254 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.28 164.71 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.478 -0.764 . . . . 0.71999999999999997 110.722 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.56 91.43 8.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.548 -0.72 . . . . 1.24 110.7 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.29 -69.73 0.02 OUTLIER Glycine 0 N--CA 1.499 2.876 0 N-CA-C 109.556 -1.418 . . . . 0.72999999999999998 109.556 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -111.09 5.33 20.08 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.551 -0.97 . . . . 1.1799999999999999 111.191 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 67.59 58.0 0.53 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.283 -0.885 . . . . 0.59999999999999998 109.515 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 45.7 p90 -137.56 136.42 37.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.428 -0.795 . . . . 0.66000000000000003 111.193 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -129.63 151.88 19.41 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.145 -1.182 . . . . 0.25 110.145 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.1 m -117.98 136.97 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.455 -1.027 . . . . 0.39000000000000001 109.462 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.0 m -88.32 152.8 21.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.714 -1.241 . . . . 0.23000000000000001 111.602 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -151.69 -173.03 4.39 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.46 -0.791 . . . . 0.35999999999999999 111.024 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.68 ' HA ' ' HB3' ' A' ' 21' ' ' SER . 7.6 m120 -76.66 -167.3 0.8 Allowed 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.261 0.553 . . . . 0.69999999999999996 110.714 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.469 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.813 . . . . 0.92000000000000004 110.098 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 120.94 0.4 . . . . 1.3100000000000001 110.004 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.29 167.55 40.26 Favored Glycine 0 N--CA 1.498 2.768 0 N-CA-C 109.658 -1.377 . . . . 0.77000000000000002 109.658 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 p -160.7 153.75 21.46 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.251 -1.146 . . . . 0.58999999999999997 110.434 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.792 HG21 ' CA ' ' A' ' 8' ' ' GLY . 32.1 mm -96.07 131.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.997 -1.064 . . . . 1.05 109.468 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.71 -72.94 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.383 -0.823 . . . . 0.67000000000000004 111.583 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.48 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 69.0 m-80 -125.28 101.5 7.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.872 -1.143 . . . . 0.67000000000000004 110.5 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.91 62.33 0.49 Allowed Glycine 0 N--CA 1.499 2.842 0 N-CA-C 110.14 -1.184 . . . . 0.51000000000000001 110.14 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.792 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -116.78 -157.82 11.04 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.707 -1.357 . . . . 0.46000000000000002 109.707 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -139.2 132.76 30.38 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.348 -1.089 . . . . 0.58999999999999997 110.431 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -128.37 165.71 20.06 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.935 -1.103 . . . . 0.28999999999999998 111.508 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -115.72 178.1 4.43 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 0.57999999999999996 110.574 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.9 -8.99 59.72 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.213 -0.929 . . . . 0.68999999999999995 111.575 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.7 t -121.1 -171.09 2.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.927 -1.108 . . . . 0.82999999999999996 110.603 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.86 144.59 27.28 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.304 -0.872 . . . . 0.64000000000000001 110.493 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 164.55 -154.69 25.66 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.727 -1.349 . . . . 0.56000000000000005 109.727 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.721 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.29 -32.92 61.11 Favored 'Trans proline' 0 CA--C 1.553 1.445 0 O-C-N 123.801 1.422 . . . . 0.47999999999999998 113.789 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.721 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.5 Cg_endo -78.43 66.03 8.5 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 CA-C-N 118.868 0.631 . . . . 0.58999999999999997 111.072 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -109.29 161.83 14.89 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.049 -1.032 . . . . 0.42999999999999999 110.919 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 32.6 m -88.67 173.5 8.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.177 -0.952 . . . . 0.28000000000000003 110.849 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 11.0 t -89.41 -48.64 7.2 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.728 -1.233 . . . . 0.40999999999999998 113.049 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.636 ' HB2' ' HA ' ' A' ' 37' ' ' ASN . 74.4 m -98.93 -73.49 0.62 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.103 -0.998 . . . . 0.38 110.695 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -174.33 23.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.503 -0.748 . . . . 0.39000000000000001 111.702 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 12.6 t80 -119.24 139.36 52.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.675 -1.266 . . . . 0.39000000000000001 110.772 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.9 t -153.03 108.62 3.28 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.744 -0.662 . . . . 0.25 109.315 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.782 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.9 t80 -89.11 79.8 7.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.008 -1.057 . . . . 0.56000000000000005 109.445 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.586 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 5.0 tt0 -109.43 154.17 22.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.776 -0.577 . . . . 0.5 110.474 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -120.01 168.99 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.381 -0.825 . . . . 0.53000000000000003 110.592 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.91 128.07 35.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.227 -0.92 . . . . 0.70999999999999996 110.75 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.92 -53.4 0.49 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.204 -1.158 . . . . 0.64000000000000001 110.204 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -127.82 7.45 6.18 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.358 -1.084 . . . . 2.27 111.949 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 11.3 t 59.57 52.19 5.88 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.249 -0.907 . . . . 0.48999999999999999 110.011 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -138.78 139.7 38.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.669 0.747 . . . . 1.03 110.846 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.586 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -162.5 178.45 38.27 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.635 -1.386 . . . . 0.28000000000000003 109.635 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.782 HG22 ' HB3' ' A' ' 25' ' ' PHE . 16.1 m -114.58 136.02 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.332 -1.099 . . . . 0.44 110.822 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 10' ' ' CYS . 87.9 m -88.6 158.66 18.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.989 -1.069 . . . . 0.28000000000000003 111.215 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -151.6 166.18 32.01 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.229 -0.896 . . . . 0.40999999999999998 110.109 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 21' ' ' SER . 24.5 m-20 -83.38 -61.22 1.9 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.122 -1.066 . . . . 0.51000000000000001 108.122 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.306 0 CA-C-N 116.313 -0.403 . . . . 0.78000000000000003 109.989 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 120.823 0.344 . . . . 0.73999999999999999 110.428 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.55 145.15 19.39 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.803 -1.319 . . . . 0.76000000000000001 109.803 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.2 p -141.0 159.72 41.61 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.255 -1.144 . . . . 0.53000000000000003 111.086 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.6 mt -128.3 106.01 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.414 -0.804 . . . . 0.79000000000000004 109.687 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HG3' ' CB ' ' A' ' 21' ' ' SER . 3.2 mptt -54.63 -32.54 59.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.523 -0.736 . . . . 0.68999999999999995 111.6 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.474 ' HA ' ' CE ' ' A' ' 36' ' ' LYS . 1.1 t-20 -97.41 8.58 44.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.103 -0.998 . . . . 0.78000000000000003 112.25 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.02 58.76 0.03 OUTLIER Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.11 -1.519 . . . . 0.5 111.591 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.8 -178.04 47.86 Favored Glycine 0 N--CA 1.502 3.055 0 N-CA-C 109.027 -1.629 . . . . 0.37 109.027 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -135.44 141.01 45.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.856 -1.379 . . . . 0.82999999999999996 110.769 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.74 -167.15 2.74 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.253 -0.904 . . . . 0.37 111.117 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 31' ' ' SER . 20.1 p-10 -151.09 -164.69 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.788 -0.57 . . . . 1.05 110.676 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.52 60.7 4.14 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.93000000000000005 110.646 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.3 m -147.59 120.59 8.8 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.233 -0.917 . . . . 1.55 110.373 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.47 72.57 4.02 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.822 -1.174 . . . . 1.3999999999999999 110.47 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . -140.64 -137.77 3.49 Favored Glycine 0 N--CA 1.499 2.875 0 C-N-CA 120.192 -1.004 . . . . 1.5700000000000001 110.728 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.673 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.7 Cg_endo -65.44 -33.1 48.26 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 O-C-N 123.814 1.428 . . . . 1.5900000000000001 114.602 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.673 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 48.5 Cg_endo -74.07 62.79 5.05 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 CA-C-N 118.96 0.664 . . . . 1.3999999999999999 111.155 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -97.31 160.03 14.57 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.077 -1.015 . . . . 0.71999999999999997 110.324 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 90.8 m -80.7 175.86 10.31 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.043 -1.036 . . . . 0.33000000000000002 111.336 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.463 ' SG ' ' HD2' ' A' ' 5' ' ' LYS . 1.5 t -87.44 -31.38 20.06 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.24 -0.912 . . . . 0.53000000000000003 112.697 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.495 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -112.9 -75.46 0.6 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.154 -0.967 . . . . 0.42999999999999999 109.95 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -172.38 14.12 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.345 -0.847 . . . . 0.73999999999999999 112.706 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 40.3 t80 -132.01 152.0 51.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.312 -1.493 . . . . 0.56000000000000005 111.981 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 2.0 t -153.57 115.74 4.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 120.92 0.391 . . . . 0.25 110.239 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.735 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.2 t80 -93.83 98.33 11.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.302 -0.874 . . . . 0.52000000000000002 109.496 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.641 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 4.6 tt0 -111.34 155.87 22.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.68999999999999995 110.442 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.34 168.51 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.414 -0.804 . . . . 0.59999999999999998 110.569 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.0 165.73 24.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.366 -0.834 . . . . 0.57999999999999996 111.846 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.27 -50.36 0.89 Allowed Glycine 0 N--CA 1.496 2.683 0 N-CA-C 108.625 -1.79 . . . . 0.46000000000000002 108.625 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' SER . 1.7 tt0 -151.79 -80.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.892 -0.769 . . . . 1.21 110.082 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 30' ' ' GLN . 0.9 OUTLIER 174.33 71.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.957 -0.757 . . . . 0.72999999999999998 108.957 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -138.14 126.97 23.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.005 -1.06 . . . . 0.56999999999999995 110.972 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.641 ' HA2' ' HA ' ' A' ' 26' ' ' GLN . . . -141.18 163.45 26.7 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.191 -1.004 . . . . 0.38 110.635 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 25' ' ' PHE . 15.3 m -109.38 134.89 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.61 -0.935 . . . . 0.40999999999999998 109.309 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 82.4 m -88.39 155.03 19.92 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.435 1.112 . . . . 0.34999999999999998 112.192 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.474 ' CE ' ' HA ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -151.21 -166.28 2.49 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.042 -0.981 . . . . 0.40999999999999998 109.834 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 21' ' ' SER . 7.3 m120 -60.6 -76.81 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.38 -0.825 . . . . 0.65000000000000002 111.348 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.464 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.187 -0.946 . . . . 1.48 111.101 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.116 0.484 . . . . 1.01 109.925 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.32 163.54 38.68 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.943 -1.263 . . . . 0.54000000000000004 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 p -153.7 168.43 26.28 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.44 110.202 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.538 ' HB ' ' HA3' ' A' ' 8' ' ' GLY . 4.7 mt -128.49 87.69 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.099 -1.001 . . . . 0.80000000000000004 110.267 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' O ' ' NZ ' ' A' ' 36' ' ' LYS . 15.6 pttp -68.42 -17.77 64.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.556 -0.715 . . . . 0.92000000000000004 111.642 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' OD1' ' HG3' ' A' ' 5' ' ' LYS . 5.7 m120 -97.42 51.37 1.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.198 -0.939 . . . . 0.76000000000000001 111.083 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.21 55.25 1.86 Allowed Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.072 -1.018 . . . . 0.41999999999999998 110.671 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.636 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -70.03 -170.4 8.27 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.554 -1.418 . . . . 0.41999999999999998 109.554 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -126.38 136.0 52.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.077 -1.249 . . . . 0.63 110.919 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 5.4 p -149.43 173.9 13.06 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.718 0.77 . . . . 0.28000000000000003 111.171 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 20.9 t-20 -155.62 143.44 19.76 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.436 -0.579 . . . . 0.48999999999999999 109.436 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.33 -20.71 66.16 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.409 -0.807 . . . . 0.57999999999999996 111.811 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -122.2 45.96 2.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.84 -1.163 . . . . 0.93999999999999995 111.169 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 11' ' ' ASN . . . -121.16 -71.38 0.74 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.096 -1.003 . . . . 0.63 110.722 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.69 -75.49 0.3 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 120.022 -1.085 . . . . 0.51000000000000001 110.71 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.744 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.8 Cg_endo -61.58 -37.05 72.75 Favored 'Trans proline' 0 CA--C 1.552 1.408 0 O-C-N 123.708 1.373 . . . . 0.52000000000000002 114.315 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.744 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 53.6 Cg_endo -73.94 65.82 5.03 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.168 0.738 . . . . 0.39000000000000001 110.299 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -83.4 160.13 21.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.3 -0.875 . . . . 0.40999999999999998 110.629 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 81.1 m -90.86 173.23 8.1 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 111.402 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -78.47 -54.84 5.73 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.163 -0.961 . . . . 0.45000000000000001 113.023 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 37' ' ' ASN . 70.0 m -101.1 -73.36 0.65 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.014 -1.054 . . . . 0.81999999999999995 110.827 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -168.9 18.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.177 -0.952 . . . . 0.52000000000000002 112.386 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.8 t80 -117.22 144.17 45.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.524 -1.36 . . . . 0.44 110.715 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.624 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 17.6 t -152.54 108.06 3.3 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 109.521 -0.548 . . . . 0.31 109.521 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.644 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.2 t80 -95.71 90.11 5.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.101 -1.0 . . . . 0.81000000000000005 110.13 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.677 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.9 tm0? -117.98 144.83 45.19 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.397 -0.814 . . . . 0.68000000000000005 110.937 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 163.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.486 -0.759 . . . . 0.56000000000000005 110.737 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.46 0.53 57.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.5 -0.75 . . . . 0.76000000000000001 111.757 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.71 -50.85 45.36 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.642 -1.383 . . . . 0.68999999999999995 109.642 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -122.96 5.59 9.32 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -1.061 . . . . 1.0800000000000001 111.147 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.81 48.71 3.12 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.477 -0.764 . . . . 0.54000000000000004 110.764 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 15.4 p90 -138.88 144.17 39.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.442 -0.786 . . . . 0.66000000000000003 110.182 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -144.21 168.63 26.55 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.431 -1.366 . . . . 0.31 111.757 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 25' ' ' PHE . 26.9 m -123.32 134.66 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.862 -0.787 . . . . 0.44 110.201 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 77.3 m -88.78 158.21 18.23 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.796 -1.19 . . . . 0.27000000000000002 111.894 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -151.54 -162.38 1.52 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.333 -0.849 . . . . 0.45000000000000001 110.187 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.482 ' H ' ' HD3' ' A' ' 36' ' ' LYS . 7.6 m120 -69.34 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.568 -0.707 . . . . 0.54000000000000004 110.48 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.153 -0.967 . . . . 0.95999999999999996 110.408 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.857 0.361 . . . . 3.1000000000000001 110.186 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.89 85.54 0.59 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.243 -1.143 . . . . 0.71999999999999997 110.243 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 p -152.19 165.0 36.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.167 -1.196 . . . . 0.37 110.48 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 20' ' ' CYS . 30.3 mt -120.59 122.24 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 0.80000000000000004 109.433 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -52.33 -43.27 64.49 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.528 -0.732 . . . . 0.46000000000000002 111.573 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -130.42 99.96 5.19 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.514 -0.741 . . . . 1.3 110.604 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.84 68.21 0.78 Allowed Glycine 0 N--CA 1.499 2.833 0 N-CA-C 109.928 -1.269 . . . . 0.52000000000000002 109.928 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.35 172.72 14.77 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 109.551 -1.42 . . . . 0.28999999999999998 109.551 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.61 132.7 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.139 -1.212 . . . . 0.91000000000000003 110.719 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.496 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 17.2 p -150.34 -171.14 3.84 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.124 -0.985 . . . . 0.26000000000000001 111.268 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.19 138.48 11.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.703 -0.623 . . . . 0.57999999999999996 109.593 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.21 60.55 6.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.333 -0.855 . . . . 0.58999999999999997 110.276 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -136.81 -162.96 1.34 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.427 -0.796 . . . . 0.71999999999999997 110.663 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.56 101.53 13.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.165 -0.959 . . . . 0.93000000000000005 110.428 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 161.23 -72.9 0.21 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.193 -1.163 . . . . 0.51000000000000001 110.193 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.91 120.14 7.21 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.914 1.481 . . . . 0.52000000000000002 111.046 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.16 -164.52 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.945 1.497 . . . . 0.53000000000000003 110.863 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -58.05 153.09 15.23 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.286 -0.884 . . . . 1.0700000000000001 111.051 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 m -72.51 -171.87 0.87 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.26 -0.9 . . . . 0.23000000000000001 110.7 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 4' ' ' ILE . 1.8 t -70.77 -39.31 73.3 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.656 -1.278 . . . . 0.27000000000000002 112.436 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 10.1 m -101.11 -75.0 0.6 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.105 -0.997 . . . . 0.32000000000000001 109.333 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.67 ' HB3' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER -175.64 18.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.726 -0.609 . . . . 0.34999999999999998 111.92 179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 23.3 t80 -137.93 154.19 49.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.504 -1.372 . . . . 0.47999999999999998 111.791 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 41.9 t -151.33 120.62 6.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.407 -0.96 . . . . 0.32000000000000001 108.407 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.547 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 3.4 t80 -113.44 114.8 27.08 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.263 -0.898 . . . . 0.60999999999999999 110.981 -178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.524 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 41.4 tt0 -126.59 147.64 49.86 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.207 -0.933 . . . . 0.87 111.174 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.18 169.7 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.541 -0.724 . . . . 0.72999999999999998 110.892 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.05 155.32 26.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.486 -0.759 . . . . 1.01 111.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.54 -47.33 1.03 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.472 -1.851 . . . . 0.97999999999999998 108.472 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -138.37 -2.94 1.76 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.761 -0.846 . . . . 1.47 111.9 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t 64.96 51.98 1.64 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.012 -1.055 . . . . 0.72999999999999998 110.15 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -126.06 134.53 51.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.339 -0.851 . . . . 0.67000000000000004 110.969 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 25' ' ' PHE . . . -121.61 149.5 17.21 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.007 -1.237 . . . . 0.53000000000000003 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 25' ' ' PHE . 27.4 m -117.29 139.13 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.274 -1.133 . . . . 0.46000000000000002 110.007 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 75.2 m -88.15 156.64 19.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.889 -1.132 . . . . 0.23000000000000001 111.1 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.523 ' HB2' ' HD2' ' A' ' 23' ' ' TYR . 8.8 mmtt -148.92 179.64 7.71 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.862 -0.608 . . . . 0.47999999999999998 110.458 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 17.9 m-80 -55.73 -63.63 1.11 Allowed 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.479 -0.763 . . . . 0.63 110.369 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.67 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.475 -0.766 . . . . 0.46999999999999997 110.549 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.004 0.431 . . . . 1.0900000000000001 110.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -66.39 119.78 13.64 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.518 -1.433 . . . . 1.26 109.518 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.9 p -107.25 143.49 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.402 -1.058 . . . . 0.51000000000000001 110.45 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.496 HG21 ' CA ' ' A' ' 8' ' ' GLY . 48.1 mm -107.41 130.95 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.36 -0.838 . . . . 0.56000000000000005 109.556 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -71.62 -39.16 70.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.427 -0.796 . . . . 0.65000000000000002 111.671 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.7 133.24 15.66 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.359 -0.838 . . . . 0.57999999999999996 111.517 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.53 34.24 54.43 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.931 -0.868 . . . . 0.58999999999999997 110.931 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -87.41 -153.16 24.41 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.274 -1.13 . . . . 0.45000000000000001 110.274 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 tpp180 -140.68 121.64 14.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -1.05 . . . . 0.70999999999999996 109.989 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 11.4 p -151.51 -168.55 3.12 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.116 -0.99 . . . . 0.32000000000000001 111.31 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 0.7 OUTLIER -140.86 157.6 45.15 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.493 -0.754 . . . . 0.52000000000000002 109.63 179.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.67 -51.69 66.4 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.357 -0.839 . . . . 0.54000000000000004 109.765 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 p -101.78 44.57 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.46 -0.775 . . . . 1.0700000000000001 109.692 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.597 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -83.47 128.49 34.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.332 -0.855 . . . . 0.76000000000000001 110.916 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.18 -84.34 1.22 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.168 -1.573 . . . . 0.58999999999999997 109.168 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.0 Cg_endo -64.96 -34.2 48.74 Favored 'Trans proline' 0 CA--C 1.555 1.535 0 O-C-N 123.79 1.416 . . . . 0.75 113.674 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 50.6 Cg_endo -83.76 64.24 7.31 Favored 'Trans proline' 0 N--CA 1.486 1.044 0 CA-C-N 118.912 0.647 . . . . 0.5 110.511 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -91.52 163.99 13.95 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.241 -0.912 . . . . 0.87 110.994 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 85.9 m -90.28 170.86 9.91 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.023 -1.048 . . . . 0.26000000000000001 111.292 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' HB2' ' N ' ' A' ' 4' ' ' ILE . 2.0 t -92.08 -39.08 11.82 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.287 -0.883 . . . . 0.40000000000000002 111.466 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 36' ' ' LYS . 37.3 m -84.75 -0.14 52.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.275 -0.891 . . . . 0.81000000000000005 110.463 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 21' ' ' SER . 5.2 t 83.68 -3.17 1.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.002 -0.436 . . . . 0.65000000000000002 111.907 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.563 ' HB2' ' HA ' ' A' ' 38' ' ' ARG . 46.8 t80 -101.33 151.33 22.03 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.422 -1.424 . . . . 0.38 110.419 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.8 t -151.26 118.5 5.96 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.794 -0.566 . . . . 0.28999999999999998 110.803 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.3 t80 -104.72 94.71 5.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.328 -0.857 . . . . 0.62 110.227 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.669 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.4 tm0? -120.05 144.94 47.3 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.366 -0.834 . . . . 0.40999999999999998 110.454 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.563 HD13 ' N ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -114.26 170.06 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.408 -0.807 . . . . 0.87 110.615 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 154.65 19.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.55000000000000004 110.705 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.64 -43.68 1.43 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 109.133 -1.587 . . . . 0.5 109.133 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.92 -3.79 2.5 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.74 -0.859 . . . . 0.79000000000000004 111.539 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.9 50.94 3.06 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.149 -0.97 . . . . 0.40000000000000002 110.31 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 13.2 p90 -128.33 131.96 48.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.331 -0.856 . . . . 0.83999999999999997 110.269 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.669 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -140.94 172.73 23.55 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.903 -1.141 . . . . 0.33000000000000002 111.194 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.6 m -129.57 148.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.586 -0.95 . . . . 0.35999999999999999 110.523 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 59.2 m -89.23 153.84 20.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.742 -1.224 . . . . 0.27000000000000002 111.813 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.97 -171.78 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.344 -0.843 . . . . 0.45000000000000001 110.068 178.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -55.23 -80.79 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.725 -0.61 . . . . 0.70999999999999996 111.24 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HA ' ' HB2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 1.75 110.713 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 109.911 -0.403 . . . . 1.3 109.911 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.69 154.88 26.24 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.282 -1.527 . . . . 0.77000000000000002 109.282 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.09 150.07 21.85 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.19 -1.182 . . . . 0.58999999999999997 110.634 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.507 HG21 ' CA ' ' A' ' 8' ' ' GLY . 3.0 mt -108.48 122.44 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.65000000000000002 110.021 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -67.52 -48.78 66.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.526 -0.734 . . . . 0.88 110.989 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -143.62 128.28 18.16 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.053 -1.03 . . . . 0.71999999999999997 111.185 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.94 24.46 27.39 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.629 -0.988 . . . . 0.56999999999999995 110.629 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.507 ' CA ' HG21 ' A' ' 4' ' ' ILE . . . -84.83 -153.06 18.47 Favored Glycine 0 N--CA 1.498 2.795 0 O-C-N 121.059 -1.26 . . . . 0.37 110.304 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.523 ' NH2' HG12 ' A' ' 34' ' ' VAL . 0.7 OUTLIER -141.19 129.8 22.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.56999999999999995 110.468 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.1 p -151.7 -178.44 6.72 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.114 -0.991 . . . . 0.32000000000000001 111.126 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' HA ' ' CG ' ' A' ' 26' ' ' GLN . 2.6 p-10 -166.41 -169.91 1.52 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.691 -0.63 . . . . 0.56000000000000005 110.656 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.04 60.45 5.48 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.177 -0.952 . . . . 0.76000000000000001 110.406 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.3 m -144.91 133.66 22.28 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.036 -1.04 . . . . 0.84999999999999998 110.228 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.56 108.83 20.17 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.296 -0.877 . . . . 1.1100000000000001 110.663 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 170.61 -128.01 1.56 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.032 -1.227 . . . . 0.78000000000000003 110.032 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.65 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 38.1 Cg_endo -65.85 -31.56 47.65 Favored 'Trans proline' 0 CA--C 1.555 1.556 0 O-C-N 123.716 1.377 . . . . 0.87 114.35 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.65 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 55.2 Cg_endo -77.69 59.27 6.74 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 118.97 0.668 . . . . 0.94999999999999996 111.793 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -108.25 146.6 32.61 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 0.68999999999999995 110.487 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 74.1 m -90.32 170.56 10.16 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.28999999999999998 110.452 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -91.54 -47.35 7.46 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.036 -1.04 . . . . 0.47999999999999998 112.554 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -87.95 10.01 20.28 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.132 -0.98 . . . . 0.46999999999999997 112.256 -177.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' A' ' 21' ' ' SER . 23.2 t 84.27 -5.04 1.06 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 121.885 -0.509 . . . . 0.41999999999999998 112.289 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.695 ' CD1' ' HB2' ' A' ' 36' ' ' LYS . 18.1 t80 -96.04 146.01 24.98 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.069 -1.644 . . . . 0.41999999999999998 110.743 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -151.04 112.14 4.33 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.085 0.469 . . . . 0.28999999999999998 110.213 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.786 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.5 t80 -99.61 86.36 3.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.427 -0.796 . . . . 0.51000000000000001 110.345 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.527 ' CA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.18 149.55 41.54 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.464 -0.773 . . . . 0.42999999999999999 110.115 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.435 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -109.11 165.42 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.233 -0.917 . . . . 0.55000000000000004 111.009 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.1 35.32 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.512 -0.743 . . . . 0.68999999999999995 110.976 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.47 -55.37 0.49 Allowed Glycine 0 N--CA 1.497 2.76 0 N-CA-C 109.046 -1.622 . . . . 0.58999999999999997 109.046 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -122.74 0.21 9.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.678 -0.895 . . . . 1.3600000000000001 111.398 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.43 54.45 1.96 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.149 -0.969 . . . . 0.35999999999999999 110.063 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 30' ' ' GLN . 33.0 p90 -139.2 138.61 37.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.431 -0.793 . . . . 0.55000000000000004 110.628 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA3' ' CA ' ' A' ' 26' ' ' GLN . . . -159.82 -166.17 18.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 120.124 -1.036 . . . . 0.26000000000000001 110.982 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.786 HG22 ' HB3' ' A' ' 25' ' ' PHE . 11.6 m -132.73 143.89 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.673 -0.898 . . . . 0.34999999999999998 110.268 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 79.3 m -88.67 156.81 18.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.753 -1.217 . . . . 0.31 110.817 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.695 ' HB2' ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -151.12 -167.14 2.72 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.268 0.556 . . . . 0.67000000000000004 111.174 -179.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' A' ' 21' ' ' SER . 10.4 m120 -68.4 -89.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.701 -0.624 . . . . 0.81000000000000005 111.402 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.583 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 2.3 tpm_? . . . . . 0 N--CA 1.486 1.359 0 O-C-N 120.439 -1.413 . . . . 0.55000000000000004 111.666 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 120.942 0.401 . . . . 3.4700000000000002 110.968 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.08 115.42 6.47 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.875 -1.29 . . . . 2.2999999999999998 109.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 20' ' ' CYS . 19.1 p -126.27 165.99 17.94 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.42 -1.047 . . . . 1.0900000000000001 110.351 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' CYS . 41.7 mm -106.63 123.97 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.377 -0.827 . . . . 0.76000000000000001 110.326 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -55.12 -44.99 75.51 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.345 -0.847 . . . . 0.45000000000000001 110.57 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.605 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -150.44 127.28 11.03 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.48999999999999999 110.855 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.83 32.5 7.96 Favored Glycine 0 N--CA 1.498 2.817 0 N-CA-C 110.452 -1.059 . . . . 0.60999999999999999 110.452 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -86.92 -156.42 29.19 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.44 -1.464 . . . . 0.46999999999999997 109.44 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.03 122.92 18.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 1.46 110.339 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.0 p -151.08 176.15 11.43 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.109 -0.995 . . . . 0.39000000000000001 111.53 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.82 172.35 7.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.889 -0.507 . . . . 0.46000000000000002 110.448 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.09 -44.84 83.54 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.501 -0.749 . . . . 0.51000000000000001 111.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.49 81.97 7.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.174 -0.954 . . . . 1.1799999999999999 109.64 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 17' ' ' PRO . . . -129.79 -70.92 0.62 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.82999999999999996 111.025 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' C ' ' HD2' ' A' ' 17' ' ' PRO . . . 94.0 -111.08 4.08 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.988 -1.245 . . . . 0.83999999999999997 109.988 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 37.9 Cg_endo -65.02 -33.41 51.14 Favored 'Trans proline' 0 CA--C 1.554 1.486 0 O-C-N 123.696 1.366 . . . . 1.1499999999999999 114.107 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.0 Cg_endo -76.51 76.28 4.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 118.889 0.639 . . . . 0.80000000000000004 110.578 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -89.59 173.69 8.17 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.201 -0.937 . . . . 0.87 110.914 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 88.8 m -76.74 -178.66 4.92 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.927 -1.108 . . . . 0.37 110.829 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 4' ' ' ILE . 1.3 t -89.23 -36.85 15.39 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.522 -1.361 . . . . 0.60999999999999999 112.942 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.617 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 28.2 t -109.9 -75.39 0.63 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.984 -1.072 . . . . 0.56000000000000005 110.526 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.512 ' OG ' ' NH2' ' A' ' 38' ' ' ARG . 29.8 t -170.46 25.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.52000000000000002 112.154 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.562 ' HD2' ' CB ' ' A' ' 36' ' ' LYS . 3.3 t80 -135.4 150.29 49.85 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.348 -1.47 . . . . 0.39000000000000001 112.08 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 36.9 t -150.34 106.15 3.42 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.799 -0.815 . . . . 0.33000000000000002 108.799 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 34' ' ' VAL . 3.4 t80 -91.68 90.59 7.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.298 -0.876 . . . . 0.57999999999999996 110.344 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.584 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -119.69 147.74 44.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.48 -0.763 . . . . 0.5 110.16 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -113.77 164.93 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.24 -0.912 . . . . 0.59999999999999998 111.103 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.5 143.78 28.33 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.493 -0.754 . . . . 0.79000000000000004 111.279 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.95 -52.54 0.7 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 108.693 -1.763 . . . . 0.62 108.693 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 3.5 tt0 -131.57 -3.27 3.76 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.668 -0.901 . . . . 1.8300000000000001 111.579 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 30' ' ' GLN . 0.2 OUTLIER 70.61 60.46 0.21 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.318 -0.864 . . . . 0.39000000000000001 110.189 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 32.2 p90 -144.55 146.12 32.19 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.82 . . . . 1.0700000000000001 110.936 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 26' ' ' GLN . . . -167.16 -157.36 10.52 Favored Glycine 0 N--CA 1.498 2.81 0 C-N-CA 120.252 -0.975 . . . . 0.34000000000000002 110.712 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 25' ' ' PHE . 33.4 m -141.98 145.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.518 -0.99 . . . . 0.48999999999999999 110.901 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.492 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 98.2 m -88.99 158.67 17.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.897 -1.127 . . . . 0.34000000000000002 110.85 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -151.83 179.2 8.64 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.534 -0.757 . . . . 0.54000000000000004 110.471 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.617 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 4.5 m120 -63.02 -61.71 2.2 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.365 -0.834 . . . . 0.46000000000000002 110.168 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' NH2' ' OG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 O-C-N 121.656 -0.653 . . . . 0.55000000000000004 110.374 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.158 0.504 . . . . 1.1399999999999999 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.33 163.22 38.92 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.736 -1.346 . . . . 0.42999999999999999 109.736 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p -162.85 175.21 11.47 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.398 -1.06 . . . . 0.33000000000000002 110.721 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.36 120.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.239 -0.913 . . . . 0.46999999999999997 110.435 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.78 -29.5 70.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.527 -0.733 . . . . 0.47999999999999998 111.318 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.51 121.86 10.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.093 -1.004 . . . . 0.57999999999999996 111.082 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.47 25.04 37.33 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 120.386 -0.911 . . . . 0.35999999999999999 110.875 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -73.62 -160.67 6.5 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.838 -1.305 . . . . 0.35999999999999999 109.838 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -137.87 124.21 20.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.003 -1.292 . . . . 0.54000000000000004 110.622 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 10.9 p -150.55 -180.0 7.7 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.227 -0.92 . . . . 0.28999999999999998 111.183 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -160.21 -169.91 2.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.547 . . . . 0.58999999999999997 110.652 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.07 56.86 1.04 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.326 -0.859 . . . . 0.64000000000000001 110.835 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.3 t -149.1 132.52 16.61 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.198 -0.939 . . . . 1.4099999999999999 110.659 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.89 89.69 4.96 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.397 -0.814 . . . . 2.1099999999999999 110.735 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.51 -119.99 0.51 Allowed Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.323 -1.511 . . . . 0.75 109.323 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.728 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 36.4 Cg_endo -63.6 -33.15 68.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.795 1.418 . . . . 0.67000000000000004 113.217 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.728 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 56.0 Cg_endo -82.14 58.58 6.7 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 CA-C-N 118.946 0.659 . . . . 0.72999999999999998 110.439 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -96.58 148.55 22.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.068 -1.02 . . . . 0.45000000000000001 110.155 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 84.4 m -87.05 178.37 6.94 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.25 110.894 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.62 -43.18 10.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.075 -1.016 . . . . 0.33000000000000002 112.793 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.588 ' CB ' ' HA ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -107.46 -73.23 0.69 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.078 -1.014 . . . . 1.22 110.632 -179.136 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.406 ' HB3' ' HD3' ' A' ' 38' ' ' ARG . 1.2 m -171.17 15.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.356 -0.84 . . . . 0.39000000000000001 112.453 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.76 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 18.1 t80 -119.15 147.64 43.96 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.358 -1.464 . . . . 0.39000000000000001 110.654 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 34.9 t -151.86 106.17 3.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.99 -0.444 . . . . 0.27000000000000002 109.933 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' A' ' 34' ' ' VAL . 4.4 t80 -97.9 91.12 5.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.071 -1.018 . . . . 0.68000000000000005 110.422 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.548 ' HA ' ' CA ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -116.85 149.12 40.55 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.89000000000000001 110.577 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.413 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -119.86 162.18 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.393 -0.817 . . . . 0.58999999999999997 110.507 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.28 154.65 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.522 -0.736 . . . . 0.80000000000000004 111.107 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 126.4 -43.95 1.3 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.269 -1.532 . . . . 0.68000000000000005 109.269 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.583 ' HB3' ' CD1' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -143.47 5.2 1.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.634 -0.921 . . . . 1.47 112.487 -179.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 30' ' ' GLN . 7.1 t 61.08 51.1 4.6 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.147 -0.971 . . . . 0.60999999999999999 109.684 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 30' ' ' GLN . 27.3 p90 -132.03 137.74 47.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.449 -0.782 . . . . 0.80000000000000004 110.649 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.548 ' CA ' ' HA ' ' A' ' 26' ' ' GLN . . . -156.18 -167.68 17.91 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.584 -1.006 . . . . 0.25 110.584 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 25' ' ' PHE . 34.0 m -135.27 138.5 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.839 -0.801 . . . . 0.38 110.894 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 71.2 m -88.81 159.08 17.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.958 -1.089 . . . . 0.23999999999999999 111.863 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.592 ' CB ' ' HB3' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -151.39 -167.07 2.69 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.315 -0.857 . . . . 0.33000000000000002 110.458 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.588 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 14.5 m120 -75.51 -76.01 0.16 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.364 -0.835 . . . . 0.40999999999999998 111.447 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.76 ' HB2' ' HB2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.556 0 C-N-CA 122.436 0.294 . . . . 0.5 110.536 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 120.949 0.404 . . . . 0.52000000000000002 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.32 149.67 47.47 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.439 -1.465 . . . . 0.55000000000000004 109.439 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 1.8 p -70.02 138.81 52.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.196 -1.179 . . . . 0.34000000000000002 110.602 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.412 HD13 ' HA2' ' A' ' 8' ' ' GLY . 2.2 mt -106.96 126.86 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.54000000000000004 110.401 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -89.49 -18.48 26.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.621 -0.675 . . . . 1.25 111.017 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 36' ' ' LYS . 9.1 t30 -149.81 113.61 5.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.188 -0.945 . . . . 0.5 110.448 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.2 33.14 15.16 Favored Glycine 0 N--CA 1.499 2.865 0 O-C-N 121.187 -0.946 . . . . 0.33000000000000002 110.845 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 34' ' ' VAL . . . -75.12 -167.58 20.94 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.081 -1.608 . . . . 0.25 109.081 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -140.34 114.06 8.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.071 -1.252 . . . . 0.67000000000000004 110.784 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 p -135.56 176.67 8.47 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.195 -0.941 . . . . 0.28999999999999998 111.222 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.575 ' HA ' ' HG3' ' A' ' 26' ' ' GLN . 28.4 t-20 -161.19 -141.88 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.196 -0.668 . . . . 0.69999999999999996 109.196 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.78 -26.81 25.51 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.907 -1.12 . . . . 0.56999999999999995 110.158 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.3 t -126.83 -166.52 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.393 -0.817 . . . . 0.75 110.024 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.11 -52.62 7.18 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.245 -0.91 . . . . 0.46000000000000002 110.817 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.96 172.39 39.2 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.955 -1.258 . . . . 0.32000000000000001 109.955 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.718 ' HG2' ' HD3' ' A' ' 17' ' ' PRO . 35.3 Cg_endo -61.78 -33.4 85.28 Favored 'Trans proline' 0 CA--C 1.551 1.373 0 O-C-N 123.511 1.269 . . . . 0.39000000000000001 113.302 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.718 ' HD3' ' HG2' ' A' ' 16' ' ' PRO . 52.7 Cg_endo -96.49 40.62 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 120.943 1.096 . . . . 0.32000000000000001 109.88 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -53.58 164.29 0.54 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 122.023 0.916 . . . . 0.56000000000000005 112.185 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 3.9 m -73.36 160.42 31.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.389 -0.819 . . . . 0.23000000000000001 110.155 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 3' ' ' CYS . 6.9 t -90.45 -44.19 9.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.074 -1.016 . . . . 0.28999999999999998 112.127 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 p -99.28 -72.27 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.301 -0.874 . . . . 0.27000000000000002 109.965 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -173.37 13.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 112.895 0.702 . . . . 0.35999999999999999 112.895 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 15.1 t80 -103.64 141.51 35.91 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.01 -1.681 . . . . 0.33000000000000002 110.856 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 5.5 t -152.2 106.99 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 116.008 -0.542 . . . . 0.23999999999999999 109.981 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.547 ' HB3' ' CG2' ' A' ' 34' ' ' VAL . 4.6 t80 -92.47 88.37 6.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.075 -1.016 . . . . 0.59999999999999998 110.36 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.605 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -113.61 149.52 34.44 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.479 -0.763 . . . . 0.55000000000000004 110.91 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -125.86 162.82 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.464 -0.772 . . . . 0.58999999999999997 111.029 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.18 14.69 11.9 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.505 -0.747 . . . . 0.84999999999999998 112.066 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.17 -53.54 4.14 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.826 -1.309 . . . . 0.69999999999999996 109.826 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -121.24 7.51 10.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.563 -0.963 . . . . 2.25 111.707 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t 65.99 54.5 1.0 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.279 -0.888 . . . . 0.67000000000000004 109.769 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -148.51 149.08 31.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.339 -0.851 . . . . 0.66000000000000003 110.675 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 26' ' ' GLN . . . -148.78 168.95 29.31 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.174 -1.013 . . . . 0.29999999999999999 110.988 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 18.3 m -128.71 133.31 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.54 -0.976 . . . . 0.35999999999999999 110.126 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 75.7 m -87.21 159.53 18.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.20000000000000001 111.739 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -150.64 174.71 12.69 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.349 -0.842 . . . . 0.45000000000000001 110.852 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -66.1 -64.54 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.53000000000000003 109.827 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.854 -0.529 . . . . 0.60999999999999999 110.245 179.536 . . . . . . . . 1 1 . 1 stop_ save_